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Abstract 
 
An individual’s rate of age-related cognitive decline and risk for later-life dementia is 
influenced by environmental and genetic factors. One protective environmental factor that 
may mitigate cognitive decline is cognitive reserve (CR) and is generated by participation in 
tasks that involve complex cognitive engagement. Two genes that may influence CR through 
their associations with synaptic plasticity are apolipoprotein E (APOE) and brain-derived 
neurotrophic factor (BDNF). Participants from the on-going Tasmanian Healthy Brain 
Project, a longitudinal investigation into whether an intervention of later-life tertiary 
education increases CR, contributed to the data analysed in this thesis.  It was aimed: to 
develop two operational measures of CR; to quantify the cognitive implications of variation in 
APOE and BDNF Val66Met; and to detect genetic interactions with CR. Comprehensive 
neuropsychological assessments were conducted as part of the baseline testing for Tasmanian 
Healthy Brain Project participants. APOE and BDNF Val66Met polymorphisms were 
determined through analysis of saliva samples. The statistical analyses yielded three main 
results. First, factor analysis was successful in identifying latent variables in both prior and 
current models of CR. Second, while variation in APOE or BDNF did not produce significant 
main effects in any assessed cognitive domain, an APOE x BDNF interaction was present in 
episodic memory function. Third, BDNF moderated the association between CR and 
executive function, with a significantly reduced association between the variables present in 
BDNF Met carriers. Overall, this investigation developed a method of assessing CR that can 
provide a comprehensive estimate of an individual’s CR and furthered knowledge on the 
effect single genes exert on healthy cognitive function. The most important finding to emerge 
was a CR x BDNF interaction in cognitive function, which suggests that CR-based 
interventions aimed at delaying dementia onset may have a higher efficacy in BDNF Val 
homozygotes than in BDNF Met carriers.  
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Introduction 
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Australia’s ageing population is typical of most developed countries. Over the previous 100 
years, average life expectancy in Australia has increased by 24 years for males and 25 years 
for females, mainly due to reduced mortality rates as a result of medical, public health and 
social advances (ABS, 2010a). Consequently, the average life expectancy of a child born in 
1901 was 55.2 years for males and 58.8 years for females and has increased for a child born 
in 2006 to 78.7 years for males and to 83.5 years for females (ABS, 2010a). Not only are 
Australians living longer, but the overall Australian population is also ageing proportionately, 
with the proportion of Australians aged 65 years and over increasing from 4% in 1901 to 
13.5% in 2010 (ABS, 2010a). 
 
The trend towards a progressively older Australia is not likely to halt, with the proportion of 
65-85 year olds estimated to double, and the proportion of those aged 85 years and over 
expected to quadruple, by 2050 (ABS, 2011). Notably, the growth in older Australians will 
not be linear; the proportion of Australians aged over 65 years will increase from 13% in 
2007 to 25% in 2050 (ABS, 2008). The significance of Australia’s ageing population is 
pertinent when the rates of disability are considered, with 88% of Australians aged 90 years 
or older reporting a disability in 2011 (ABS, 2011). If similar rates of age-related disability 
are observed in the coming years, a greater proportion of Australians will be living with a 
disability over time. Such conclusions partially account for the projected increase in aged-
care-related spending by the Australian government, from 0.8% of GDP in 2010 to 1.8% of 
GDP by 2050 (Australian Government, 2010).  
 
One of the major causes of death and disability in older Australians is dementia (ABS, 2010b; 
Mathers, Vos, Stevenson, & Begg, 2001), with the incidence of dementia in Australia 
expected to rise from 266,574 in 2010 to 942,624 by 2050 (Access Economics, 2011). As 
Alzheimer’s disease (AD) accounts for 50-70% of dementia cases (Hardy, 1997), a 
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considerable amount of research has been undertaken to identify psychosocial or 
pharmacological treatments that can halt or slow the progression of AD. If an intervention is 
successful in delaying the average onset of AD by five months, the incidence of new AD 
cases would be reduced by 5% per year (Access Economics, 2004). Similarly, a reduction in 
the incidence of AD would correspond to a reduction in the mortality attributable to AD 
(James et al., 2014). Recent reports have indicated that potentially modifiable risk factors, 
such as low education, may account for between a third (Norton, Matthews, Barnes, Yaffe, & 
Brayne, 2014) to a half (Barnes & Yaffe, 2011) of all dementia cases. 
 
With a high degree of importance placed upon research into AD and other dementing 
illnesses, an often overlooked population are those ageing older Australians who do not 
develop dementia, but who will have to cope with non-pathological reductions in cognitive 
function associated with normal ageing. This demographic, as with that of dementia sufferers, 
is expected to rise considerably over the next 50 years (Access Economics, 2011). 
 
Healthy ageing 
 
Ageing is a complex biological process. With increasing age, the deterioration of 
physiological function and increasing vulnerability occurs (De Magalhaes, 2011). In addition 
to reductions in physiological function, cells in all regions of the nervous system are affected 
by ageing (Hofer, Berg, & Era, 2003) and the organism’s ability to maintain cellular 
homeostasis is progressively impeded (Kowald, 2002). This leads to normal age-related 
declines in many cognitive domains, but not all (Deary et al., 2009). A contentious feature of 
ageing is that it is non-pathological, and normal ageing has been defined as the absence of an 
increase number of conditions (Brayne, 2007), while others note that the absence of illness 
and accidents allows the ageing process to occur naturally (Hansen-Kyle, 2005). This 
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distinction between normal ageing-related decline and pathology-induced decline is crucial 
for elucidating ageing processes and consideration of both processes separately defines the 
two-component model of ageing (Hedden & Gabrieli, 2004). 
 
Cognitive ageing 
 
Other than age-related conditions affecting physical function, reports of cognitive difficulties 
associated with increasing age are common. Certainly, an inevitable and gradual reduction in 
cognitive and mental capacities is associated with growing older (Salthouse, 2012; 2009). An 
important feature of cognitive ageing is that decline in cognitive function is not uniform 
across different cognitive domains. For example, while it is well established that general 
memory performance declines with age (Small, Stern, Tang, & Mayeux, 1999), not all 
components of memory are affected equally (Craik & McDowd, 1987). Although cross-
sectional and longitudinal experiments report different patterns of cognitive decline onset and 
severity (Salthouse, 2009; Schaie, 1996), results from both methodologies show some 
overlap. Typically, age-related cognitive decline is observed in the capacity for episodic 
memory, working memory, and processing speed, whereas cognitive stability is generally 
observed among short-term memory, semantic knowledge, autobiographical memory, and 
emotional processing (Hedden & Gabrieli, 2004; Hoogendam, Hofman, Geest, Lugt, & 
Ikram, 2014). 
 
Selective cognitive functions display decline across the lifespan, beginning early in adulthood 
(Salthouse, 2009). An early review identified robust age-related decline to working memory, 
processing speed, and episodic memory encoding (Craik, 1994) and has been supported by 
subsequent studies (Park et al., 2002; 1996; Schaie, 1996). For example, a cross-sectional 
investigation of 301 participants, aged 20-90 years, reported significant linear life-long 
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decline in the three cognitive domains reported by Craik, after having matched participants 
for education, health, and demographic variables (Park et al., 1996). Significantly, an 
interrelationship was identified between processing speed, working memory performance, and 
other memory tasks, indicating that the efficacy of these processes was a significant predictor 
of age-related decline in memory function, a result confirmed in a later study (Park et al., 
2002). Cross-sectional data from the Seattle Longitudinal Study also identified linear age-
related declines in processing speed, episodic memory, spatial ability, and reasoning (Schaie, 
1996). 
 
Although cross-sectional designs indicate life-long decline in some cognitive processes 
begins in early adulthood, longitudinal investigations tend to describe a later onset of decline. 
In addition to examining cross-sectional effects, the main longitudinal analyses from the 
Seattle Longitudinal Study reported no decline in verbal ability, inductive reasoning, numeric 
ability, verbal memory, and spatial orientation until the age of 60, after which, a curvilinear 
decline became apparent, with the rate of decline increasing with age (Schaie, 1996). Notably, 
processing speed showed steady and linear decline from the age of 25, consistent with cross-
sectional results.  
 
Age-related decline in well-practiced or knowledge-based tasks is minimal until very late-life 
(70+ years of age; Hedden & Gabrieli, 2004). In one cross-sectional study, verbal knowledge, 
a composite score composed from Shipley vocabulary, synonym vocabulary, and antonym 
vocabulary, showed slight improvements throughout life until decline began at age 70 (Park 
et al., 2002). Similarly, in both longitudinal and cross-sectional analyses from the Seattle 
Longitudinal Study, measures of verbal ability and semantic knowledge remained stable until 
very late in life (Schaie, 1996). For short-term memory, slight, but uniform, age-related 
decline was present in both forward and backward digit span, with the onset of accelerated 
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decline at age 70 (Gregoire & Van Der Linden, 1997). The very late-life declines in verbal 
ability, semantic knowledge, and short-term memory have been attributed to disease 
processes, with the suggestion that pathology-free ageing may result in either no late-life 
decline, or a more linear decline (Hedden & Gabrieli, 2004). 
 
Ageing is commonly thought to be associated with universal cognitive decline, but some 
processes show patterns of stability over time. For example, implicit memory, or memory that 
is measured indirectly, shows minimal age-related reduction (La Voie & Light, 1994). 
Defined as the unconscious influence of previously encountered information on subsequent 
performance (Hedden & Gabrieli, 2004), implicit memory is an automatic memory process 
(Hasher & Zacks, 1979) and consequently should show minimal age-related decline. A meta-
analysis of adult age differences in repetition priming, a method of assessing implicit 
memory, found no or minimal age-related change (La Voie & Light, 1994). Similarly, the 
processing of emotional information does not decline with age. Here, older adults are better at 
remembering emotional information, particularly positive memories (Charles, Mather, & 
Carstensen, 2003), and report less anxiety and depression (Jorm et al., 1998a), relative to 
younger adults. 
 
Overall, despite disparities in the conclusions drawn from cross-sectional and longitudinal 
investigations, some broad patterns emerge. Measures of acquired knowledge tend to increase 
until 60 years of age and decline thereafter, whereas measures of efficiency or effectiveness 
of processing show a linear decline from early adulthood (Salthouse, 2011).  
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Age-related neural changes 
 
The divergent patterns of age-related decline for separate cognitive processes indicate the 
potential selective vulnerability of specific neural circuits underlying these cognitive 
processes. With advances in brain-imaging techniques such as structural (MRI) and functional 
(fMRI) magnetic resonance imaging, and positron emission tomography (PET), it is now 
possible to quantify the brain’s response to advancing age for discrete cognitive tasks in vivo. 
Structural MRI captures high resolution images that have been widely used to study anatomy 
and function (Cheng et al., 2006). When the voxel based morphometric analytic method is 
applied to MRI data, grey and white matter volume and density can be assessed (Ashburner & 
Friston, 2000). Both fMRI and PET assess neural activity during cognitive tasks and, while 
their temporal resolution is limited by the slow hemodynamic response, both methods can be 
used to identify neural networks responsible for cognitive processing (Cabeza & Nyberg, 
2000).  
 
Increasing age is associated with a progressive decline in whole-brain volume, in addition to 
the heightened vulnerability of specific brain regions (Kruggel, 2006). In addition to age-
related differences in overall brain structures, grey matter and white matter have both shown 
differential ageing effects. For instance, whole-brain white matter increases linearly in 
volume until mid-life, after which an accelerated decline takes place, while whole-brain grey 
matter declines linearly with age beginning in early adulthood (Allen, Bruss, Brown, & 
Damasio, 2005; Sowell et al., 2003). Although the associations between regional volumes and 
cognitive functions tend to be weak to moderate, the strength of such correlations appears to 
increase with age (Greenwood, 2007).     
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Frontal lobe 
 
Frontal cortices, as well as the hippocampus, have been found to show the greatest volumetric 
declines with age (Raz et al., 2005; Tisserand et al., 2002), particularly when compared to the 
relatively spared temporal and occipital lobes (Resnick, Pham, Kraut, Zonderman, & 
Davatzikos, 2003). Age-related cortical volume loss in the prefrontal cortex (PFC) has been 
estimated at about 5% per decade after the age of 20 (Raz et al., 2004), with the lateral 
structures undergoing the greatest volumetric declines with age (Tisserand et al., 2002). A 
longitudinal investigation estimated annual rates of volume loss in the lateral PFC at 0.91% 
and in the orbitofrontal PFC at 0.85% (Raz et al., 2005). Cortical thickness of the PFC also 
significantly declines with age, first evident in mid-life, while temporal and parahippocampal 
corticies remain intact (Salat et al., 2004).  
 
A number of investigations have related these frontal volumetric effects to cognitive 
performance. Age-related shrinkage of the PFC has been associated with an increase in 
perseverative errors, reflecting a reduced control of executive functions (Raz, Gunning-
Dixon, Head, Dupuis, & Acker, 1998). In support, one investigation reported that smaller 
frontal lobe volume, particularly white matter, was associated with a greater decline in 
executive functioning at one-year follow-up (Cardenas et al., 2011). Prefrontal volume has 
also been positively associated with fluid intelligence (Godfrey et al., 2000). Similarly, 
accuracy during a fast working memory task, a cognitive process associated with intelligence, 
was positively associated with grey matter volume of the right dorsolateral PFC (Takeuchi et 
al., 2012). Frontal regions have also been implicated in visual memory, with a positive 
association of left orbital PFC volume and performance (Steffens, McQuoid, Welsh-Bohmer, 
& Krishnan, 2003). The cognitive implications of variation in PFC volume are not limited to 
simple effects on performance, with PFC white matter volume negatively associated with 
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within-person variability in choice-reaction time and dorsolateral PFC volume negatively 
associated with within-person variability in episodic memory (Lövdén et al., 2013). Finally, 
atrophy and reduced PFC volume is strongly associated with dementia, and may predict 
clinical symptoms more sensitively than atrophy of the medial temporal lobe (Burgmans et 
al., 2009). 
 
Although neuronal death was once erroneously considered to account for age-related declines 
in cortical volume (Brody, 1955), the loss of neurons due to advancing age is minimal 
(Pakkenberg & Gundersen, 1997; Yankner, Lu, & Loerch, 2008). Rather, age-related volume 
loss has been attributed to, for example, dendritic and axonal pruning (Dickstein et al., 2007; 
Pannese, 2011), reductions in synaptic density (Peters, Sethares, & Luebke, 2008), white 
matter loss (Gunning-Dixon, Brickman, Cheng, & Alexopoulos, 2009), and demyelination 
(Peters, 2002). Such changes likely account for the under- and over-recruitment of cortical 
regions during cognitive processing (Grady, 2008; Kalpouzos, Persson, & Nyberg, 2012) and 
the general reduction in the coordination of brain systems that occurs with age (Bishop, Lu, & 
Yankner, 2010). Specifically, the age-related disruption in white matter integrity may explain 
the non-specific recruitment of structures that is significantly more localised in younger adults 
(Andrews-Hanna et al., 2007; Bishop et al., 2010). Overall, the associations of regional brain 
volumes with age-related cognitive deficits are likely mediated by neural dysfunction and 
changes to functional recruitment that occur with age (Grady, 2008). 
 
Functional MRI investigations have demonstrated the engagement of the PFC during the 
processing of a variety of cognitive tasks, particularly executive function, including decision-
making and working memory (Cabeza, 2002; Cabeza & Nyberg, 2000). Research indicates 
that PFC recruitment is altered with advancing age. For working memory, ageing is 
associated with an increased prefrontal activity (Fakhri, Sikaroodi, Maleki, Ali Oghabian, & 
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Ghanaati, 2012; Grady, Yu, & Alain, 2007; Mattay et al., 2006), particularly in the left PFC. 
In support, a meta-analysis of 32 fMRI studies concluded that during working memory the 
cortical engagement by older adults is characterised by increased activation in bilateral 
regions of the dorsolateral PFC, as well as supplementary motor cortex and left inferior 
parietal lobule (Turner & Spreng, 2012). For another component of executive function, 
inhibitory control, a similar increase in the recruitment of regions of the PFC is observed with 
age (Mathis, Schunck, Erb, Namer, & Luthringer, 2009; Wood, Ischebeck, Koppelstaetter, 
Gotwald, & Kaufmann, 2009). Typically, the age-related over-recruitment of cortical regions 
within the PFC is localised in areas that are either not active in, or contralateral and 
homologous to those activated in, younger individuals (Grady, 2008). 
 
It is uncertain whether increased cortical activation reflects compensatory processes or the 
non-selective recruitment of brain regions (Grady, 2008). However, the pattern of increased 
activity in older adults is often reported in those who perform better on tasks. Importantly, in 
one study the increased activity in the left inferior PFC was observed in older participants 
only during the successful encoding of information or during a working memory task with no 
evident ageing effects (Grady et al., 2007). Similarly, an age-related effect of increased 
bilateral dorsolateral PFC recruitment was present in older participants only when they 
performed similarly to the younger participants (Mattay et al., 2006). Here, older participants 
demonstrated reduced activation compared to younger when task difficulty was increased. 
Furthermore, even when activity in visual and auditory cortices is reduced in aged 
individuals, heightened activation of the PFC is still present, suggesting that the PFC may 
attempt to compensate for reduced function in other cortices (Fakhri et al., 2012).  
 
The PFC also undergoes age-related alterations in neurotransmitters. Reduced efficiency of 
the dopamine system, which plays an important role in attention and executive control of 
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memory, is evident in the PFC with advancing age (Ghosh, Agarwal, & Haggerty, 2011). 
Dopamine concentration, transporter availability, and D1, D2 and D3 receptor density have 
all been shown to decline with age (Bäckman et al., 2011; Park & Reuter-Lorenz, 2009). As 
such, it has been proposed that many of the age-related cognitive deficits can be attributed to 
loss of such receptors (Li, Lindenberger, & Sikström, 2001). Further, it has been 
demonstrated that reductions in D2 dopaminergic receptor binding explain more of the 
variance in cognitive performance across the adult lifespan than chronological age (Bäckman 
et al., 2000). One investigation determined that age-related reductions in the PFC’s capacity 
to synthesise dopamine, irrespective of cortical atrophy, were associated with reduced 
processing speed (Kalbitzer et al., 2012). Greater intra-individual variability was also 
associated with diminished D1 receptor in the dorsolateral prefrontal cortex, anterior cingulate 
gyrus, and parietal cortex, during a reaction time task (MacDonald, Karlsson, Rieckmann, 
Nyberg, & Bäckman, 2012).  
 
Rather than simply affecting cognitive performance, D1 receptor binding also alters 
functional connectivity in healthy individuals. In one study of working memory, age was 
negatively associated with load-dependent left frontal recruitment; however, once D1 binding 
was controlled for, the age-related reduction in load-dependent blood-oxygen-level dependent 
signal in the left frontal cortex was eliminated (Bäckman et al., 2011). Similarly, the use of a 
D1 antagonist induced increased frontal bilateral connectivity in healthy young adults 
(Rieckmann, Karlsson, Fischer, & Bäckman, 2012), a pattern of cortical engagement 
characteristic of older age (Cabeza, 2002). In subjects who were administered the D1 
antagonist, those who showed increased bilateral recruitment of the dorsal frontal network 
demonstrated a reduced negative effect of the dose on spatial working memory, leading the 
authors to suggest that this additional functional recruitment is consistent with the 
compensation hypothesis (Cabeza, 2001). 
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Alzheimer’s disease 
 
Although it was historically believed that AD is an inevitable, natural, consequence of the 
ageing process, a two-component model of ageing is generally accepted, in which the first 
step involves normal age-related decline in brain functioning and the second step involves 
separate, potentially avoidable, pathological changes (Ghosh et al., 2011). AD is the most 
common cause of dementia in older age (Hardy, 1997). Overall, dementia due to AD is 
characterised by early impairment to memory processes followed by an overall decline in 
global cognitive function, including executive dysfunction (Weintraub, Wicklund, & Salmon, 
2012). The pathological hallmarks of AD are the accumulation of amyloid-beta (Aβ) fibrils 
into amyloid plaques, followed by the aggregation of hyperphosphorylated intracellular tau 
protein to form neurofibrillary tangles (NFT; Vickers et al., 2000). 
 
Alzheimer’s disease pathology 
 
Consisting of fibrillar Aβ, amyloid plaques are the predominant feature of AD pathology 
(Glenner & Wong, 1984) and are derived via sequential proteolytic cleaves of the amyloid 
precursor protein (APP; Prox, Rittger, & Saftig, 2012). In the original amyloid cascade 
hypothesis, the deposition of Aβ was believed to cause neuronal dysfunction and cell death in 
the brain due to the toxic effect of the total amyloid load (Hardy & Higgins, 1992). However, 
more recent research has focused on how APP is differentially cleaved into Aβ peptides of 
different amino acid lengths (Hartmann et al., 1997). Here, Aβ peptides 42 amino acids in 
length are more likely to form into toxic insoluble fibres, which subsequently aggregate into 
amyloid plaques (Haass & Selkoe, 2007).  
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In addition to amyloid plaques, AD is characterised by aggregates of tau, a microtubule-
associated protein, that take the form of NFTs within neurons (Vickers et al., 2000). In a non-
pathological state, tau is expressed during neuronal development and becomes integrated into 
axons to maintain axon morphology (Caceres & Kosik, 1990). The formation of NFTs occur 
when tau becomes hyperphosphorylated, disassociates from the microtubules and aggregates 
into intraneuronal fibrillar inclusions (Gendron & Petrucelli, 2009). Although the formation 
of tau fibrils has been proposed to mediate the AD-related neuronal cell death, the exact 
mechanisms are unknown (Beharry et al., 2014; Chun & Johnson, 2007). Furthermore, why 
tau becomes hyperphosphorylated in AD is yet to be fully answered, but evidence suggests 
that accumulated Aβ may initiate the hyperphosphorylation process in tau (Huang & Jiang, 
2009). 
      
The toxicity of Aβ on synapses and neural networks has been established (Mucke & Selkoe, 
2012) and Aβ correlates closely with the rate of other neurodegenerative biomarkers (Hyman, 
2011). However, cognitive decline is only weakly associated with amyloid deposition (Jack et 
al., 2009). The characteristic early deficits in episodic memory are unlikely to be accounted 
for by amyloid pathology, which is typically deposited in regions comprising the default-
mode network (DMN; Weintraub et al., 2012).The DMN encompasses functionally connected 
cortical areas that project onto structures within the medial temporal lobe (MTL; Buckner, 
Andrews-Hanna, & Schacter, 2008). Rather, reductions in memory function are more likely 
due to the formation of NFT in the MTL, which interrupt the neural networks responsible for 
memory function (Braak & Braak, 1991). Relative to amyloid load, NFT density is more 
closely related to both episodic memory function and risk for developing clinical AD 
(Bennett, Schneider, Wilson, Bienias, & Arnold, 2004; Guillozet, Weintraub, Mash, & 
Mesulam, 2003).  
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Dementia risk modification 
 
An important finding that emerged from a post-mortem examination of aged-care residents 
was the identification of a group of individuals who displayed typical AD pathology yet 
retained cognitive performance similar to that of non-demented control participants (Katzman 
et al., 1988). In 137 participants, it was found that cognitively intact but pathologically 
compromised individuals had significantly higher brain weights than those that exhibited 
clinically reduced cognitive function. This led the authors to propose that there is not 
necessarily a direct relationship between neuropathological burden and cognitive outcome. 
Furthermore, the authors proposed that larger brain weight and subsequently more neurons 
confer a greater reserve that allows the extension of non-impaired function into old age 
(Katzman, 1993). 
 
Other investigations have supported the association between measurements of brain size and 
risk for dementia. For example, a cross-sectional population-based study of ageing recorded 
neurological, psychological, and anthropometric measurements for 640 participants 
(Schofield, Logroscino, Andrews, Albert, & Stern, 1997). After adjusting for age, education, 
ethnicity, gender, and height, smaller head circumference was associated with increased risk 
for AD. Similarly, AD patients with smaller head circumferences were found to have either 
had the disease longer, or progressed more rapidly, than those with larger head 
circumferences (Graves et al., 1996).  
 
More recent studies have provided support for these earlier findings. One study of AD 
patients demonstrated that participants with larger head circumferences showed a reduced 
negative association between level of brain atrophy and cognitive function, indicating a 
protective effect of brain size (Perneczky et al., 2010). Another study demonstrated that larger 
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intracranial volume was associated with a slower deterioration in cognitive function due to 
AD-related atrophy in patients with amnestic mild cognitive impairment (MCI; Guo et al., 
2012). The finding that smaller head size is related to lower early-life socioeconomic status 
provides one explanation for such findings, as such associations may reflect the detrimental 
effect of economic disadvantage on brain and skeletal development (Kim et al., 2008). 
 
Brain reserve capacity 
 
Such associations have led researchers to propose the existence of a reserve that allows 
individuals with larger brains, and, potentially more neurons or synapses, to function at a non-
impaired level for longer despite neuropathology (Satz, 1993). A critical review of the 
literature that related measurements of brain size to cognitive outcome following brain 
damage concluded that brain size may be a major factor in explaining the spectrum of 
outcomes (Satz, 1993). Satz proposed that a person has a critical level of brain reserve 
capacity and, once their reserve has been depleted, functional and clinical deficits may 
emerge. Although it is acknowledged that brain reserve is a hypothetical construct, measures 
of overall brain size and synapse count may help to operationally define the concept (Stern, 
2002).  
 
While brain size likely contributes to an individual’s reserve, the brain reserve capacity model 
can only explain part of the variance in the association between neurological burden and 
cognitive ability. This is due to the lack of consideration of individual differences in how the 
brain’s cognitive processing of a task is disrupted by neuropathology (Stern, 2002) and the 
wealth of literature that indicates that reserve is modifiable through adult life (Petrosini et al., 
2009; Reed, Dowling, & Farias, 2011; Richards & Deary, 2005; Valenzuela & Sachdev, 
2007). On the contrary, the brain reserve capacity theory suggests that reserve is not 
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influenced throughout adulthood, as maximal brain volume is generally achieved by five 
years of age (Reiss, Abrams, Singer, Ross, & Denckla, 1996). However, the modification of 
the brain’s neurophysiological properties is possible. For instance, new neurons are 
continuously generated in the adult brain (Eriksson et al., 1998), with exercise, stimulating 
environments, and potentially diet, shown to promote neurogenesis (Stangl & Thuret, 2009; 
van Praag, Shubert, Zhao, & Gage, 2005; Wu et al., 2008). Despite this, it is unlikely that 
these mechanisms would lead to meaningful increases in intracranial volume (Valenzuela & 
Sachdev, 2007).  
 
The brain capacity formulation of reserve is referred to as a ‘passive’ model of reserve, as 
whether a patient shows cognitive deficits due to neuropathology is determined by whether 
the degree of damage exceeds that patient’s pre-determined neurological capacity (Stern, 
2002). In contrast, the ‘active’ formulation of reserve, cognitive reserve (CR), allows for 
individual differences in the efficiency and effectiveness in which a task is processed in the 
presence of neural damage (Stern et al., 2005; 2003). Rather than simply considering 
anatomical data as conferring reserve, the ‘active’ model considers the efficacy in use of brain 
networks (Solé-Padullés et al., 2009). 
 
Cognitive reserve 
 
CR is a model of reserve that proposes that the brain actively attempts to cope with damage 
through pre-determined cognitive strategies, such as the efficient use, and differential 
recruitment, of brain networks (Stern, 2002). Changes in the recruitment of brain networks 
are a normal response to increased task demands (Stern et al., 2012), and individual 
differences in neural efficiency exist in non-pathological cognitive function (Solé-Padullés et 
al., 2009). Therefore, it is likely that, in addition to being clinically relevant, CR is a construct 
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that is developed throughout healthy adulthood and is present in older adults without disease. 
CR focuses on the processes that allow the brain to maintain function despite neural 
interruption and differs from ‘passive’ models that propose a fixed threshold at which 
impairment will occur. CR also offers an explanation as to how one patient can display 
clinical symptoms of AD where another, with the same head circumference, intracranial 
volume, or number of healthy neurons and synapses, can continue to function at a subclinical 
level (Stern, 2009). 
 
Neurologically, CR has two main complementary facets that assist the individual to maintain 
cognitive function despite neural disruption by pathology: neural reserve and neural 
compensation (Stern et al., 2005). Neural reserve refers to the pre-existing differences in 
neural network efficiency that exist between individuals. Higher neural reserve manifests as 
brain networks that are either more efficient or have greater capacity when faced with 
increased task demand. In addition, individuals with higher neural reserve may more readily 
recruit additional brain networks to support performance when the original networks are 
insufficient. The other component of CR, neural compensation, is a response specific to brain 
damage that reflects the individual differences in the ability to use alternative brain structures 
or networks resulting from disruption to the original networks. Here, engaging compensatory 
neural networks may not result in improved performance, but may serve to maintain 
performance in the face of ageing or pathology (Stern et al., 2005). 
 
CR provides one explanation for the individual differences in the relationship between 
neuropathological burden and cognitive outcome but, as a hypothetical construct, is inherently 
difficult to measure. One approach to CR measurement is to quantify the difference between 
observed and expected cognitive performance due to the pathology present in the brain, but 
accurate measures of both performance and neuropathology must be acquired (Jones et al., 
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2011). One study estimated CR by the residual term in the regression of cognitive function on 
brain pathology, providing an operational measure of an individual’s current reserve (Reed et 
al., 2011). However, such an approach requires in vivo estimates of brain pathology, the 
acquisition of such data being time-consuming and costly. 
 
Other methods of measuring CR have been suggested, such as through the assessment of 
neurocomputational factors such as network efficiency, redundancy, and dynamic range 
(Valenzuela, 2008). However, for practicality, it is recommended that a behavioural approach, 
ascertaining how mentally active and engaged a person is, be adopted (Stern, 2002; 
Valenzuela, 2008). In the past two decades, multiple studies have endeavoured to identify 
factors that support subclinical cognitive performance in the presence of neuropathology. 
These studies have led to the identification of several potential proxy measures of CR. These 
proxy measures comprise estimates of lifetime exposures that display an inverse relationship 
with dementia risk, and include: educational attainment; the nature and complexity of 
occupational history; participation in cognitively stimulating leisure activities; and, general 
intelligence. Importantly, research has demonstrated that different lifetime exposure to CR 
proxies contribute independently to reserve capacity (Foubert-Samier et al., 2012; Reed et al., 
2011). 
 
Educational attainment 
 
The notion that greater participation in education reduces the prevalence of AD was first 
given consideration after researchers recognised the importance of adjusting for education 
when screening for dementia (Kittner et al., 1986). A subsequent investigation identified 
significantly increased risk for dementia among individuals with either low education or low 
lifetime occupational attainment (Stern et al., 1994). The authors proposed that lifetime 
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educational or occupational attainment either increase the difficulty in detecting clinical AD 
or impart a level of CR that delays onset of clinical symptoms. Soon after, multiple studies 
provided support for the hypothesis that education provides protection from dementia and AD 
(Letenneur et al., 1999; Mortel, Meyer, Herod, & Thornby, 1995; Ott et al., 1995). However, 
such associations are not always found. One longitudinal investigation found that less 
educated adults had a later age of dementia onset, a similar load of neurodegenerative lesions 
(senile plaques, neurofibrillary tangles, Lewy bodies), but a greater number of 
cerebrovascular lesions, than higher educated patients (Del Ser, Hachinski, Merskey, & 
Munoz, 1999). The authors proposed that education modifies dementia risk through a 
reduction in cerebral infarcts rather than by enhancing CR, supporting a ‘brain-battering 
model’. Other research has identified an independent contribution of education on healthy 
cognitive function, after adjusting for multiple socioeconomic status measures (Cagney & 
Lauderdale, 2002). 
 
Many epidemiological investigations have provided support for the association between 
educational attainment and risk for dementia. For example, after adjusting for age and gender, 
education but not occupational attainment was negatively associated with dementia in two 
independent samples (Fritsch, McClendon, Smyth, & Ogrocki, 2002; Ravaglia et al., 2002). 
The possibility that greater educational attainment is associated with reduced dementia risk 
due to its status as a proxy variable for socioeconomic status has also been investigated. One 
study demonstrated that education reduces the risk for dementia even after adjusting for 
multiple demographic, socioeconomic, vascular, and lifestyle characteristics (Ngandu et al., 
2007). Here, the authors proposed that unhealthy lifestyles might contribute to dementia risk 
due to the depletion of CR or through direct effects on pathological processes. Similarly, 
greater years of education reduced dementia risk in older female members of a religious order 
who lived together, effectively excluding the influence of environmental factors and lifestyle 
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(Bickel & Kurz, 2009). In 488 subjects who were demented at death, although education did 
not alter neurodegenerative or vascular pathologies, more years of education mitigated the 
impact of pathology on cognitive function, decreasing the risk for clinical symptoms of 
dementia (Brayne et al., 2010). Further, a faster AD-related cognitive decline was found in 
individuals with higher education compared to individuals with lower education (Bruandet et 
al., 2008). Higher education has also been related to protection from cognitive impairment 
resulting from stroke (Ojala-Oksala et al., 2012) and brain injury in professional fighters 
(Banks et al., 2014). 
 
Rather than modifying the neurobiological processes of AD, education seems to act through 
the buffering of cognitive impairment associated with AD pathology (Brayne et al., 2010). 
Two separate investigations that quantified neuropathological markers at autopsy found that 
higher education was associated with a reduced impact of AD pathology upon cognitive 
function, while having no impact on the severity of the pathology present (Bennett et al., 
2003; Koepsell et al., 2008). Studies that have determined in vivo estimates of amyloid plaque 
load using Pittsburgh Compound B (PiB) have reported similar findings (Rentz et al., 2010). 
In higher educated and lower educated participants matched on level of cognitive 
deterioration, a greater PiB uptake in the lateral prefrontal cortex was identified in those with 
more years of education (Kemppainen et al., 2008). Similarly, in participants with elevated 
PiB uptake, performance on multiple tests of cognitive function was increased with more 
years of education (Roe et al., 2008). Brain glucose metabolism, another pathological marker 
of AD, is also more severely reduced in higher educated individuals when compared to lower 
educated individuals, despite comparable cognitive impairment (Garibotto et al., 2008; 
Kemppainen et al., 2008). Structural pathology is also modified by education. Here, more 
education was associated with higher cognitive function at any level of medial temporal lobe 
atrophy (Perneczky et al., 2009) and, after being matched for dementia severity, higher 
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education was associated with more severely reduced white matter integrity in the medial 
temporal lobe and association fibre tracts (Teipel et al., 2009). 
 
Although associations between education and risk for dementia are reliable, education has 
shown inconsistent protective effects on the rate of normal cognitive ageing (Christensen et 
al., 2009). A longitudinal study of 872 healthy individuals, aged 49-81 years at baseline, did 
not show any alteration of cognitive ageing trajectory due to education level after six years 
(Van Dijk, Van Gerven, van Boxtel, Van der Elst, & Jolles, 2008). Likewise, in 1,014 
participants followed over 12 years, education did not alter rates of change in any cognitive 
domain (Zahodne, Glymour, & Sparks, 2011). One investigation showed a protective effect of 
education on the association between amyloid deposition and cognition in cognitively intact 
participants, albeit only when using an especially difficult memory test (Rentz et al., 2010). 
Overall, the protective effects of education on age-related cognitive decline are likely small or 
non-existent. However, one finding that is consistent across longitudinal studies is of higher 
baseline cognitive function as a result of education (Gottesman et al., 2014; Singh-Manoux et 
al., 2011; Zahodne et al., 2011). In this regard, one reason why education may delay the onset 
of dementia is due to higher cognitive function resulting in neuropsychological performance 
that reaches clinical significance later than those with lower education. 
 
Occupational attainment 
 
Although education is the most commonly used proxy measure for CR, other life experiences 
have also been proposed to increase reserve. One of these life experiences is occupational 
attainment, with earlier research suggesting that occupational attainment and education 
independently or synergistically contribute to higher reserve (Mortel et al., 1995; Stern et al., 
1994; 1995). Epidemiologically, the results are mixed, with some studies reporting significant 
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reductions in risk for dementia due to level of occupational attainment (Mortel et al., 1995; 
Qiu et al., 2003), while others have found no association between occupation and dementia 
risk (Fritsch et al., 2002; Jorm et al., 1998b). In both of these studies that reported negative 
results, the authors suggested that any relationship is likely due to premorbid cognitive 
differences, established prior to entering the workforce. A longitudinal study of 2,950 
subjects, 251 of whom developed AD, found no support for the hypothesis that occupation 
alters the risk for AD (Helmer et al., 2001). Despite this, more recent evidence reports 
protective effects of occupation on dementia risk (Andel et al., 2005; Bickel & Kurz, 2009), 
particularly in those occupations that involve complex interactions and skills (Karp et al., 
2009; Kröger et al., 2008). A meta-analysis of 12 studies found that a history of high 
occupational attainment was associated with a 44% decreased risk of incident dementia 
(Valenzuela & Sachdev, 2006). 
 
Like education, data have implicated occupational attainment in influencing the clinical 
expression of AD. In AD patients matched on clinical impairment, a history of participation 
in occupations that involved more complexity, interpersonal skills, and physical demands was 
associated with greater cerebral blood flow deficits in the parietal lobe (Stern et al., 1995). 
Similarly, in patients with MCI or probable AD who were later diagnosed with AD, despite 
comparable cognitive function, a more severe reduction in glucose metabolism was found in 
patients with more education/occupational attainment when compared to patients with less 
(Garibotto et al., 2008). In both studies, the cognitive deficits associated with the pathological 
progression of AD were mitigated due to occupational history. 
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Cognitively stimulating leisure activities 
 
Participation in cognitively stimulating leisure activities is a further life experience that may 
contribute to CR (Stern, 2002). Longitudinal investigations examining measures of physical, 
mental, and social activity have demonstrated a significantly lower risk of dementia in 
individuals who were more active (Paillard-Borg, Fratiglioni, Winblad, & Wang, 2009; Wang 
et al., 2013; Wilson et al., 2002b). In two of the studies, such associations remained even after 
adjusting for education and baseline cognitive function (Wang et al., 2013; Wilson et al., 
2002b), indicating that these leisure activities provide a unique contribution to CR. Frequent 
cognitive activity has been reported to compress the cognitive morbidity associated with AD, 
such that frequent cognitive activity slows the annual rate of global cognitive decline by 52% 
in cognitively normal individuals, yet hastened the rate of decline by 42% in individuals with 
AD (Wilson et al., 2010). A cognitively inactive individual is 2.6 times more likely to develop 
AD than a cognitively active person, even after controlling for current social and physical 
activity (Wilson, Scherr, Schneider, Tang, & Bennett, 2007). More frequent participation in 
specific cognitive activities, such as completing crossword puzzles in later-life, is also related 
to a later memory decline in individuals who develop dementia (Pillai et al., 2011). 
 
There is evidence suggesting that cognitively stimulating leisure activities modify the impact 
of AD pathology on cognitive function. One study investigated the associations between 
regional cerebral blood flow, cognitive function, and intellectual, social, and physical 
engagement (Scarmeas et al., 2003). After controlling for education and intelligence, greater 
reductions in regional cerebral blood flow, indicating a more advanced AD-related pathology, 
were found in participants with a higher activity score while matched for clinical severity. 
Another study quantified the difference between expected cognitive function due to AD 
pathology and actual level of performance, capturing CR as a latent variable (Reed et al., 
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2011). Here, potential lifetime contributors of reserve (socioeconomic status, education, 
cognitive leisure activities at age 40, cognitive leisure activities in late life) were regressed 
onto the latent CR variable, with cognitive leisure activities at age 40 found to be the 
strongest correlate of CR. In this study, activities such as reading, writing letters, visiting a 
library, and keeping a journal were most effective at suppressing the detrimental cognitive 
outcomes of neuropathology. 
 
Intelligence 
 
Although less frequently investigated than other CR proxies, intellectual capacity may be 
another lifetime factor that exerts a protective influence against age-related or disease-related 
cognitive dysfunction (Stern, 2009). A large-scale longitudinal investigation of 2,063 elderly 
subjects, followed for four years, demonstrated that low IQ predicted incident dementia better 
than low level of education (Schmand, Smit, Geerlings, & Lindeboom, 1997). Another study 
found that low abstract reasoning capacity, a component of intelligence, was one of the 
strongest predictors of AD over 22 years of follow-up (Elias, Beiser, Wolf, & Au, 2000). 
Intellectual capacity does not just protect from cognitive deficits arising from dementing 
illnesses, but also from cognitive impairment resulting from obesity (Galioto, Alosco, 
Spitznagel, Stanek, & Gunstad, 2013). Here, the authors demonstrated that in participants 
with higher premorbid intellectual ability, the expression of obesity-related cognitive 
impairment was attenuated. Intelligence has also been demonstrated to moderate the 
association between AD pathology and cognitive function, with a higher CR level negating 
the detrimental association between amyloid deposition and cognitive performance (Rentz et 
al., 2010). However, in a separate investigation of 109 cognitively normal subjects, 192 
amnestic MCI patients, and 98 AD patients, an independent additive effect of IQ was found 
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on cognitive function in the presence of AD biomarkers, rather than a compensatory 
interaction between the variables (Vemuri et al., 2011). 
 
A lifetime of cognitive engagement 
 
Rather than determining an individual’s CR through measurement of a single CR proxy 
(education, occupational attainment, cognitively stimulating leisure activities, intelligence), 
examination of mental engagement over the lifespan that reflects multiple CR proxies may 
more accurately estimate an individual’s CR. This approach has been suggested as a means of 
assessing CR effectively (Sánchez, Torrellas, Martín, & Barrera, 2011) and a meta-analysis 
that examined the protective effect of multiple CR proxies in combination reported a 
reduction in the risk of incident dementia of 46% for those with higher reserve (Valenzuela & 
Sachdev, 2006). However, although the construct validity of the a priori grouping of 
correlated CR proxies approach has been criticised (Satz, Cole, Hardy, & Rassovsky, 2011), 
recent investigations increasingly take into account multiple proxy measures when assessing 
CR (Foubert-Samier et al., 2012). Furthermore, a more precise estimate of CR may be 
obtained through combining several indicators (Jones et al., 2011). 
 
The Lifetime of Experiences Questionnaire (LEQ) incorporated the lifetime approach to 
estimating CR (Valenzuela & Sachdev, 2007). The LEQ is a retrospective self-report tool that 
is designed to comprehensively assess complex mental activity over the lifespan. To achieve 
this, the LEQ records information relating to education, occupational attainment, and 
cognitive lifestyle in different life stages (early life: 13-30; midlife: 30-65; late life: 65+ 
years). An analysis of the inter-correlations between CR proxies in different life stages has 
underlined the importance of a lifespan approach to estimating CR (young adulthood and 
midlife, r = 0.65; midlife and late life, r = 0.26; Valenzuela & Sachdev, 2007). However, the 
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LEQ may be best suited to provide a measure of pre-existing cognitive lifestyle (Suo et al., 
2012) rather than a point measure of CR, a form of measurement required for longitudinal 
research or for the examination of potential benefits of interventions and treatments. 
Furthermore, while the LEQ assesses multiple proxies for CR, it does not assess intellectual 
capacity, a previously identified contributor to CR (Galioto et al., 2013; Rentz et al., 2010; 
Vemuri et al., 2011) independent of other proxies (Stern, 2009). 
 
Mechanisms of action 
 
Although participation in cognitively stimulating activities develops cognitive strategies that 
offset dementia (Stern, 2002), neuroimaging studies have indicated that life experience 
preserves cognition above and beyond these strategies. Evidence supporting an overlap 
between CR and cerebral reserve hypotheses is provided by in vivo investigations that have 
demonstrated an association between CR proxies and the integrity of neurological structures 
(Barulli & Stern, 2013). In an MRI investigation of healthy adults, participants with more 
years of education had larger regional cortical thickness in transverse temporal cortex, insula, 
and isthmus of cingulate cortex than participants with low education (Liu, Julkunen, 
Paajanen, & Westman, 2012). Similarly, education has been positively correlated with both 
grey and white matter brain volumes (Foubert-Samier et al., 2012), as well as the integrity of 
white matter tracts (Teipel et al., 2009). Another CR proxy, intelligence, has demonstrated 
positive correlations with grey matter volume in multiple brain regions (Colom, Jung, & 
Haier, 2006; Haier, Jung, Yeo, Head, & Alkire, 2004). 
 
In addition to the associations between CR proxies and larger regional brain volumes, 
individuals with more CR show slower rates of age-related cortical atrophy. In 37 healthy 
older adults who completed the LEQ and underwent MRI at baseline and at three years 
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follow-up, participants with more CR, as estimated by the LEQ, possessed both greater 
hippocampal volumes and experienced less hippocampal atrophy over the follow-up period 
(Valenzuela, Sachdev, Wen, Chen, & Brodaty, 2008). In a follow-up study with a larger 
sample of 1,037 older adults aged over 70 years, a similar effect was observed (Suo et al., 
2012). After excluding participants with MCI at their three-year follow-up MRI, the rate of 
hippocampal atrophy in late-life was five-times slower for those participants with high level 
supervisory experience in midlife when compared to those with no midlife supervisory 
experience. 
 
Functional MRI and PET investigations have identified altered patterns of neural activation 
that represent functional reorganisation of neural networks associated with more frequent 
participation in CR proxy variables (Barulli & Stern, 2013), even in younger adults (Stern et 
al., 2003). Such findings have supported the two main hypothesised neural implementations 
of CR: neural reserve and neural compensation (Stern, 2009; Stern et al., 2005). For example, 
during a memory task, education and frontal activity were negatively correlated in younger 
adults but positively correlated in older adults, implicating the frontal cortex as an alternative 
network that may be engaged by higher educated individuals in later life (Springer, McIntosh, 
Winocur, & Grady, 2005). In addition, a specific network has been identified in two separate 
cognitive tasks that increases in activation as a function of CR (Stern et al., 2005). More 
efficient use of the task-associated neural networks was also found in individuals with more 
CR (Morbelli & Nobili, 2014). For example, a higher score on a composite estimate of CR 
was related to reduced activity during cognitive processing of a visual encoding task in 
healthy adults (Solé-Padullés et al., 2009). Similarly, healthy older adults with low CR 
showed higher functional connectivity while performing a memory task when compared to 
participants with high CR, despite no difference in cognitive performance (Lopez et al., 
2014). In comparison, active compensatory mechanisms have been identified in MCI and AD 
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patients, with higher CR associated with increased brain activity during cognitive processing 
(Solé-Padullés et al., 2009). 
 
Rather than impacting solely on cognitive processing, higher neural efficiency associated with 
higher CR may also modify the rate of AD pathology accumulation (Jagust & Mormino, 
2011). A recent imaging investigation assessed the association between lifetime participation 
in cognitively stimulating activities and cortical PiB uptake in 65 healthy older participants 
(Landau et al., 2012). The authors reported that greater early- and mid-life engagement was 
associated with a significantly reduced Aβ deposition in later life. Similarly, reductions in the 
levels of cerebral Aβ and amyloid deposits are found in mice exposed to an enriched 
environment when compared to mice raised in standard housing (Lazarov et al., 2005). 
Another investigation examined CR proxy variables and longitudinal change in AD 
biomarkers in 819 participants with normal cognitive function, MCI, and mild AD (Lo & 
Jagust, 2013). Here, cerebrospinal fluid Aβ 42 decline was slowed by higher levels of 
education, occupation, and premorbid intelligence in cognitively normal subjects, with an 
additional effect of preserved glucose metabolism present in AD patients with higher 
premorbid intelligence. 
 
Genetic contributions to reserve 
 
As genetic influences account for over 50% of the variability in adult cognitive function 
(Petrill et al., 2004), it is likely that a measurement of CR based on environmental exposures 
alone is incomplete (Lee, 2003). The notion of biological, or inherited, reserve has not come 
under the same level of exploration as environmental contributors to CR. Yet, high 
heritability has been identified in both general cognitive ability (Bouchard & McGue, 1981; 
Deary, Spinath, & Bates, 2006; Plomin, 2004) and specific cognitive functions, such as 
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working memory and verbal ability (Ando, Ono, & Wright, 2001; Blokland et al., 2008). 
Furthermore, the heritability of general cognitive ability has been demonstrated to increase 
with age rather than diminish (Davis, Haworth, & Plomin, 2009; Haworth et al., 2010). 
Research that examines the interaction between genes and CR proxies is justified. The most 
likely candidate genes for CR are those that interact with environmental factors to induce 
effects on cognitive functions (Lee, 2003). 
 
Genetic associations with cognitive function 
 
Although there is strong evidence from genome-wide investigations that variation in genetic 
makeup affects the cognitive function of a healthy adult (Plomin et al., 2013), replicable 
single gene associations with cognitive ability or cognitive ageing are rare (Houlihan et al., 
2009). For example, one large-scale investigation examined 325 single nucleotide 
polymorphisms (SNPs) in 109 genes that have been previously implicated in oxidative stress 
and/or cognitive function in two separate cohorts totalling 922 participants (Harris, Fox, 
Wright, & Hayward, 2007). The authors failed to find support for any of the previous 
associations in both cohorts, but identified an intronic SNP in the APP gene (rs2830102) that 
was significantly associated with cognitive ageing in the first cohort alone and in a combined 
sample of both cohorts. Further candidate genes for cognitive ability and ageing are 
apolipoprotein e (APOE) and brain-derived neurotrophic factor (BDNF), both of which have 
shown inconsistent associations with cognitive functions (Foster et al., 2013; Stuart, 
Summers, Valenzuela, & Vickers, 2014). Despite this, synaptic plasticity is a key mechanism 
that facilitates the development of CR from participation in cognitively stimulating activities 
(Esiri & Chance, 2012), and both APOE and BDNF have been shown to impact upon 
components of plasticity (Chen, Durakoglugil, Xian, & Herz, 2010; Pattwell et al., 2012). As 
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such, investigations that examine whether APOE or BDNF are associated with an 
environmental estimate of CR are important. 
 
Apolipoprotein E 
 
One of the key genes that accounts for a major proportion of studies that investigate genetic 
associations with cognitive ability, ageing, and AD is APOE. The human APOE gene is 
located on chromosome 19 and is composed of 299 amino acids, with APOE isoforms 
differing due to the presence of cysteine or arginine at amino acid residues 112 and 158: 
APOE ε2 (Cys 112, Cys 158), APOE ε3 (Cys 112, Arg 158), APOE ε4 (Arg 112, Arg 158) 
(Mahley & Rall, 2000); a meta-analysis of worldwide prevalence rates for the three variants 
are reported to be 8.4%, 77.9% and 13.7%, respectively (Farrer et al., 1997). However, an 
Australian population reported slightly different prevalence rates of 14.7%, 73.5%, and 
11.8%, respectively (Vickers et al., 2002). 
 
The APOE protein is involved in regulating lipid homeostasis by transporting lipids between 
tissues or cells (Mahley & Rall, 2000). In the central nervous system, APOE is produced 
primarily by astrocytes and transports cholesterol to neurons through APOE receptors; 
however, the liver and macrophages also produce APOE (Liu, Kanekiyo, Xu, & Bu, 2013a). 
Although APOE isoforms differ by only one or two amino acids, the physiologic effects are 
particularly evident. For instance, APOE ε4 is associated with calcific valvular heart disease 
(Novaro, Sachar, Pearce, Sprecher, & Griffin, 2003), atherosclerosis (Mahley & Rall, 2000), 
hyperlipidemia (Ghiselli, Schaefer, Zech, Gregg, & Brewer, 1982), and glaucoma (Vickers et 
al., 2002); while APOE ε2 has been associated with Parkinson’s disease (Huang, Chen, & 
Poole, 2004). However, the most robust finding is the link between APOE polymorphisms 
and late-onset sporadic AD (Verghese, Castellano, & Holtzman, 2011). 
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The APOE ε4 gene dose has been shown to be the largest genetic risk factor for late-onset AD 
(Lovati et al., 2010). An increased risk for developing AD and an earlier age of onset of 
clinical AD has been reported with an increasing number of ε4 alleles (Corder et al., 1993). 
Specifically, the frequency of AD and mean age of clinical onset are 91% and 68 years in ε4 
homozygotes, 47% and 76 years in ε4 heterozygotes, and 20% and 84 years in ε4 noncarriers 
(Corder et al., 1993). In support, it has been reported that while the prevalence of ε4 in the 
general population was 13.7%, the prevalence of the ε4 allele was 40% in patients with AD 
(Farrer et al., 1997). Here, ε4 heterozygous participants had a 3-4 times increased risk for AD 
while ε4 homozygous participants had 10-12 times the risk of AD. Despite this, the presence 
of ε4 is not diagnostic, as ε4 alone is not sufficient to cause the pathogenesis of AD and some 
APOE ε4 carriers achieve old age without developing dementia (Tiraboschi et al., 2004). 
 
The APOE ε4 allele may increase risk for AD due to an allele-specific increase in the rate of 
abnormal AD pathology accumulation in the brain (Corder et al., 1993; Morris et al., 2010). 
An autopsy study of 603 deceased subjects, aged 0 to 97 years, found that the presence of ε4 
was associated with an earlier onset of AD-related brain changes (Kok et al., 2009). Here, ε4 
carriers had more amyloid plaques compared to ε4 non-carriers in most age brackets, with a 
particularly strong effect in subjects aged 50-59 years: 40.7% of ε4 carriers had amyloid 
plaques compared to 8.2% in noncarriers. This may be due to APOE effects on the rate of Aβ 
deposition to form amyloid plaques (Liu et al., 2013a) or the disruptive effect of ε4 isoforms 
on mechanisms that clear Aβ peptide from the brain (Castellano et al., 2011; Deane et al., 
2008). In addition to affecting amyloid pathways, it has been proposed that ε4 may also 
contribute to AD risk through the promotion of tau hyperphosphorylation (Kim, Basak, & 
Holtzman, 2009) and through driving atrophy to the medial temporal lobe (Manning et al., 
2014; Pievani et al., 2011). Conversely, ε2 has demonstrated protective effects from the 
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accumulation of AD pathology (Castellano et al., 2011; Suri, Heise, Trachtenberg, & Mackay, 
2013; Tiraboschi et al., 2004). 
 
Although the link between APOE and risk for AD is established, the notion that APOE 
polymorphism accounts for variance in healthy non-pathological cognitive function is less 
clear. Some investigations have identified detrimental cognitive effects associated with the ε4 
allele in healthy adults (Boardman, Barnes, Wilson, Evans, & Mendes De Leon, 2012; Deary 
et al., 2004; Ready et al., 2011), while others have failed to support such associations (Foster 
et al., 2013; Jorm et al., 2007). Two meta-analyses have demonstrated that the ε4 allele 
imparts a negative effect on a variety of cognitive functions in healthy older individuals 
(Small, Rosnick, Fratiglioni, & Bäckman, 2004; Wisdom, Callahan, & Hawkins, 2011): 
global cognitive ability, episodic memory, executive functioning, and perceptual speed were 
all significantly impaired in ε4 carriers. Despite this, more recent data refutes the notion that a 
specific ε4-related cognitive phenotype exists independent of dementia or MCI (Foster et al., 
2013; Quintas et al., 2013). 
 
Part of the reason why APOE polymorphisms may influence healthy cognitive function is due 
to the allele-specific effects on the structure and function of the brain. For example, in 
individuals aged 49-79 years, ε4 alleles were associated with significantly reduced right 
hippocampal volumes, with the most pronounced effect found before the age of 65 (Lind et 
al., 2006). Similarly, relative to ε3 homozygotes, ε4 carriers aged 51-59 years had a thinner 
cortex in superior frontal, left rostral, and right caudal midfrontal regions (Fennema-Notestine 
et al., 2011). The ε2 allele exerts a positive effect on brain volume, with healthy ε2 carriers 
showing thicker right parahippocampal cortex when compared to ε3 homozygotes (Fennema-
Notestine et al., 2011). In patients with AD, ε2 alleles appear to be protective: relative to ε3 
homozygotes, ε2 carriers show thicker entorhinal cortex, transverse temporal cortices, and 
! !!
!
33!
whole cerebral gray matter, and left hippocampal volumes (Liu et al., 2010; Pievani et al., 
2011). APOE polymorphism also affects white matter, with less white matter volume present 
in ε4 carriers when compared to noncarriers (Ready et al., 2011). 
 
Similarly to low CR, APOE ε4 has been associated with reduced neural efficiency when 
processing cognitive tasks. Even in young healthy individuals aged 20–35 years, ε4 alleles are 
associated with greater hippocampal activation during an encoding task, despite no difference 
in memory performance (Filippini et al., 2009). In the same investigation, brain activity at rest 
revealed increased activity in the default-mode network (DMN) in ε4 carriers relative to 
noncarriers. Two other studies have demonstrated greater neural activation in multiple 
components of the temporal lobes in ε4 carriers when compared to noncarriers (Dennis et al., 
2010; Scarmeas, 2005). In healthy older individuals, aged 60-79 years, ε4 carriers exhibited 
increased functional connectivity but reduced complexity of spontaneous brain activity, a 
suggested hallmark of illness and ageing, indicating compensatory neural recruitment (Yang 
et al., 2013). Overall, a lifetime of heightened neural activity associated with ε4 may 
contribute to a faster rate of Aβ peptide accumulation (Jagust & Mormino, 2011). 
 
Brain-derived neurotrophic factor 
 
A second gene that warrants investigation for potential interactions with CR is brain-derived 
neurotrophic factor (BDNF). The BDNF gene is located on chromosome 11 and encodes a 
precursor peptide which, once cleaved, forms the mature BDNF protein (Egan et al., 2003). 
BDNF is a nerve growth factor that is expressed in the central nervous system and is vital for 
the maintenance, survival, and growth of neurons (Mattson, Maudsley, & Martin, 2004), but 
has also been well characterised for its role in synaptic plasticity (Yoshii & Constantine-
Paton, 2010). Many SNPs have been identified within the region that codes for BDNF, yet a 
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valine (Val) to methionine (Met) substitution at position 66 in the pro-domain has been the 
most widely studied (Mizuno, Yamada, Olariu, Nawa, & Nabeshima, 2000). A US-based 
study reported Val66Met allele frequencies of 82% and 18% for Val and Met, respectively 
(Egan et al., 2003), although ethnicity-dependent frequencies have also been identified 
(Shimizu, Hashimoto, & Iyo, 2004). 
 
As BDNF has been implicated in neurodegenerative diseases, factors that influence the rate at 
which BDNF is expressed have been the target of research. Reduced BDNF levels are found 
as a result of AD in frontal and parietal cortices and the hippocampus (Ferrer et al., 1999; 
Hock, Heese, Hulette, Rosenberg, & Otten, 2000). Similarly, normal ageing has been 
associated with a decreased BDNF signalling capacity, with age-related decreases in BDNF 
proposed to account for age-related impairments in cognitive function (Mattson et al., 2004). 
Of particular interest is the BDNF Val66Met polymorphism associated with protein 
expression (Egan et al., 2003). Not only does the Met variant of the polymorphism cause 
impaired activity/depolarisation-dependent secretion of BDNF in hippocampal neurons, but, 
where the Val variant results in secretory granules within synapses, the Met variant results in 
secretory granules that are accumulated in the cell body and rarely in synapses (Egan et al., 
2003). As a consequence of these deficits, the BDNF Met variant has been linked to 
impairments in synaptic plasticity and transmission (Cheeran et al., 2008; Ninan et al., 2010; 
Pattwell et al., 2012). 
 
The previously identified associations between BDNF and synaptic plasticity and growth 
indicate that the protein plays an important role in cognitive functions (Lu, Nagappan, Guan, 
Nathan, & Wren, 2013). Despite this, following an initial report that the Met variant impairs 
memory performance in healthy individuals (Egan et al., 2003), conflicting data have been 
reported. In 1063 Scottish individuals with a mean age of 70 years, variation in the Val66Met 
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polymorphism did not account for significant variance in any cognitive test (Houlihan et al., 
2009). In two other investigations, the polymorphism was shown to not significantly alter 
learning and memory function in either healthy younger (Gong et al., 2012) or older (Stuart et 
al., 2014) individuals. However, other investigations have supported deficits in healthy 
cognitive function due to inheritance of the Met allele (Hariri et al., 2003). One study of 189 
adults aged 18 – 89 years reported that carriers of the Met variant displayed reduced memory 
performance and slower processing speed when compared to Val homozygotes (Raz, 
Rodrigue, Kennedy, & Land, 2009). Another demonstrated slower processing speed in female 
Met carriers relative to female Val homozygotes (Laing et al., 2011). 
 
Multiple pathways may account for data that have related the BDNF Val66Met polymorphism 
to alterations in healthy cognitive function. Long term potentiation, a process of synaptic 
plasticity that allows memories to be encoded (Bliss & Collingridge, 1993), is dependent on 
the presence of BDNF in the hippocampus (Ying et al., 2002). Consequently, the impaired 
expression of BDNF associated with the Met variant may lead to a disruption in the memory 
encoding process. In addition, abnormal morphology and activation is associated with the Met 
variant. A significantly reduced total hippocampal volume is present in Met carriers when 
compared to Val homozygotes (Frodl et al., 2007; Kauppi, Nilsson, Persson, & Nyberg, 2014) 
even in a young sample with a mean age of 34.2 years (Pezawas et al., 2004). In support, a 
recent meta-analysis of 5,298 healthy individuals found a small but significant reduction in 
hippocampal volumes related to the Met variant (Harrisberger et al., 2014). In addition, 
reduced activity in the medial temporal lobe and hippocampus during the encoding of 
information while performing memory tasks, an indicator of subsequently forgotten memories 
(Eichenbaum, Yonelinas, & Ranganath, 2007), has been identified in Met carriers (Kauppi et 
al., 2014; 2013). 
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The BDNF gene has been widely investigated for its role in brain development and for 
mediating the neurological benefits of environmental enrichment (Casey et al., 2009; Lu et 
al., 2013). For example, exposure to cognitively stimulating environments results in a 
widespread increase in BDNF expression in the brain (Ickes et al., 2000) and in the 
upregulation of BDNF, resulting in the promotion of neural plasticity (van Praag, 
Kempermann, & Gage, 2000). One study demonstrated that hippocampal neurogenesis 
resulting from environmental enrichment in wild-type mice was absent in BDNF heterozygote 
knock-out mice (Rossi et al., 2006). Such effects also impact upon cognitive function: when 
BDNF activity is blocked in the hippocampus, exercise is no longer associated with 
improvements in spatial memory (Vaynman, Ying, & Gomez-Pinilla, 2004). Similarly, 
dietary restriction, another modifiable variable that enhances hippocampal neurogenesis, does 
not positively influence neurogenesis in BDNF knock-out mice (Lee, Duan, & Mattson, 
2002). In humans, the BDNF Val66Met polymorphism has been implicated in moderating the 
association between physical activity and risk of incident dementia (Kim et al., 2011). 
 
Genetic interactions with CR 
 
That individuals with higher CR display greater resistance to the effects of neuropathology is 
likely due to induced cortical plasticity caused by a prolonged mismatch between functional 
supply and task demands (Lövdén, Bäckman, Lindenberger, Schaefer, & Schmiedek, 2010), 
resulting in more flexible and denser neural networks (Barulli & Stern, 2013; Stern, 2009). As 
such, synaptic plasticity is a key mechanism that facilitates the development of CR (Esiri & 
Chance, 2012) and genes that impact upon the processes of synaptic and neuronal plasticity 
are viable candidates for genetic influences on CR. Both APOE (Chen et al., 2010; Levi, 
Jongen-Relo, Feldon, & Michaelson, 2005) and BDNF Val66Met (Cheeran et al., 2008; Egan 
et al., 2003) have shown such associations. 
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Although it would be convenient to assume that CR is determined solely by environmental 
factors, this does not appear to be the case, as studies have demonstrated interactions between 
genetic and environmental factors when determining risk for dementia (Wang et al., 2012). In 
this regard, a reliable finding is that higher CR can reduce the additional risk for dementia 
associated with APOE ε4 alleles due to higher education (Ferrari et al., 2013; Shadlen et al., 
2005; Wang et al., 2012), occupational attainment (Garibotto et al., 2011), and participation in 
leisure activities (Ferrari et al., 2013). In one study, it is reported that higher education halved 
the risk of dementia associated with inheritance of APOE ε4 (Wang et al., 2012). Although 
these investigations indicate that CR can reduce an individual’s genetic risk for dementia, a 
separate study has implicated that the impaired plasticity associated with APOE ε4 impacts on 
the association between CR and cognitive function (Runge, Small, McFall, & Dixon, 2014). 
Here, it was found that lifestyle activities involving cognitive effort predicted verbal fluency 
and semantic memory recall in APOE ε4 non-carriers but not in carriers. 
 
Environmental enrichment in experimental animals and measures of CR in humans are 
unlikely to be analogous; however, a comprehensive review of the literature concluded that, 
as with human educational and occupational attainment, environmental enrichment develops 
reserve that can be used to offset the impact of cortical lesions (Petrosini et al., 2009). In 
BDNF Met carriers, the reduced presence of BDNF in the synapses (Egan et al., 2003) and an 
impaired capacity for long term potentiation/depression may cause a reduction in the ability 
of connected cells to undergo synaptic and/or neuronal plastic changes (Egan et al., 2003; van 
Praag et al., 2000). As a result, variation in the BDNF Val66Met polymorphism may affect 
the association between participation in cognitively stimulating activities and cognitive 
function: for two individuals exposed to the same level of extrinsic environmental 
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stimulation, the individual who carries the BDNF Met polymorphism may exhibit lesser 
cortical changes as a result. 
 
Thesis aims and hypotheses 
 
One of the major issues that the CR theory faces is how to measure an individual’s reserve, 
but the development of an operational method of CR quantification could lead to practical 
advancements, such as more accurate diagnoses and prognoses offered to patients suffering 
from neurodegenerative disorders (Stern, 2013). However, no single approach to quantifying 
CR has been agreed upon, yet many attempts have been made. Another major issue that is 
present in ageing literature is the lack of reliable associations between single genes and 
cognitive processes (Harris & Deary, 2011). Studies that examine multiple genes, and that 
have substantial sample sizes, are the most likely to identify true and reliable genetic effects 
on cognitive function. Although genetic variation may also influence the rate of age-related 
cognitive decline and risk for dementia, it is possible that genes exert an effect on these 
processes through interaction with CR (Lee, 2003). As such, investigations aimed at 
identifying genetic interactions with CR are warranted, although are rarely seen in the 
literature. 
 
The Tasmanian Healthy Brain Project (THBP) is an on-going longitudinal investigation into 
the hypothesis that later-life tertiary education may result in increased CR, potentially 
contributing to a reduction in the rate of age-related cognitive decline and risk for dementia 
(Summers et al., 2013). Participants were healthy and free of significant medical, 
psychological, or psychiatric illness at study entry. The experimental group, exposed to a 
minimum of 12 months part-time University level study, currently comprises approximately 
500 participants; the control group, not exposed to the education intervention, currently 
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comprises approximately 100 participants. For the first four years of participation, 
participants were required to complete comprehensive neuropsychological assessments, after 
which, assessments are completed biennially. 
 
While often applied to neurological disorders, such as AD, CR may also explain variance in 
premorbid cognitive function. The present investigation utilised a cross-sectional design to 
assess a number of aims. In healthy older adults participating in the longitudinal THBP 
(Summers et al., 2013), the aims were: 
 
1. To explore the inter-relationships between CR proxy variables and develop two 
operational measures of CR: prior and current. 
2. To determine whether common genetic variation in APOE or BDNF Val66Met is 
associated, either independently or through gene-gene interaction, with cognitive 
function. 
3. To quantify the premorbid associations between CR and cognitive function. 
4. To investigate the relationship between CR, cognitive function, and APOE and BDNF 
Val66Met polymorphisms. 
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In order to achieve these aims, seven hypotheses were proposed, that: 
 
1. Traditional CR proxy variables (education, occupational attainment, intelligence, 
cognitively stimulating leisure activities) can be combined through factor analysis to 
provide a comprehensive operational estimate of CR prior to entering the THBP. 
2. Flexible measures of cognitive ability that approximate traditional CR proxy variables 
(intelligence, academic ability) can be combined through factor analysis to provide an 
estimate of change in CR due to new life experiences. 
3. APOE ε2 alleles are associated with better cognitive function and ε4 alleles are 
associated with worse cognitive function when compared to ε3 homozygotes. 
4. BDNF Val homozygotes are associated with better cognitive function when compared 
to Met carriers. 
5. A cumulative effect of the cognitive consequences associated with APOE and BDNF 
alleles results in the highest cognitive function in APOE ε2/BDNF Val homozygotes 
and the lowest cognitive function in APOE ε4/BDNF Met carriers. 
6. That higher CR is associated with better premorbid cognitive performance. 
7. That BDNF Val66Met and APOE polymorphisms independently moderate the 
association between CR and cognitive performance, with carriers of the putative 
detrimental alleles (Met and ε4, respectively) showing a reduced influence of CR 
when compared to non-carriers. 
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Chapter 2 
General Methodology 
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Study population 
 
A total of 467 healthy English-speaking participants from the longitudinal THBP completed 
the baseline neuropsychological battery. Participants were 50-79 years old at entry into the 
THBP and were community-residing and were recruited through a campaign that involved 
print, radio and television advertising, and community information presentations. All 
participants underwent comprehensive screening before being invited to participate in the 
THBP and were excluded if they had a history of any medical, psychiatric or psychological 
condition known to be independently associated with cognitive deficits. Conditions included 
dementia; multiple sclerosis; previous significant head injury requiring hospitalization; 
epilepsy; history of cerebro-vascular complications; diabetes – poorly controlled; blood 
pressure complications – poorly controlled; other neurological disorders; chronic obstructive 
pulmonary disease; heart disease; blindness; deafness; and psychiatric disorders. 
 
Participants were not compensated for their time. However, those participating in the THBP 
experimental group were eligible to receive a waiver of individual course charges (Australian 
Higher Education Contribution Scheme) for a study load equivalent to a 12.5% unit per 
academic year at the University of Tasmania. The study had full approval from the Tasmania 
Human Research Ethics Network (Ref: H11070) and was conducted in accordance with the 
ethical guidelines of the National Health and Medical Research Council of Australia 
(NHMRC). 
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Neuropsychological stream 
 
Materials !
As part of the THBP, participants completed a comprehensive assessment battery each year. 
Full details of the administered tests can be found elsewhere (Summers et al., 2013). The 
assessment battery was designed to gain comprehensive measures of neuropsychological, 
health, and psychosocial function, as well as estimates of variables associated with CR. 
 
Screening !
For the screening of the sample, the Mattis Dementia Rating Scale-2 (DRS-2; Jurica, Leitten, 
& Mattis, 2001) was used to detect symptoms of dementia, the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983) was used to assess psychological health, 
and the Medical Health Status questionnaire (Summers et al., 2013) collected data on health, 
medical conditions, medication use, and drug and alcohol use for the preceding 12 months. 
An experienced neuropsychologist reviewed performance on these tools to determine 
participant inclusion. !
Mattis Dementia Rating Scale-2 (DRS-2; Jurica et al., 2001) - The DRS-2 is a screening 
task used to objectively assess the presence and progression of AD, vascular dementia, 
Parkinson’s disease, and Huntington’s disease. The DRS-2 consists of 36 tasks and 32-
stimulus cards, is a neuropsychological measure of cognitive status for adults with cortical 
impairment, and is individually administered. The task yields five subscale scores (Attention, 
Initiation/Perseveration, Construction, Conceptualization, and Memory) as well as an overall 
score for cognitive functioning. Within each subscale the most difficult tasks are presented 
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first and if the subject performs well subsequent tasks in the subscale are credited with correct 
performance. Completion time for cognitively intact individuals is therefore shorter. 
Administration time takes, depending on the individual, 15-30 minutes (Strauss, Sherman, & 
Spreen, 2006). 
 
Medical Health Status Questionnaire (MHSQ; Summers et al., 2013) – The MHSQ is a 
structured self-report questionnaire that assesses health, medical conditions, prescription 
medication use, and drug and alcohol use for the preceding 12 months. This questionnaire 
was developed for the THBP and also collects demographic data such as age, gender, 
handedness, height, weight, and marital status. The questionnaire is completed each year and 
a short-form version is used for subjects completing their third annual assessment and 
onwards. The Medical Health Status questionnaire takes 5-10 minutes to complete. 
 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) - The HADS is a 
screening measure of clinically significant symptoms of anxiety or depression disorders 
among hospital patients. The HADS consists of 14-items, half measuring anxiety and half 
measuring depressive symptoms, and allows for four different responses to each item. The 
participant is asked to underline the response that most accurately reflects how they have been 
feeling over the past week. Ordinal data is generated for each anxiety (HADS-A) and 
depression (HADS-D) subscale with higher scores indicating the presence of clinical 
symptoms. The HADS has been widely used, and one review from 2002 identified 747 papers 
that referred to HADS (Bjelland, Dahl, Haug, & Neckelmann, 2002). ! !
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Neuropsychological assessment battery 
 
Although there are no established measures of CR in the individual, the THBP protocol 
included multiple proxy indicators previously used to estimate CR. To estimate prior CR, the 
Wechsler Test of Adult Reading (WTAR; The Psychological Corporation, 2001) was used as 
an estimate of premorbid IQ; the Lifetime of Experiences Questionnaire (LEQ; Valenzuela & 
Sachdev, 2007) was used to quantify prior lifetime experience; and the number of years of 
prior formal education were recorded on the Medical Health Status questionnaire (Summers et 
al., 2013). To estimate current CR, the Wechsler Adult Intelligence Scale, 3rd edition, Short 
Form 1 (WAIS-III-SF1; Donnell, Pliskin, Holdnack, Axelrod, & Randolph, 2007) was used to 
assess current intellectual capacity; and four components (spelling, math computation, 
sentence completion, word reading) from the Wide Range Achievement Test, 4th edition, 
Progress Monitoring Version (WRAT-4-PMV; Roid & Ledbetter, 2006), were used to assess 
current academic ability. 
 
Tests of cognitive function were selected to assess learning and memory, working memory, 
executive function, and language processing. Episodic memory was assessed using the Rey 
Auditory Verbal Learning Test (RAVLT; Strauss et al., 2006), the Logical Memory test (LM; 
Wechsler, 1997b) and the visual Paired Associates Learning test (PAL; Cambridge Cognition 
Ltd., 2004) from the Cambridge Automated Neuropsychological Assessment Battery 
(CANTAB). Working memory was assessed using WAIS-III Digit Span (DSP; Wechsler, 
1997a), WAIS-III Letter-Number Sequencing (LNS; Wechsler, 1997a), CANTAB Spatial 
Span (SSP; Cambridge Cognition Ltd., 2004), and CANTAB Spatial Working Memory 
(SWM; Cambridge Cognition Ltd., 2004). Executive function was assessed using CANTAB 
Rapid Visual Processing (RVP; Cambridge Cognition Ltd., 2004), 24-item Victoria version 
Stroop test (Lezak, Howieson, Bigler, & Tranel, 2004), and Trail Making Test (TMT; Lezak 
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et al., 2004). Language processing was assessed using WAIS-III Vocabulary (VOC; 
Wechsler, 1997a), WAIS-III Comprehension (COM; Wechsler, 1997a), and Boston Naming 
Test (BNT; Kaplan, Goodglass, & Weintraub, 1983). 
 
Cognitive reserve 
 
Wechsler Test of Adult Reading (WTAR; The Psychological Corporation, 2001) – The 
WTAR allows the estimation of premorbid intellectual functioning for individuals aged 16 to 
89 years, takes less than 10 minutes to administer, and has extensive clinical validity with a 
number of groups including AD patients. The task requires the individual to read 50 words 
with atypical grapheme-phoneme translations aloud. Using words with irregular 
pronunciations minimises the individual’s current ability to apply standard pronunciation 
rules to assess previous learning of the word, and capacity to read such words is preserved 
until late stages of dementia. Correct pronunciations are printed on the record form to assist in 
scoring; total score is the number of words read correctly. A raw score is converted to a 
standard score by using the participant’s age at testing. Scores are then converted to WAIS-III 
Full Scale IQ estimates (Wechsler, 1997a). 
 
Lifetime of Experiences Questionnaire (LEQ; Valenzuela & Sachdev, 2007) – Designed to 
assess complex lifespan mental activity in individuals aged over 65 years, the LEQ is a self-
report questionnaire that assesses the full range of complex mental pursuits that build up over 
a person’s lifetime from young adulthood (13-30 years of age), mid-life (30-65 years of age), 
and late life (65 years onwards) stages. For each life stage, respondents answer questions on 
frequency of mental activities that are specific to that life stage (e.g. educational, occupational 
activity) as well as questions on mental activities that are more general in nature (e.g. sport, 
hobbies, recreational activity, musical activities). Participants complete the LEQ on the basis 
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of retrospective recall of information from each of the age bands. Specific and non-specific 
subscores for each life stage are calculated, yielding an overall total LEQ score. Higher LEQ 
scores indicate that the respondents have undertaken more complex mental activity over their 
lifespan and has been shown to independently predict reduced age-related cognitive decline as 
well as a reduced rate of hippocampal atrophy (Valenzuela et al., 2008). 
 
Wechsler Adult Intelligence Scale, 3rd edition, Short Form 1 (WAIS-III-SF1; Donnell et 
al., 2007)  – The WAIS-III-SF1 provides an estimate of current intellectual capacity. This is 
achieved through the extrapolation of a full scale WAIS-III intelligence quotient from 
performance across four WAIS-III subtests. Perceptual organisation, processing speed, 
working memory, and verbal comprehension are assessed through completion of picture 
completion, digit symbol-coding, arithmetic, and similarities subtests, respectively. 
Summation of performance on these tests provides an accurate and reliable estimate of 
WAIS-III FSIQ and is validated in both normal and clinical samples (Donnell et al., 2007). 
The WAIS-III-SF1 can also be rapidly administered in less than 20 minutes. 
 
Wide Range Achievement Test, 4th edition, Progress Monitoring Version (WRAT-4-
PMV; Roid & Ledbetter, 2006) – The WRAT-4-PMV assesses word reading, sentence 
comprehension, spelling, and math computation in adults with higher secondary education. 
Each individual task (e.g. word reading) takes approximately 5-10 minutes to complete and 
includes four parallel versions to allow for effective retesting. Raw scores on each subtest can 
be converted to Level Equivalent Scores (LES), which provides a comparable score for forms 
(Roid & Ledbetter, 2006). Originally developed to assess the academic progress of 
individuals exposed to education, the WRAT-4-PMV is ideal for quantifying the cognitive 
benefits that the THBP experimental group obtain from participation in tertiary education 
(Summers et al., 2013). 
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Memory and learning 
 
Rey Auditory Verbal Learning Test (RAVLT; Strauss et al., 2006) – The RAVLT assesses 
verbal episodic learning and memory and is useful in evaluating recent memory, susceptibility 
to (proactive and retroactive) interference, encoding versus retrieval, retention of information 
after a certain period of time, and recognition memory. The RAVLT is sensitive to memory 
decline in early AD and MCI (Saunders & Summers, 2010; 2011), as well as predicting risk 
for progressing to AD from MCI (Summers & Saunders, 2012). The examiner reads aloud a 
list of 15 words (List A) at the rate of one word per second. The subject must repeat as many 
words from List A that they remember in any order. List A is read aloud to the participant on 
four subsequent trials, with the participant recalling as many of the 15 words following each 
presentation trial. Following the fifth presentation of List A, the examiner verbally presents a 
second list of 15 words (List B), allowing the test-taker only one attempt at recall. 
Immediately following this, the subject must recall as many words from List A as they can. 
Finally, a recognition trial is completed whereby participants are presented with a block of 50 
words and they must circle those that they recognise from List A. Parallel versions of the 
RAVLT are available that reduce the potential for practice effects. 
 
WMS-III Logical Memory (LM; Lezak et al., 2004) – LM assesses verbal episodic memory 
through the free recall of two paragraphs and has been extensively used in the detection of 
MCI (Petersen et al., 1999). Participants are read two independent stories (A and B) with 
immediate recall after each story. After recalling story B, verbal presentation is repeated for 
that story and recall is again recorded. After a 30-minute delay, participants are asked to recall 
as much of the stories as possible, followed by a yes/no recognition test. Each story consists 
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of 25 bits of information and unit score and thematic score determine performance (Strauss et 
al., 2006). 
 
Paired Associates Learning (PAL; Cambridge Cognition Ltd., 2004) – the PAL subtest of 
the CANTAB assesses visual memory, conditional learning of pattern-location associations, 
and can be used as a tool to assess age-related memory loss. Additionally, PAL is sensitive to 
memory decline in early AD (Ahmed, Mitchell, Arnold, Nestor, & Hodges, 2008) and MCI 
(Summers & Saunders, 2012). White boxes are displayed on the screen and are opened in a 
randomised order whereby one (or more) box contains a pattern (Figure 2.1). After all the 
boxes have opened (and subsequently closed) the subject is required to touch the box where 
the centrally displayed pattern was originally located. If the subject makes an error, the 
patterns are re-presented to remind the subject of their locations. The difficulty of the task 
increases from displaying just a single pattern to displaying eight. The task is ended if the 
subject repeatedly makes mistakes on any of the levels. 
 
 
 
Figure 2.1. Display screen for Paired Associates Learning (PAL). 
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Working memory 
 
WAIS-III Digit Span (DSP; Lezak et al., 2004) - DSP assesses verbal working memory 
through the measurement of the number of discrete sequential units that an individual can 
successfully recall. DSP is sensitive to age-related declines in working memory, with more 
pronounced deficits observed after the age of 70 (Gregoire & Van Der Linden, 1997). In the 
digits-forward condition, the assessor presents digits verbally to the participant (e.g. ‘4’ ‘6’ 
‘2’), who is required to immediately repeat them back in the same order that they were 
presented in (i.e. “4,6,2). In the digits-backward condition, the participant is required to 
immediately repeat the sequence in reverse order (i.e. “2,6,4”). Either condition is 
discontinued after two consecutive incorrect responses are recorded on the same sequence 
length. DSP takes approximately 5-10 minutes for completion. 
 
WAIS-III Letter-Number Sequencing (LNS; Lezak et al., 2004) – LNS assesses the 
capacity to manipulate verbally presented information in short-term memory. This auditory 
learning task requires the reordering of an initially unordered set of letters and numbers. The 
examiner reads out a group of alternating numbers and letters (e.g. ‘7’ ‘A’ ‘2’ ‘G’) and the 
subject must say the numbers back first, in lowest-highest numerical order, and then the 
letters in alphabetical order. As the subject successfully completes trials, the length of the 
presented sequence increases. A curvilinear age-related decline is evident on the LNS, 
indicating increasingly worse scores associated with advancing age (Myerson, Emery, White, 
& Hale, 2002). The task is discontinued if the subject responds erroneously to three trials of 
the same length. LNS takes approximately 5-10 minutes for completion. 
 
Spatial Span (SSP; Cambridge Cognition Ltd., 2004) - SSP is a CANTAB subtest developed 
as a visuospatial version of the digit span test and computerised adaptation of the Corsi Block 
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Span test; as such it is designed to assess visuospatial working memory capacity. The test 
presents a pattern of white squares on the screen that change colour, one at a time, in a 
sequence (Strauss et al., 2006). The subject must correctly remember the sequence and touch 
each of the target boxes in the same order after the presentation phase has ended. After each 
correct trial, the sequence of boxes increases until either the subject can no longer respond 
with the correct sequence or the subject correctly responds to nine boxes. The test provides 
multiple measurements, including sequence length, number of errors, attempts, and delay 
time. The test takes approximately 5 minutes to complete. 
 
Spatial Working Memory test (SWM; Cambridge Cognition Ltd., 2004) – SWM is a 
CANTAB subtest that requires participants to retain and manipulate spatial information in 
working memory (Strauss et al., 2006). While SWM is sensitive to frontal lobe damage, 
damage to the temporal lobe does not affect performance (Robbins & Sahakian, 1994). The 
aim of the test is for the participant to find a blue token in each of the white boxes and fill up 
the column to the right (Figure 2.2). The subject decides the order in which boxes are opened, 
with the key instruction being that each box will only contain one blue token per level. 
Returning to an empty box already sampled on the search is an error (Strauss et al., 2006). 
Each successive trial displays boxes differing in colour and position to the previous trial to 
discourage stereotyped search strategies. SWM takes approximately eight minutes to 
administer, with total errors providing a measure of monitoring errors, whereby the subject 
has returned to a box that was certain not to contain a token. SWM total errors measures 
aspects of the central executive. 
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Figure 2.2. Display screen for Spatial Working Memory (SWM). 
 
 
 
Executive function 
 
Stroop test (Lezak et al., 2004)– The Stroop test provides a measure of executive functioning 
through assessment of cognitive control, the ease with which a person can maintain a goal in 
mind and suppress a habitual response in favour of a less familiar one (Strauss et al., 2006). 
The Victoria version is a 24-item short version assessing speed of information processing and 
impulse control for auditory-verbal information (Lezak et al., 2004). The test consists of three 
cards, each containing six rows of four items. The first card requires the subject to name, as 
quickly as possible, the colour of 24 dots printed in blue, green, red, or yellow. The second 
card is similar to the first, except the dots are replaced by common words (e.g. ‘when’, 
‘hand’, ‘over’), and the subject must name the colours of the words. The final card is similar 
to the previous two, but the coloured stimuli are colour names (‘blue’, ‘green’, ‘red’, 
‘yellow’). This requires the participant to inhibit an automatic reading response and to 
produce a more effortful colour-naming response. The extra time required to name colours in 
the interference task, compared to the time required to name colours in the control task, gives 
the interference score. 
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Rapid Visual Processing (RVP; Cambridge Cognition Ltd., 2004) – RVP is a test of 
sustained attention with a working memory component. Sensitive to dysfunction in the frontal 
and parietal lobes of the brain (Sahakian & Coull, 1993), the test displays a white box in the 
centre of the screen, inside which digits, from 2 to 9, appear in a pseudorandom order, at the 
rate of 100 digits per minute. The subject must detect three distinct digit sequences (3-5-7; 2-
4-6; and 4-6-8), occurring at a rate of 16 every two minutes, and register responses by 
pressing a button on the response pad. The target digit sequences are displayed on the screen 
to the right of the central stimulus window, thereby reducing the memory load for task 
performances. The test takes approximately seven minutes to complete, and no cues or 
feedback are given regarding accuracy. Prior to commencing the assessed block, a practice 
phase is completed (Figure 2.3). Measures of target detection threshold and sustained 
attention are given by accuracy and mean latency, respectively, are obtained. 
 
 
 
Figure 2.3. Display screen for Rapid Visual Processing (RVP). 
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Trail Making Test (TMT; Lezak et al., 2004) provides an assessment of processing speed, 
sequencing, mental flexibility and visual-motor skills (Bowie & Harvey, 2006). The test 
comprises Part A and Part B. In Part A, the subject is required to draw a line that connects 
numbered circles, sequentially, from ‘1 to 25’. In Part B, the subject is required to draw a line 
that connects alternating circles of numbers and letters. From ‘1’, the subjects first draws to 
‘A’, then to ‘2’, then to ‘B’, and so on (Lezak et al., 2004). In both Part A and Part B, the 
subject is required to complete the task as quickly and as accurately as possible. While Part A 
is considered to be a test of visual search and motor speed skills, Part B is said to assess 
higher level cognitive skills, such as divided attention and mental flexibility (Bowie & 
Harvey, 2006). 
 
Language processing 
 
WAIS-III Vocabulary (VOC; Lezak et al., 2004) – VOC assesses the capacity to recognise 
common words and provide definitions for them in the English language. Words are 
presented visually (using a stimulus book) and verbally by the examiner simultaneously, 
participants are asked to correctly define each word with the words becoming progressively 
more difficult (i.e. less common usage). For example, easier words include ‘winter’ and 
‘breakfast’, whereas more difficult words include ‘encumber’ and ‘tirade’. Responses are 
recorded and matched to answers supplied in the scoring booklet. A complete answer gives 
two-points, a less complete answer gives one-point, and an irrelevant response scores zero. 
The assessor may prompt the subject for more information (‘Can you tell me any more about 
it?’) if a relevant but incomplete response is given. The task is discontinued if the subject 
scores zero on eight items in succession. 
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WAIS-III Comprehension (COM; Lezak et al., 2004) – COM assesses capacity to use 
language to express ideas and understand verbal communication. The task requires subjects to 
respond to questions that require understanding of concepts and social practices. For example, 
‘Why does the state require marriages to be officially registered?’. Responses are recorded 
and matched to answers supplied in the scoring booklet. A complete answer gives two-points, 
a less complete answer gives one-point, and an irrelevant response scores zero. The assessor 
may prompt the subject for more information (‘Can you tell me any more about it?’) if a 
relevant but incomplete response is given. The task is discontinued if the subject scores zero 
on four items in succession. 
 
Boston Naming Test (BNT; Kaplan et al., 1983) – The BNT is a widely used naming test 
that requires the respondent to identify objects represented as line drawings. Impairments to 
word-finding ability is a characteristic of preclinical AD (Jacobs et al., 1995) and the BNT 
has been demonstrated to predict the rate of cognitive decline in AD (Rasmusson, Carson, 
Brookmeyer, Kawas, & Brandt, 1996). The test comprises 60 drawings with the respondent 
beginning on the 30th item and continuing forwards unless an error is recorded within the first 
eight items. As the test progresses, the objects that the respondent is required to identify 
become less frequently encountered and, as such, the items are more difficult. On average, the 
test takes approximately 5 minutes to complete. 
 
Procedure 
 
Trained assessors undertook the testing for baseline THBP assessments in a quiet room. The 
screening, neuropsychological, and CANTAB tests were administered in the following order: 
WTAR; LEQ; DRS-2; MHSQ; WAIS-III-SF1; WRAT; PAL; RAVLT; LM; SSP; SWM; 
DSP; LNS; VOC; COM; RVP; BNT; Stroop; TMT; HADS. The LEQ and WTAR were only 
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administered during the baseline assessment. As these tests were part of the THBP’s larger 
test battery, baseline assessments took approximately 4 hours to administer, with subsequent 
assessments completed in approximately 3.5 hours. Subjects were encouraged to take 10-
minute breaks whenever required to reduce fatigue. The CANTAB tests were administered 
through a standardised script on a Cambridge Cognition Ltd. supplied 17-inch touch-sensitive 
screen with response pad to measure reaction time. Participants were seated approximately 
50cm from the touch-screen with the response pad positioned in a comfortable position 
approximately 15cm from the screen. 
 
Genetic stream 
 
In addition to the neuropsychological stream, genetic samples were collected from THBP 
subjects for APOE and BDNF genotyping. These genes were investigated due to their 
involvement in cognitive ageing, AD risk, and neuroprotective mechanisms. Although not an 
exhaustive list of potential genetic polymorphisms related to cognition, other candidate genes 
(e.g. KIBRA, COMT) were the subject of parallel investigations within the THBP and, as 
such, were not analysed in the present thesis.  
 
Materials 
 
DNA samples were collected with Oragene DNA self-collection kits supplied by Genotek. 
Instruments and reagents used for DNA extraction and purification were a microcentrifuge 
(Eppendorf), 1.5 mL microcentrifuge tubes (Astral Scientific: 11210-00), PrepIT.L2P reagent 
(Genotek: QUO-09611-KZNX), DNA TE storage buffer (pH 8.0), ethanol, and an air 
incubator. 
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BDNF Val66Met and APOE genotypes were determined through one-step amplified 
refractory mutation system polymerase chain reaction (ARMS-PCR; Little, 2001) and 
subsequent gel electrophoresis. Common instruments and reagents used for APOE and BDNF 
genotyping were a vortex, a Mastercycle gradient thermal-cycler (Eppendorf), Red-extract-N-
Amp (Sigma: R4775), Diethyl Pyrocarbonate (DEPC) treated water (150903), Sybr-safe 
DNA gel stain (Invitrogen: 533102), a Chemi-do UV light source (Biorad), wide-mini gel 
electrophoresis trays (Biorad), Tris-acetate-EDTA (TAE) buffer, agarose powder (Bioline 
Australia: Bio-41025), and Hyperladder IV (Bioline: Bio-33031). 
 
PCR primers specific to APOE genotyping were used from an established assay (Donohoe, 
Salomäki, Lehtimäki, Pulkki, & Kairisto, 1999): Cys158/Arg158 (5’-
ATGCCGATGACCTGCAGAATT-3’)/(5’ATGCCGATGACCTGCAGAATC-3’), 
Cys112/Arg112 (5’-CGCGGACATGGAGGACGTTT-3’)/(5’-
CGCGGACATGGAGGACGTTC-3’). The 3’-most nucleotide recognised either A or G 
corresponding to Arg or Cys at positions 112 or 158, respectively. To enhance primer 
specificity, the penultimate nucleotide (underlined) was mismatched. Additionally, a common 
primer was used (5’-GTTCAGTGATTGTCGCTGGGCA-3’) that paired with Arg/Cys 158 or 
Arg/Cys 112 and produced an amplicon of 588 and 451 base pairs (bp), respectively. To act 
as an internal positive control, the α-antitrypsin gene was coamplified at 360-bp. 
 
PCR primers specific to BDNF genotyping were used from an established assay (Sheikh, 
Hayden, Kryski, Smith, & Singh, 2010): P1 forward 
(CCTACAGTTCCACCAGGTGAGAAGAGTG); P2 reverse 
(TCATGGACATGTTTGCAGCATCTAGGTA); P3 G allele specific (5’-
CTGGTCCTCATCCAACAGCTCTTCTATAAC-3’); P4 A allele specific (5’-
ATCATTGGCTGACACTTTCGAACCCA-3’). The first set of primers (P1 and P2) 
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amplified the 401 bp region containing the SNP of interest (rs6265) and the second set (P3 
and P4) were allele specific. Underlined nucleotides represent intentional mismatching to 
enhance primer specificity. 
 
Procedure 
 
Prior to taking part in the genetic component of the study, participants were supplied with 
information sheets and informed consent was obtained. Participation in the genetic 
component was not a requirement of the THBP. For those who consented (response rate: 
92%), Oragene DNA self-collection kits were mailed to participants with instructions to 
complete and return. Alternatively, subjects could opt to donate their sample during their 
annual assessment. Before genotyping, the sample was extracted and purified. Genotyping 
was repeated on samples to ensure accuracy. DNA extraction, purification, and genotyping 
took place at the Menzies Research Institute laboratories. 
 
DNA extraction and purification 
 
Each Oragene kit contained a buffer solution which, when mixed with the sample, stabilised 
the DNA at room temperature. Samples were then air-incubated at 50oC overnight to 
inactivate nucleases and to ensure DNA was adequately released. For each sample, 500 µL 
was transferred to a 1.5 mL microcentrifuge tube with 20 µL of PT-L2P added to precipitate 
impurities and inhibitors. The remaining 1.5 mL of sample stored in a secure location. 
Samples were then vortex-mixed and incubated on ice for 10 minutes, which assisted in 
impurity removal. Following this, centrifuge for 5 minutes at 13,000 rpm formed a pellet of 
impurities in each sample. The clear supernatant was transferred to a fresh microcentrifuge 
tube and the pellet discarded. To precipitate the DNA, 600 µL of room temperature 95% to 
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100% ethanol was added, and mixed gently by inversion 10 times. The samples were allowed 
to stand at room temperature for 10 minutes to allow the DNA to fully precipitate. After 
precipitation, the samples were centrifuged, in a known orientation, for 2 minutes at 13,000 
rpm. A pellet of DNA was formed and the impurity-containing supernatant was carefully 
removed. The final steps involved an ethanol wash to removal residual inhibitors and the 
addition of 500 µL of Tris-EDTA buffer followed by vortex to ensure hydration of DNA. The 
DNA was stored in a refrigerator at 4°C for seven days before use. 
 
APOE genotyping 
 
Two SNPs (rs429358, rs7412) were assessed to determine APOE polymorphisms. Two 
separate PCR reaction mixtures were assembled using amplification-refractory mutation 
system (ARMS; Little, 2001). Reaction A contained 0.8 µmol/L Cys 158 (451 bp) and 0.4 
µmol/L Cys112 (588 bp) primers while Reaction B contained 0.8 µmol/L Arg158 (451 bp) 
and 0.4 µmol/L Arg112 (588 bp) primers. Both reactions contained RED Extract-N-Amp 
PCR mix and ARMS primer. Depending on how many samples were being genotyped, 11 µL 
of Reaction A PCR mixture was added to each well in the first three to four rows of a 96 well 
plate. Similarly, 11 µL of Reaction B PCR mixture was added to wells in the lower rows of 
the plate. Subsequently, 1 µL of the participants DNA sample was pipetted into the Reaction 
A wells, with 1 µL of the same sample, corresponding to the first, added to the Reaction B 
wells. Each reaction had a no template control to exclude contamination. The DNA product 
was amplified by placing the 96 well plate in a thermal-cycler for initial denaturation at 95°C 
for 4 min, followed by 35 cycles of denaturation at 96°C for 45 s, annealing at 65°C for 45 s, 
and extension at 72°C for 45 s. Finally, one last cycle of extension at 72°C for 5 min 
completed the amplification. 
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For gel electrophoresis, 1 x TAE was mixed with agarose powder and dissolved in a 
microwave oven to yield a 1.5% concentration agarose solution. Eighty millilitres of agarose 
solution were combined with 5 µL of Sybr-safe DNA stain for visualisation and poured into a 
mould with a comb inserted. After the gel had set, the comb was removed revealing wells in 
to which amplified DNA product could be pipetted. To support conductivity, the gel was 
placed into a wide sub cell gel tray and covered with 1 x TAE. Using a pipette, 5 µL of 100 
bp DNA ladder was loaded into the first well, with 9 µL of amplified DNA product loaded 
into subsequent wells, in order: Sample 1 Reaction A, Sample 1 Reaction B; Sample 2 
Reaction A, Sample 2 Reaction B. The no template control samples were loaded last. The 
samples were electrophoresed for 30-40 minutes at 110 volts, with resulting bands visualised 
with UV light and Quantity One software (Figure 2.4). 
 
To determine genotypes, banding was compared to previously established banding patterns 
(Donohoe et al., 1999). An ε2 ε2 genotype was identified by a Cys112 (588 bp) and Cys158 
(451 bp) positive double band in Reaction A, with banding absent in Reaction B. An ε2 ε3 
genotype was identified by a Cys112 (588 bp) and Cys158 (451 bp) positive double band in 
Reaction A, with a Arg112 (588 bp) positive single band in Reaction B. An ε3 ε3 genotype 
was identified by a Cys158 (451 bp) positive single band in Reaction A and an Arg112 (588 
bp) positive single band in Reaction B. An ε3 ε4 genotype was identified by a Cys158 (451 
bp) positive single band in Reaction A and an Arg112 (588 bp) and Arg158 (451 bp) positive 
double band in Reaction B. An ε4 ε4 genotype was identified by banding absent in Reaction 
A, with an Arg112 (588 bp) and Arg158 (451 bp) positive double band in Reaction B. Finally, 
an ε2 ε4 genotype was identified by a Cys112 (588 bp) and Cys 158 (451 bp) positive double 
band in Reaction A and an Arg112 (588 bp) and Arg158 (451 bp) positive double band in 
Reaction B. 
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Figure 2.4. An imaged APOE gel electrophoresis for six DNA samples and a no template 
control sample. All APOE genotypes are present except ε2 ε2.  
 
 
 
BDNF Val66Met genotyping 
 
A SNP (rs6265) was assessed to determine BDNF polymorphisms. A PCR reaction mixture 
was assembled using ARMS (Little, 2001) that contained 1.5 µmol/L P1 (forward), 1.25 
µmol/L P2 (reverse), 0.75 µmol/L P3 (G allele specific), 1.25 µmol/L P4 (A allele specific), 
and RED Extract-N-Amp PCR mix. For each 1.0 µL of DNA, 11 µL of PCR mix was added 
to a 96 well plate. The DNA product was amplified by placing the 96 well plate in a thermal-
cycler for initial denaturation temperature of 94°C for 5 min, followed by 30 cycles of 
denaturation at 94°C for 45 s, annealing at 62.5°C for 60 s, and extension at 72°C for 60 s. 
Finally, one last cycle of extension at 72°C 5 min completed the amplification. 
 
For gel electrophoresis preparation, an identical method was used as per APOE genotyping. 
After the gel had set it was placed into a wide sub cell gel tray and covered with 1 x TAE to 
support conductivity. Using a pipette, 5 µL of 100 bp DNA ladder was loaded into the first 
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well, with 9 µL of amplified DNA product loaded into subsequent wells. The no template 
control sample was loaded last. The samples were electrophoresed for 30-40 minutes at 110 
volts, with resulting bands visualised with US light and Quantity One Software (Figure 2.5). 
A Val/Val genotype was identified by a single 253 bp band, a Met/Met genotype was 
identified by a single 201 bp band, and a double band (253 and 201 bp) identified a Val/Met 
genotype. The 400 bp line was the control amplicon. 
 
 
 
 
Figure 2.5. An imaged BDNF gel electrophoresis for 12 DNA samples and a no template 
control sample. V/V = Val/Val, V/M = Val/Met, M/M = Met/Met. 
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Chapter 3 
Modelling cognitive reserve in healthy middle and older aged adults: The Tasmanian 
Healthy Brain Project 
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Abstract 
 
Cognitive reserve (CR) is a protective factor that supports cognition by increasing the 
resilience of an individual’s cognitive function to the deleterious effects of cerebral lesions. A 
single environmental proxy indicator is often used to estimate CR (e.g. education), possibly 
resulting in a loss of the accuracy and predictive power of the investigation. Furthermore, 
while estimates of an individual’s prior CR can be made, no operational measure exists to 
estimate dynamic change in CR resulting from exposure to new life experiences. This chapter 
aimed to develop two latent measures of CR through factor analysis: prior and current, in a 
sample of 467 healthy older adults. The prior CR measure combined proxy measures 
traditionally associated with CR, while the current CR measure combined variables that had 
the potential to reflect dynamic change in CR due to new life experiences. The main finding 
of this chapter was that the analyses uncovered latent variables in hypothesised prior and 
current models of CR. The prior CR model supports multivariate estimation of pre-existing 
CR and may be applied to more accurately estimate CR in the absence of neuropathological 
data. The current CR model may be applied to evaluate and explore the potential benefits of 
CR-based interventions prior to dementia onset. 
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Introduction 
 
The predicted epidemic increase in the incidence of dementing degenerative illnesses, such as 
AD over the next 10-20 years (Access Economics, 2011) has focused international research 
efforts on identifying potential pharmacological agents that can delay or prevent AD. An 
alternative, non-pharmacological approach receiving less attention is increasing 
understanding of what contributes to, and how to increase, the brain’s ability to sustain 
effective cognitive function in the presence of cerebral lesions. CR is a hypothetical construct 
that describes neurological processes that support cognitive function in the face of pathology-
related neural disruption (Stern, 2002). Two complimentary neural processes, neural reserve 
and neural compensation, result in brain networks being better able to resist or compensate for 
the effects of neurological degeneration (Stern et al., 2005). Individuals with higher CR, 
generated by a lifetime of cognitive engagement, have lower risk for dementia despite no 
decrease in their risk for accumulating frank AD pathology (Stern, 2002). Although CR has 
been researched intensively, few factor-supported operational measures exist for accurately 
estimating an individual’s CR. 
 
The notion that CR protects against the emergence of clinical symptoms in neurodegenerative 
disorders is supported by an autopsy investigation that found a subset of pathologically-
confirmed AD cases with preserved cognition prior to death (Katzman et al., 1988). 
Subsequent investigations identified education, occupational attainment, intelligence, and 
participation in cognitively stimulating leisure activities as being lifetime contributors to CR 
(Stern, 2002). Excluding intelligence, the majority of proposed CR proxies are measures of 
environmental exposure (Stern, 2002), with measures of individual cognitive processes 
tending not to be used as estimates of CR, with the possible exception of executive function 
(Satz et al., 2011). Earlier studies demonstrating an inverse relationship between educational 
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or occupational attainment and risk for dementia (Ott et al., 1995; Stern et al., 1994) have 
been supported by more recent data (Basu, 2012; Brayne et al., 2010; Karp et al., 2009; Meng 
& D'Arcy, 2012). Intellectual factors have been shown to possess similar cognition-preserving 
effects (Galioto et al., 2013; Rentz et al., 2010; Vemuri et al., 2011). Importantly, CR is 
modifiable throughout life and cognitively stimulating leisure activities in adults over the age 
of 65 years are also associated with a reduced risk for dementia (Akbaraly et al., 2009; Norton 
et al., 2012; Wilson et al., 2010)  and age-related cognitive decline (Small, Dixon, McArdle, 
& Grimm, 2012; Wang et al., 2012). However, such studies using longitudinal designs 
focused solely on a single-point measure of cognitive activities at baseline and neglect 
consideration of potential change in activities over time.  Nonetheless, two systematic reviews 
have reported significant reductions in risk for dementia in people who lived cognitively 
engaged lives (Fratiglioni & Wang, 2007; Valenzuela & Sachdev, 2006). 
 
Neuroimaging studies indicate that life experience contributes to the preservation of cognition 
above and beyond the development of cognitive strategies that offset dementia. For example, 
in vivo investigations have linked some CR proxies to the integrity of neurological structures, 
suggesting an overlap between CR and cerebral reserve hypotheses (Barulli & Stern, 2013). 
Healthy individuals with more education have larger regional cortical thickness in transverse 
temporal cortex, insula, and isthmus of cingulate cortex (Liu et al., 2012), and greater grey 
and white matter brain volumes (Foubert-Samier et al., 2012). As people with higher IQs 
obtain more education which, in turn, increases IQ (Brinch & Galloway, 2012; Ceci, 1991), 
the expected positive correlation between IQ and grey matter volume has also been reported 
(Colom et al., 2006; Haier et al., 2004). Life experience may also provide benefits through 
direct modification of detrimental age or disease processes, and data that relate lifetime 
cognitive engagement to reductions in Aβ deposition (Landau et al., 2012) and rates of 
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hippocampal atrophy (Valenzuela et al., 2008) have further underlined the importance of a 
lifespan approach to measuring CR. 
 
As education, occupational attainment, and participation in leisure activities have been found 
to differently and independently contribute to CR (Foubert-Samier et al., 2012), a 
comprehensive estimate of CR must incorporate a number of contributors effectively 
(Sánchez et al., 2011). To date, the majority of research has focused on a single CR proxy 
when investigating potential relationships with dementia, whereas the assessment of multiple 
proxies over a lifespan may lead to research that improves understanding, and accurate 
application, of the theoretical construct. Despite criticism of the a priori grouping of CR 
proxies regarding construct validity (Satz et al., 2011), recent investigations increasingly take 
into account multiple proxy measures when assessing CR (Foubert-Samier et al., 2012). The 
method of combining several indicators of CR may provide a more precise estimate of reserve 
than can be obtained from the use of a single indicator (Jones et al., 2011). 
 
Estimates of pre-existing CR that incorporate a range of proxy measures will most accurately 
reflect the individual’s ability to compensate for neuropathology, yet commonly used CR 
variables do not allow for dynamic change in an individual’s reserve due to new life 
experiences. Importantly, CR is not set in early life and, rather than being static, continues to 
develop and be affected by new life experiences across the lifespan (Richards & Sacker, 
2003). Despite this, CR proxies commonly used in research do not have the capacity to reflect 
a dynamic developmental change in CR, with measures of early life education, occupational 
attainment, and intelligence being relatively resistant to modulation from later life 
experiences. Another retrospectively measured CR proxy variable is frequency of 
participation in cognitively stimulating activities (Wilson et al., 2010). However, participation 
in leisure activities in adult life is susceptible to change over time, and CR-based 
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interventions that determine the effect of modulation in cognitive activities are eagerly 
awaited (Stern, 2012). Although interventions that aim to increase CR in later life hold 
promise (Tucker & Stern, 2011), no operational measure exists to provide an estimate of 
dynamic change in CR resulting from exposure to new experiences. Such a measure might 
comprise cognitive tests that can detect changes in cognitive function due to exposure to 
environmental factors that contribute to prior CR (e.g., education). It is in the interest of the 
CR hypothesis that a validated measure of current CR is developed so that the efficacy of 
later life interventions can be assessed prior to dementia onset. 
 
The THBP is an on-going longitudinal investigation into the hypothesis that later-life tertiary 
education may result in increased CR, potentially contributing to delayed expression of 
clinical dementia symptoms (Summers et al., 2013). The sample consists of cognitively 
healthy older community-residing subjects, aged 50-79 years at study entry, who will 
complete annual comprehensive neuropsychological assessments. The need for factor-
supported operational measures of CR is high, and the present study aims to develop two 
latent constructs of reserve: prior and current. The prior CR factor was derived from proxy 
measures traditionally associated with CR: estimated pre-existing intellectual capacity; 
cognitive life experience; and prior education. The current CR factor was derived from 
measures that had the potential to reflect dynamic change in CR in response to later life 
activities that increase reserve: current intellectual capacity and academic ability. This 
measure of CR would allow preliminary examination of the efficacy of the later life education 
intervention central to the THBP, prior to dementia onset. Both latent CR variables, prior and 
current, were constructed through factor analysis with the principal component analysis 
extraction method. This generated weighted linear combinations of CR proxies, which, when 
added together, represented quantifiable estimates of CR, both prior and current, for each 
participant in the THBP. 
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Method 
 
Study population 
 
A total of 467 healthy English-speaking participants from the longitudinal THBP completed 
the baseline neuropsychological battery after informed consent was obtained. Trained 
assessors obtained measures of CR variables, neuropsychological function, and health and 
psychosocial function (Summers et al., 2013). Subjects were community residing 50-79 year 
olds at their first neuropsychological assessment, were predominantly female (68.1%), and 
were recruited through an on-going campaign that involved print, radio, television 
advertising, and community information presentations. All participants underwent screening 
as described in chapter 2. Participants were not compensated for their time; however, those 
participating in the THBP’s experimental group were eligible to receive a waiver of 
individual course charges (Australian Higher Education Contribution Scheme) for a study 
load equivalent to a 12.5% unit per academic year at the University of Tasmania. The study 
had full approval from the Tasmania Human Research Ethics Network and was conducted in 
accordance with the ethical guidelines of the National Health and Medical Research Council 
of Australia (NHMRC). 
 
Materials 
 
Participants completed a comprehensive test battery as described in detail elsewhere (chapter 
2). To ensure that the sample was free from dementia symptoms and in good physical and 
psychological health, the Mattis Dementia Rating Scale-2 (DRS-2; Jurica et al., 2001), 
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Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983), and the Medical 
Health Status questionnaire (Summers et al., 2013) were used . The DRS-2 objectively 
assessed the presence and progression of dementia of Alzheimer’s type, vascular dementia, 
Parkinson’s disease, and Huntington’s disease. The HADS assessed symptoms of anxiety and 
depression via self-report and has been widely used to detect such disorders among 
respondents (Bjelland et al., 2002). A self-report medical health status questionnaire assessed 
health, medical conditions, prescription medication use, drug and alcohol use for the 
preceding 12 months (Summers et al., 2013). This questionnaire was developed for the THBP 
and also collected demographic information such as age, gender, handedness, height, weight, 
marital status, and educational and occupational history. An experienced neuropsychologist 
(MS) reviewed performance on these tools to determine participant inclusion. 
 
Prior cognitive reserve variables 
 
To generate factors associated with prior CR, the Wechsler Test of Adult Reading (WTAR; 
The Psychological Corporation, 2001) was used to estimate pre-existing intellectual capacity, 
the Lifetime of Experiences Questionnaire (LEQ; Valenzuela & Sachdev, 2007) was used to 
quantify prior lifetime experience, and number of years of prior formal education was 
recorded on the Medical Health Questionnaire (Summers et al., 2013). The WTAR provided a 
stable and reliable estimate of pre-existing intellectual capacity by assessing the capacity of 
the participant to correctly pronounce 50 atypical grapheme-phoneme words (e.g. ‘ogre’). 
Using words with irregular pronunciations minimises the individual’s current ability to apply 
standard pronunciation rules to assess previous learning of the word. As such, the WTAR can 
be applied to estimate intellectual function prior to traumatic brain injury (Green et al., 2008) 
and dementia onset (Donnell et al., 2007). Furthermore, tests of reading ability are frequently 
used to estimate CR (Lo et al., 2013; Vemuri et al., 2011). The LEQ is a self-report 
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retrospective questionnaire that assessed the full range of complex mental pursuits 
(educational, occupational, and leisure activities) that build up over a person’s lifetime from 
young adulthood, mid-life, and late-life stages (Valenzuela & Sachdev, 2007). The LEQ has 
demonstrated adequate validity (Cronbach’s α = 0.66) and reliability (3-6 month test-retest r = 
.98; Valenzuela & Sachdev, 2007). For the purpose of factor analysis, only specific, non-
specific, and continuing education sub-scores from Young Adulthood and Mid-Life sections 
of the LEQ were used. The LEQ Midlife Specific subscale, which provided a measure of 
occupational attainment, comprised a set of questions that determined the classification of 
each occupation engaged in and the managerial capacity of each occupation within the 30-65 
years age bracket (Valenzuela & Sachdev, 2007). Total number of years of prior formal 
education was calculated as the sum of school education and post-secondary education 
reported by each participant. 
 
Current cognitive reserve variables 
 
To identify factors associated with current CR, the Wechsler Adult Intelligence Scale, 3rd 
edition Short Form 1 (WAIS-III-SF1; Donnell et al., 2007) was used to assess current 
intellectual capacity and two components from the Wide Range Achievement Test, 4th 
edition, Progress Monitoring Version (WRAT-4-PMV; Roid & Ledbetter, 2006), were used 
to assess current academic ability. The WAIS-III-SF1 extrapolates the full scale WAIS-III 
intelligence quotient from the performance across four WAIS-III subtests (picture completion, 
digit symbol coding, similarities, and arithmetic; Donnell et al., 2007). The WRAT-4-PMV 
assesses academic performance factors: word reading; sentence comprehension; spelling; and 
math computation ability in adults with higher secondary education (Roid & Ledbetter, 2006). 
Scores in each WRAT-4-PMV subtest increase with level of education, including into 
college/university level. The WRAT-4-PMV was selected for its capacity to detect increased 
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performance in subtests associated with increasing levels of education (Roid & Ledbetter, 
2006). This differentiates education’s contribution to prior CR, as measured by years, from 
current CR, by estimating future education-related change in cognitive function. For the 
current CR model, only spelling and math computation were included, as reading could 
confound with the WTAR, which comprises prior CR, and sentence comprehension reported 
a very low extracted communality value (.31). A previous version of the WRAT (WRAT-R) 
has been shown to correlate highly (r = .73) with the WTAR (Strauss et al., 2006), and in the 
present sample high correlations were found between WTAR and WRAT reading (r = .69) 
and WRAT spelling (r = .61), but not between WTAR and WRAT math computation (r = 
.30). 
 
Procedure 
 
Participants were administered the selected tests by trained assessors as part of the larger 
THBP assessment battery (Summers et al., 2013), which examined additional cognitive 
domains (memory and learning, working memory, language, executive function). The 
assessment process took four hours to complete, on average, and was undertaken in a quiet 
room. Subjects were encouraged to take 10-minute breaks as needed to reduce symptoms of 
fatigue. 
 
Data analysis 
 
The data’s factorability was examined via Bartlett’s test of sphericity and Kaiser-Meyer-Olkin 
measure of sampling adequacy. Factor analysis with the principal components extraction 
method was conducted separately for the prior CR factors and for the current CR factors. 
Principal components extraction was selected to maximize the likelihood that each variable 
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would contribute to final CR models. Varimax rotation was used to ensure that the extracted 
factors remained independent and because it produced the simplest factor structure, which 
allowed for increased interpretability - a priority when using factor analysis (Kline, 2002). For 
prior CR, the variables entered into the analysis were: Prior education (years); LEQ Young 
Adulthood Specific; LEQ Young Adulthood Nonspecific; LEQ Mid Life Specific; LEQ Mid 
Life Nonspecific; LEQ Midlife Continuing Education Bonus. For current CR, the variables 
entered into the analysis were: WAIS-III-SF1 FSIQ; WRAT-4-PMV Spelling Level 
Equivalent Score (LES); WRAT-4-PMV Math Computation LES. Factor scores for the prior 
CR factors and the current CR factor were generated for each participant using the regression 
method. For prior CR, a subject’s individual scores on all factors were added together to yield 
their overall prior CR score. All data were analysed using SPSS v21. 
 
Results 
 
Participants 
 
Participant demographics and characteristics of the final 467 THBP subjects that comprised 
the study population for this chapter are presented in Table 3.1, along with summaries of CR 
variables.  
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Table 3.1.  Descriptive statistics for the study population (N = 467) 
Variable N Mean SD Range 
Characteristics     
    Age (years) 467 60.64 6.81 50-79 
    Gender (% male/female) 467 31.7 / 68.3   
    DRS-2 AEMSS 467 12.01 2.13 6-17 
    HADS anxiety 466 5.28 3.05 0-16 
    HADS depression 466 2.48 2.24 0-12 
Prior CR     
    WTAR Est. FSIQ 466 112.50 5.47 83-123 
    Prior education (years) 467 13.83 2.75 3-28 
    LEQ Young Adulthood Specific 467 15.69 7.67 0-46.20 
    LEQ Young Adulthood Nonspecific 467 24.84 5.52 11-41 
    LEQ Mid Life Specific 466 18.93 4.73 0-25.50 
    LEQ Mid Life Nonspecific 467 24.50 5.37 7.87-38 
    LEQ Mid Life Continuing Education 466 9.52 8.30 0-46.20 
Current CR     
    WAIS-III-SF1 FSIQ 466 118.97 13.42 85-155 
    WRAT-4-PMV Spelling LES 467 568.78 16.04 499-603 
    WRAT-4-PMV Math Computation LES 466 534.99 19.97 480-588 
Note: Data represent proportions for categorical variables. DRS-2 = Dementia Rating Scale-2; 
AEMSS = Age- and education-corrected Mayo Older American normative Studies (MOANS) 
scaled score; HADS = Hospital Anxiety and Depression Scale; WTAR = Wechsler Test of 
Adult Reading; FSIQ = Full-scale IQ; LEQ = Lifetime of Experiences Questionnaire; WAIS-
III-SF1 = Wechsler Adult Intelligence Scale (3rd edition) short form 1; WRAT-4-PMV = 
Wide Range Achievement Test-4 Progress Monitoring Version; LES = Level equivalent 
scores. 
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Prior cognitive reserve factor analysis 
 
To develop a model of prior CR, the seven items were first examined for their factorability 
through widely used criteria. The sampling adequacy was verified by the Kaiser-Meyer-Olkin 
measure, KMO = .58. Bartlett’s test of sphericity, χ2 (21) = 519.74, p. < .05, indicated that the 
variables were sufficiently correlated for factor analysis. Communality values were all above 
.4, confirming that the entered variables shared sufficient common variance. As a result of 
these preliminary tests, the data were deemed suitable for factor analysis. As the goal was to 
combine CR proxy variables into a single construct that represents prior CR with composite 
scores computed for each subject in the study, the principal components extraction method 
was used. In order to test whether the structure of the prior CR model was resistant to lifetime 
variables, initial factor analyses were compared across age group (under 65 years vs. 65 years 
and over) and employment status (still working vs. retired). The results indicated that, in both 
cases, the lifetime variables modulated the resulting structure of the prior CR model. In order 
to rectify this, an additional factor analysis was conducted that retained a fourth component 
and produced a factor structure that was stable across both age group and employment status. 
In combination, these factors explained 77.10% of the variance in the dataset. The structure of 
the final prior CR model with associated factor loadings following an orthogonal rotation 
(Varimax) is displayed in Figure 3.1, with variable loadings under .50 considered not 
essential to the final model. The clustering of variables suggested that factor 1 represents 
education and intelligence, factor 2 represents cognitive activities, factor 3 represents mid-life 
education, and factor 4 represents occupational attainment. A z-score was generated for each 
subject on each factor using the regression method, with an estimate of overall prior CR 
resulting from the addition of each factor score into a total. The equation that resulted in total 
prior CR = [0.370 (WTAR IQ) + 0.408 (Prior education) + 0.567 (LEQ Young Adulthood 
Specific)] + [0.565 (LEQ Young Adulthood Nonspecific) + 0.630 (LEQ Mid-Life 
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Nonspecific)] + [0.875 (LEQ Mid-Life Continuing Education Bonus)] + [1.004 (LEQ Mid-
Life Specific)]. 
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Figure 3.1. The results of the exploratory factor analyses that identified hypothesised (A) 
prior CR (N = 464) and (B) current CR (N = 465) models in a sample of healthy adults. 
Variables that were directly measured are denoted by squares and circles denote latent 
variables. The numbers along the lines represent rotated factor loadings. Prior CR was 
determined through the addition of an individual’s scores on all three CR factors. WRAT-4-
PMV = Wide Range Achievement Test-4 Progress Monitoring Version, level equivalent 
scores; LEQ = Lifetime of Experiences Questionnaire. 
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Current cognitive reserve factor analysis 
 
To develop a model of current CR, the three items first had their factorability examined. The 
sampling adequacy was verified by the Kaiser-Meyer-Olkin measure, KMO = .62. Bartlett’s 
test of sphericity, χ2 (3) = 224.81, p. < .05, indicated that the variables were sufficiently 
correlated for factor analysis. Communality values were all above .3, confirming that the 
entered variables shared enough common variance. As a result of these preliminary tests, the 
data were deemed suitable for factor analysis. The initial factor analysis that used the 
principal components extraction method identified a single underlying component with an 
eigenvalue above Kaiser’s criterion of 1 (Kaiser, 1960). This factor explained 59.87% of the 
variance in the dataset. The structure of the current CR model with associated factor loadings 
is displayed in Figure 3.1, with variable loadings under .50 considered not essential to the 
final model. The clustering of variables suggested that the single component represents 
current CR. A z-score was generated for each subject for this factor using the regression 
method. The equation that resulted in total current CR = 0.454 (WAIS-III-SF1 FSIQ) + 0.369 
(WRAT-4-PMV Spelling LES) + 0.463 (WRAT-4-PMV Math Computation LES). 
 
Prior and current cognitive reserve differentiation 
 
To test whether the proposed prior and current models of CR could be differentiated 
statistically, a final factor analysis was conducted that included all 10 variables from both 
models. The sampling adequacy was verified by the Kaiser-Meyer-Olkin measure, KMO = 
.67. Bartlett’s test of sphericity, χ2 (45) = 1047.51, p. < .05, indicated that the variables were 
sufficiently correlated for factor analysis. An initial factor analysis that used the principal 
components extraction method identified three underlying components with eigenvalues 
above Kaiser’s criterion of 1 (Kaiser, 1960). These factors explained 56.17% of the variance 
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in the dataset, in combination. The structure of the model with associated factor loadings 
following Varimax rotation is displayed in Figure 3.2. The clustering confirmed that the 
variables that comprised prior and current CR models could be statistically differentiated, 
with the exception of WTAR Est. IQ, which loaded on the current CR component containing 
other intelligence- and academic-related variables. Importantly, the participant scores for prior 
and current CR were significantly correlated (r. = .40, p. < .01). This indicated that both 
models assessed a similar construct. 
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Figure 3.2. The results of the exploratory factor analysis that differentiated the prior and 
current models of CR (N = 462). Variables that were directly measured are denoted by 
squares and circles denote latent variables. The numbers along the lines represent factor 
loadings. The dotted lines denote an altered relationship from that which was hypothesised. 
WRAT-4-PMV= Wide Range Achievement Test-4 Progress Monitoring Version; LEQ = 
Lifetime of Experience Questionnaire. 
 
 
 
Discussion 
 
The present study was designed to use THBP baseline data to develop two factor-supported 
operational measures of CR, prior and current, using factor analysis with the principal 
components extraction method. Assessment of prior CR was based on the combination of 
traditional estimates of reserve: years of prior education; estimated pre-existing intellectual 
capacity; and lifetime of cognitively stimulating activities. Assessment of current CR was 
based on the combination of dynamic measures of current intellectual capacity and academic 
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ability. The results of the factor analyses indicate that significant latent variables were 
identified, which were labelled prior CR and current CR. Prior CR provided an operational 
measure of predominantly static CR, with the capacity to estimate an individual’s increased 
protection from dementia due to prior education, intelligence, cognitive activities, and 
occupational attainment. Current CR provided an operational measure of dynamic CR, 
comprising cognitive variables that approximate traditional CR predictors but have an 
increased potential to reflect change in cognitive function due to exposure to CR-related 
activities. The investigation supports the notion that multiple CR proxy measures can be used 
to assess CR. Future use of this method may lead to research that improves understanding and 
accurate application of the theoretical construct. 
 
Although the analyses produced prior and current CR models with interpretable extracted 
components, three issues that arose in the process warrant discussion. First, the initial 
attempts to identify a prior CR structure independent of lifetime factors were unsuccessful. 
Here, 3-factor models of prior CR were modulated by age and employment status, resulting in 
different structures of prior CR variables for different groups. However, the extraction of a 4-
factor model of prior CR resulted in a structure that was stable between groups and a prior CR 
equation that could be applied equally to all participants in the THBP (Figure 3.1). Second, a 
factor analysis of whether the models could be statistically differentiated resulted in an 
unexpected relationship (Figure 3.2). Specifically, when all variables were analysed 
concurrently, WTAR IQ, a measure of intelligence that was originally retained in the prior CR 
model, loaded significantly on the current, rather than prior, CR model. This may reflect an 
issue of shared variance, indicating that WTAR IQ does not contribute uniquely to the 
estimation of prior CR. However, it was not possible to include WTAR IQ simultaneously in 
both factor models for current and prior CR due to a high degree of shared variance with the 
WAIS-III IQ measure, as reported in previous research (r = .73; Strauss et al., 2006). 
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Ultimately, it may be impossible to disentangle current CR fully from prior CR, as current CR 
likely reflects a combination of prior CR plus change in CR (i.e., through further education). 
Third, the number of components retained in the differentiating model differs from the 
number retained in the final prior and current CR models. This is due to the decision to force 
the retention of four components in the prior CR model, whereas the full model only retained 
components with eigenvalues above Kaiser’s criterion of 1 (Kaiser, 1960). 
 
Historically, studies of CR have relied upon a single indicator variable to estimate CR, but 
this may not be the best method. The present finding that factor analysis was successful in 
creating a prior CR model provides evidence that a multivariate approach to CR results in a 
more comprehensive estimate of an individual’s prior CR. As the included proxy variables in 
the prior CR model have been shown to contribute to CR independently (Foubert-Samier et 
al., 2012; Stern, 2009), the factor analysis technique is likely to result in increased accuracy 
for assessing CR in the absence of neuropathological data. The present data support this 
notion, as the components extracted from the prior CR analysis were not highly correlated, 
indicating independent contributions to the overall CR model when each component was 
added together. If an investigation relies upon an estimate of CR derived from a single 
indicator, there is an increased risk of interpreting a factor with reduced predictive power. 
This is in line with a comprehensive review of the construct validity of the multiple indicator 
method, which concluded that techniques that combine a number of indicators, rather than an 
individual indicator, may increase the statistical and interpretive power of the CR 
measurement (Satz et al., 2011). However, as the present study does not include a measure of 
outcome (e.g., dementia onset), it is unknown whether this method produces an increase in 
predictive power when compared to a single indicator. 
 
! !!
!
83!
To date, there is no reliable or valid measure of changes to CR over time; such as might occur 
following interventions designed to enhance CR. While research continues to explore the 
potential benefits of various interventions to modify an individual’s CR and thereby reduce 
the risk of dementia within the individual (Tucker & Stern, 2011), there is no available 
operational measure of CR to substantiate the efficacy of the intervention before dementia 
onset. It is of significance that the present study successfully generated, through factor 
analysis, a measure of current CR that encompasses dynamic variables known to display 
change over time. Rather than using predominantly static variables to create the current CR 
model, measures that had the potential for change due to new life experience were used, 
which also closely approximated traditional measures of CR. Education was approximated 
using the WRAT-4-PMV (Roid & Ledbetter, 2006), which can detect change in academic 
performance (math computation, spelling) associated with increasing levels of education 
(Roid & Ledbetter, 2006). A measure of intelligence, WAIS-III-SF1 (Donnell et al., 2007), 
which is more likely to show change in intellectual function than the measure of crystallised 
intelligence used for prior CR estimation (WTAR; The Psychological Corporation, 2001), 
was used. The WTAR provides a stable estimate of intellectual capacity that is resistant to 
brain damage arising from traumatic brain injury or dementia (Green et al., 2008), while the 
WAIS-III is not resistant to disease states and reflects reductions in FSIQ due to ageing 
(Ardila, 2007).  
 
Fundamentally, CR is a hypothetical construct that is theorized to delay the expression of 
clinical deficits arising from cortical disease burden (Stern, 2002) and, although an estimate 
arising from multiple indicators is more likely to reflect this construct than a single 
variable/measure, this is still a limited approach. Empirical designs that incorporate an in vivo 
measure of brain damage/burden in addition to proxy measures of reserve and a measure of 
cognitive function will make the most influential contribution to CR literature. Such an 
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approach is becoming more popular as relevant technology becomes more widely available, 
and a number of studies have supported the hypothesis by demonstrating that higher CR is 
associated with comparable cognitive ability to those with less reserve despite having more 
severe AD pathology, such as cortical thinning (Querbes et al., 2009), medial temporal lobe 
atrophy (Perneczky et al., 2009; Teipel et al., 2009), and reduced cerebral blood flow 
(Scarmeas et al., 2003). 
 
A number of limitations in the present study warrant examination. First, the LEQ (Valenzuela 
& Sachdev, 2007) and the Medical Health Status questionnaire (Summers et al., 2013) are 
retrospective self-report questionnaires. Here, the accuracy of information gained in such a 
manner cannot be verified (Bernard, Killworth, Kronenfeld, & Sailer, 1984). Second, it is 
important to note that variation in prior CR variables will be experienced in participants even 
after this measure is taken, and that the estimation of prior CR, while predominantly static, is 
not completely fixed, particularly in those participants whose age has not yet reached 65 
years. Third, CR is a hypothetical construct that is mainly applied to samples experiencing 
traumatic brain injury or neurodegenerative disorders. The present sample was selected to be 
healthy, due to extensive screening of medical conditions and impairments prior to 
assessment and this may reduce the applicability of the data to less healthy samples. Fourth, 
although participant current CR scores at baseline THBP assessment likely reflect prior CR 
due to previous lifetime factors, it is expected that repeated assessment on this construct may 
demonstrate variance within scores attributable to the THBP intervention. With regard to the 
prior CR construct, no, or little, change is expected to occur due to exposure to the 
intervention.  
 
The current CR model will be used to evaluate the efficacy of the THBP (Summers et al., 
2013), with the equation applied annually to quantify the effects of the education intervention, 
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with increased scores thought to reflect increased CR. However, this observation cannot be 
confirmed until later in the project’s life, when a subset of study participants begins to 
experience cognitive decline. Additionally, after the onset of cognitive decline, the predictive 
power of a multivariate approach to CR will be assessed and compared to the predictive 
power of a single indicator (e.g. education). Initially, the THBP aims to determine which 
factors (i.e., genetic makeup, prior CR) moderate the magnitude of gain in current CR 
following the education intervention, and ultimately whether the intervention delays onset of 
cognitive decline. Other future investigations should validate the present models of CR using 
confirmatory factor analysis and attempt to identify additional proxies of CR that can be used 
to increase the predictive power of reserve estimates. 
 
In conclusion, the present study demonstrates that multiple CR proxy indicators can be 
successfully combined through factor analysis to yield two operational models of CR: prior 
and current. The prior CR model may more accurately reflect the CR hypothesis than a single 
indicator, while the current CR model provides a measure of dynamic change in CR over 
time. These methods of estimating CR will be used in the THBP to explore the modifiability 
of CR in later life due to participation in tertiary education, and will contribute data to 
elucidate why some older adults can temporarily suppress the detrimental effects of AD 
pathology, while others cannot. 
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Chapter 4 
APOE and BDNF Val66Met polymorphisms combine to influence episodic memory 
function in older adults !  
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!
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Abstract 
 
Genetic polymorphisms of APOE and BDNF have shown inconsistent associations with 
healthy adult cognitive functions. Recent investigations have suggested that APOE 
polymorphisms do not contribute to non-pathological cognitive function and that any effect is 
likely due to prodromal AD. Similarly, although BDNF Val66Met polymorphisms affect 
hippocampal morphology and function, associations with learning and/or memory have not 
always been found. This chapter sought to determine whether APOE and BDNF 
polymorphisms were associated, either independently or in combination, with adult cognition. 
Comprehensive neuropsychological assessments were conducted on 433 older adults, aged 
50-79 years (M = 62.16, SD = 6.81), which yielded measures of episodic memory, working 
memory, executive function, and language processing. Participants underwent comprehensive 
neuropsychological assessment to ensure that only cognitively intact individuals comprised 
the sample. APOE and BDNF polymorphic data were used as predictors in general linear 
models that assessed composite cognitive domain variables, while covarying for education 
and age. Although no main effects for APOE or BDNF were found, the analysis identified a 
significant APOE x BDNF interaction that predicted episodic memory performance (p. = .02, 
η2 = .02). Post-hoc analyses demonstrated that, in BDNF Val homozygotes, the cognitive 
consequences of APOE polymorphisms were minimal. However, in BDNF Met carriers, the 
hypothesised beneficial/detrimental effects of APOE polymorphisms were found. These data 
show that concurrent consideration of both APOE and BDNF polymorphisms is required in 
order to witness a cognitive effect in healthy older adults, with lowered episodic memory 
function present in APOE ε4/BDNF Met carriers. 
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Introduction 
 
Genetic variance has been postulated to account for individual differences in adult cognitive 
capacity (Bouchard & McGue, 1981). Importantly, the heritability of cognitive function 
increases over the lifespan (Haworth et al., 2010). Although genome-wide investigations have 
supported the genetic basis for cognition (Plomin et al., 2013), replicable single gene effects 
are rare. However, two candidate genes for adult cognitive function are APOE, the largest 
known contributor to genetic risk for late onset AD (Corder et al., 1993), and BDNF, a gene 
implicated in synaptic plasticity and neurogenesis (Bath & Lee, 2006). While both genes have 
been associated with variance in healthy cognition (Harris & Deary, 2011), such associations 
have not been reliably replicated. 
 
Inheritance of APOE ε4 is associated with an increased rate of accumulation of abnormal AD-
like pathology and detrimental hippocampal morphology, among other negative effects 
(Espeseth et al., 2008; Kok et al., 2009; Ready et al., 2011). Conversely, APOE ε2 is 
associated with neurological benefits (Suri et al., 2013), such as protection from the 
accumulation of AD-like pathology (Castellano et al., 2011) and increased cortical thickness 
(Liu et al., 2010). Some studies suggest no effect of APOE genotype on healthy cognition 
(Jorm et al., 2007; Small, Basun, & Bäckman, 1998), while others report lowered cognitive 
functions associated with the APOE ε4 allele in aging populations (Deary et al., 2004; 
Wilson, Bienias, Berry-Kravis, Evans, & Bennett, 2002a; Wisdom et al., 2011). Recent data 
indicate that a specific APOE ε4-related cognitive phenotype does not exist independently 
from dementia or mild cognitive impairment (Foster et al., 2013; Quintas et al., 2013). 
 
A second gene suggested to account for variance in healthy adult cognitive function is BDNF. 
The BDNF protein is a growth factor important to the maintenance, survival, and growth of 
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neurons (Lu et al., 2013), as well as synaptic plasticity, neurogenesis, and cell survival (Bath 
& Lee, 2006). The Met variant of the Val66Met human polymorphism has been linked to 
decreased activity-dependent secretion of BDNF at the synapse (Egan et al., 2003), and 
reduced hippocampal volume and function (Bath & Lee, 2006). Multiple investigations have 
reported BDNF polymorphism-related memory effects (Egan et al., 2003; Hariri et al., 2003; 
Raz et al., 2009). However, several other studies have reported negative results (Gong et al., 
2012; Houlihan et al., 2009; Laing et al., 2011; Stuart et al., 2014). 
 
This chapter investigated whether common variations in APOE and BDNF Val66Met are 
associated, either independently or through gene-gene interaction, with healthy cognitive 
function. Three hypotheses were examined using baseline data from the prospective 
longitudinal THBP (Summers et al., 2013): that APOE ε2 alleles are associated with better 
cognitive function and ε4 alleles are associated with worse cognitive function when compared 
to ε3 homozygotes; that BDNF Val homozygotes are associated with better cognitive function 
when compared to Met carriers; that a cumulative effect of the cognitive consequences 
associated with APOE and BDNF alleles results in the highest cognitive function in APOE 
ε2/BDNF Val carriers and the lowest cognitive function in APOE ε4/BDNF Met carriers. 
 
Method 
 
Study population 
 
The sample consisted of community-residing adults, aged 50-79 years, who consented to 
comprehensive annual assessments of neuropsychological, health, and psychosocial function 
as part of the longitudinal THBP, as described in chapters 2 and 3. However, as participation 
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in the genetic component was not a requirement of the THBP, data from 433 participants 
were available for analysis in this chapter (response rate: 92%). 
 
Materials 
 
Participants were screened to ensure that they were cognitively intact and completed a 
comprehensive cognitive test battery as described in detail elsewhere (chapter 2).  
 
Neuropsychological assessment battery 
 
Tests of cognitive function were selected to assess learning and memory, working memory, 
executive function, and language processing. In order to simplify data analysis and 
interpretation, a composite summary measure was derived for each assessed cognitive 
domain. The episodic memory variable comprised Rey Auditory Verbal Learning Test 
(RAVLT; Strauss et al., 2006), Logical Memory test (LM; Wechsler, 1997b), and Paired 
Associates Learning test (PAL; Cambridge Cognition Ltd., 2004). The working memory 
variable comprised WAIS-III Digit Span (DSP; Wechsler, 1997a), WAIS-III Letter-Number 
Sequencing (LNS; Wechsler, 1997a), Spatial Span (SSP; Cambridge Cognition Ltd., 2004), 
and Spatial Working Memory (SWM; Cambridge Cognition Ltd., 2004). The executive 
function variable comprised Rapid Visual Processing (RVP; Cambridge Cognition Ltd., 
2004), 24-item Victoria version Stroop test (Lezak et al., 2004), and Trail Making Test (TMT; 
Lezak et al., 2004). The language processing variable comprised WAIS-III Vocabulary 
(VOC; Wechsler, 1997a), WAIS-III Comprehension (COM; Wechsler, 1997a), and Boston 
Naming Test (BNT; Kaplan et al., 1983). 
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Genotyping 
 
DNA samples were collected with Oragene DNA self-collection kits (DNA Genotek Inc., 
n.d.). APOE and BDNF genotypes were determined through one-step amplified refractory 
mutation system polymerase chain reaction (ARMS-PCR) and subsequent gel electrophoresis. 
For APOE, rs429358 and rs7412 were determined by following the method described by 
Donohoe and colleagues (Donohoe et al., 1999). For BDNF, Val66Met was determined by 
following the method described by Sheikha and colleagues (Sheikh et al., 2010). PCR 
amplifications were undertaken in a 12 µl reaction volume that contained approximately 50 
ng of genomic DNA. PCR amplicons were resolved on 2% agarose gel. Genotyping was 
repeated on samples to ensure accuracy, with the proportion of concordance >99% for both 
polymorphisms. If a discrepancy in results was obtained, the samples were run a third time to 
establish genotype. 
 
Procedure 
 
Trained assessors performed the assessment of all participants at baseline THBP assessment 
(Summers et al., 2013). The assessment process took approximately four hours to complete 
and was undertaken in a quiet well-lit room. Subjects were encouraged to take 10-minute 
breaks when required to reduce fatigue. 
 
Data analysis 
 
In order to investigate whether APOE and BDNF genotypes were associated with healthy 
cognitive function, cognitive domain variables were first computed through factor (principal 
components extraction method). Factor coefficients for each of the test scores were combined 
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into a single factor score using a regression method for the episodic memory, working 
memory, executive function, and language processing domains. The extracted factor that 
explained the highest proportion of variance was retained to represent each domain (Table 
4.1). General linear models were then fitted to each cognitive domain, using APOE and 
BDNF genotype data as predictors, while covarying for age and education. The independent 
APOE variable had three levels: ε2 carriers (genotypes: ε2/ε2 & ε2/ε3); ε3 homozygotes; and 
ε4 carriers (genotypes: ε3/ε4 & ε4/ε4). To assist in interpretation, participants with the ε2/ε4 
genotype were excluded from the analysis. The independent BDNF variable had two levels: 
Val homozygotes and Met carriers. An alpha value of .05 was used for all statistical tests. All 
data were analysed in SPSS v21. As the four separate cognitive domain variables represent 
independent data, no multiple comparison corrections were applied to these analyses.  
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Table 4.1. Factor analysis results for composite cognitive domain variables 
Cognitive domain Initial eigenvalue Variable N Mean SD Loading 
Episodic memory 2.50 (62.39%) RAVLT 1-5 total 418 52.95 8.86 .76 
  LM I immediate recall total 418 48.45 8.02 .89 
  LM II delayed recall total 418 30.30 6.24 .86 
  PAL first trial memory score 418 18.33 3.48 .63 
Working memory 2.06 (51.53%) Digit span 418 18.66 3.93 .77 
  Letter-number sequencing 418 11.61 2.40 .80 
  SWM between errors 418 25.45 18.99 -.64 
  SSP length 418 5.75 1.20 .65 
Executive function 1.79 (59.50%) Stroop trial C 414 26.30 7.65 .75 
  RVP A’ 414 0.91 0.05 -.81 
  TMT trial B 414 59.16 19.09 .75 
Language processing 1.89 (62.88%) WAIS Vocabulary 432 56.59 6.28 .88 
  WAIS Comprehension 432 26.20 3.33 .78 
  Boston Naming Test 432 57.50 3.39 .71 
Note: Data in parentheses represent the proportion of variance (%) explained by the resulting factor. 
 
 
 
 
Results 
 
Subjects 
 
Eleven participants were excluded due to APOE ε2/ε4 genotype. The characteristics of the 
remaining 422 THBP participants are presented in Table 4.2. Participants in this chapter were 
62.16 (SD = 6.81) years old and had an above average IQ (M = 112.47, SD = 5.52), overall. 
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The majority were female (66.7%) and had completed a mean of 13.97 (SD  = 2.73) years of 
education. The APOE genotype distribution was 11.11% ε2 carrier, 56.4% ε3 homozygote, 
and 32.5% ε4 carrier, and did not differ significantly from Hardy-Weinberg equilibrium (χ2(1, 
N = 433) = 0.02, p. = 0.90). The BDNF Val66Met genotype allele distribution was 67% Val 
homozygote and 33% Met carrier, and also did not differ significantly from Hardy-Weinberg 
equilibrium (χ2(1, N = 433) = 0.37, p. = 0.54). Univariate ANOVAs were conducted on 
demographic and screening variables, with a single significant gene-related effect identified in 
education (years) measure (F(1,431) = 6.48, p. = .01, d = .26, power = .726). Here, more years 
of education were reported in BDNF Met carriers (M = 14.45, SD = 2.74) than in BDNF Val 
homozygotes (M = 13.74, SD = 2.70), overall. 
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Genotype and cognitive function 
 
General linear models, using APOE and BDNF as predictors, were fitted to the composite 
cognitive variables while covarying for education and age. The education covariate showed a 
significant association with every cognitive domain (p. < .05), while the age covariate was 
significantly associated with each cognitive domain (p. < .01), excluding language processing 
(p. = .06). When each gene was considered independently, the univariate ANCOVA did not 
detect any simple main effects within cognitive domains, after controlling for age and 
education (Table 4.3). 
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Table 4.3. Summary statistics for the general linear models that assessed the cognitive implications 
of variation in APOE and BDNF genotypes, independently and in combination 
Cognitive domain Predictor N df F P. η2 Obtained power 
Episodic memory APOE 407 2, 399 1.28 .28 .01 .268 
 BDNF 407 1, 399 0.76 .38 .00 .147 
 
APOE x BDNF 407 2, 399 3.87 .02 .02 .707 
Working memory APOE 407 2, 399 0.51 .60 .00 .152 
 
BDNF 407 1, 399 0.01 .93 .00 .064 
 
APOE x BDNF 407 2, 399 1.08 .34 .00 .228 
Executive function APOE 403 2, 395 0.71 .49 .00 .188 
 BDNF 403 1, 395 0.46 .50 .00 .097 
 APOE x BDNF 403 2, 395 1.39 .25 .01 .304 
Language processing APOE 421 2, 413 0.83 .44 .00 .195 
 BDNF 421 1, 413 0.01 .92 .00 .065 
 APOE x BDNF 421 2, 413 1.47 .23 .01 .316 
Note: Results were derived from analysis of covariance (ANCOVA) models after adjusting for age and 
education. 
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Figure 4.1. The significant APOE x BDNF Val66Met interaction in age- and education-
adjusted episodic memory scores (N = 407). * = significant post-hoc group difference (p. < 
.05). 
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Gene-gene cognitive interactions 
 
When gene-gene interactions were examined, a significant APOE x BDNF effect was detected 
by ANCOVA only for episodic memory, with age and education entered as covariates (Table 
4.3). Subsequent follow-up univariate ANCOVAs were conducted to test for APOE-related 
differences for BDNF Val homozygotes and Met carriers separately, after controlling for age 
and education. The results showed that, for BDNF Val homozygotes, no differences in 
episodic memory were identified as a result of variation in APOE genotype (F(2, 265) = 0.63, p. 
= .54, η2 < 0.01, power = .228). However, for BDNF Met carriers, APOE genotype was 
associated with significant variation in age- and education-adjusted episodic memory scores 
(F(2, 132) = 5.12, p. < .01, η2 = 0.06, power = 1.00). Post-hoc analysis by least squares 
difference (LSD) revealed that for BDNF Met carriers, those who were also APOE ε2 carriers 
had significantly higher (p. < .05) episodic memory scores than those who were APOE ε3 
homozygotes or APOE ε4 carriers. Although APOE ε3 carriers had higher episodic memory 
scores than APOE ε4 carriers, the difference did not reach significance (Figure 4.1). 
 
Discussion 
 
The present investigation sought to determine whether common genetic variations in the 
APOE and BDNF genes were associated with normal non-pathological cognitive function in 
older adults. Data from the THBP were used to generate composite variables of episodic 
memory, executive function, working memory, and language processing, with general linear 
models subsequently fitted. The first and second hypotheses, that variation in APOE or BDNF 
genotype is independently associated with cognitive function, were not supported. The third 
hypothesis, that a cumulative effect of the alleles’ cognitive consequences resulted in the 
highest cognitive function in APOE ε2/BDNF Val carriers and the lowest cognitive function 
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in APOE ε4/BDNF Met carriers, was partially supported. Although the lowest mean episodic 
memory performance was found in APOE ε4/BDNF Met alleles carriers, unexpectedly high 
episodic memory performance was observed in APOE ε2/BDNF Met carriers. The main 
finding of this study is that the predicted effect of variation in APOE was identified in our 
dataset, but only in carriers of the BDNF Met allele. 
 
The hypothesis that APOE is independently associated with a distinct cognitive phenotype in 
healthy adults has not received consistent support. Earlier studies described an APOE ε4-
related impairment in episodic memory (Deary et al., 2004; Wilson et al., 2002c) that was not 
seen in the present investigation. Methodological differences may account for this. The 
sample in the present study is comprised of older adults with extensive cognitive assessment 
confirming that they were all cognitively intact and medical screening to ensure that they 
were physically healthy. The extensive screening of the present sample to ensure all were 
healthy may have reduced the likelihood that we would detect cognitive effects attributable to 
APOE ε4’s effect on risk for dementia. Furthermore, if APOE ε4 is associated with 
accelerated cognitive ageing rather than simply conferring reduced cognitive processing 
(Harris & Deary, 2011; Wisdom et al., 2011), then it is possible that the present sample may 
be younger than the age at which ageing-related differences can be identified by cross-
sectional analysis. The present sample was, on average, 10 years younger than those cohorts 
in studies reporting APOE-related differences (Deary et al., 2004; Wilson et al., 2002c). 
Despite this, even at this younger age, the accumulation of toxic Aβ would have been 
initiated, particularly in those who carry the APOE ε4 allele (Kok et al., 2009). The findings 
of this chapter add to an increasing body of evidence from recent investigations that report no 
cognitive differences in healthy individuals due to APOE genotype, even in subjects aged 
above 70 years (Foster et al., 2013; Quintas et al., 2013). The present data provide further 
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evidence that an association between APOE genotype and cognition in cognitively intact 
subjects may instead reflect emerging prodromal AD in these samples (Laukka et al., 2013). 
 
Similarly, support for the hypothesised cognitive effect associated with variation in BDNF 
Val66Met was not found in the present dataset. Although the BDNF Met variant is associated 
with deficits to hippocampal morphology and function (Bath & Lee, 2006; Frodl et al., 2007), 
no significant differences were found between Val homozygotes and Met carriers on any 
cognitive domain. This supports previous investigations reporting no differences in cognitive 
processing and memory due to BDNF polymorphic variation (Gong et al., 2012; Houlihan et 
al., 2009; Stuart et al., 2014). However, the notion that BDNF is associated with memory 
function is not likely to be spurious, with a number of studies finding that a deficit in memory 
function is associated with the BDNF Met variant (Egan et al., 2003; Hariri et al., 2003; Raz 
et al., 2009). Disparities in results may be due to the profound differences in effects that 
variation in BDNF exerts across the lifespan (Casey et al., 2009). Such gene by environment 
interactions indicate that the neurological effects conferred by the BDNF polymorphism are 
complex, and ensure that differences in sample demographics, particularly age, diminish the 
idea of a simple risk allele for cognitive function. 
 
The present investigation identified a significant APOE x BDNF gene-gene interaction that 
was associated with episodic memory function. The basis for this interaction was the BDNF 
genotype-dependent effects that variation in APOE exerted. Here, the hypothesised beneficial 
and detrimental effects on episodic memory function associated with the APOE ε2 and APOE 
ε4 polymorphisms, respectively, were found only in BDNF Met carriers, with no cognitive 
implication associated with variation in APOE in BDNF Val homozygotes. Two possible 
explanations for this effect are given. First, there is a biological interaction related to the 
systems or ageing-related roles of the encoded proteins. Second, the additive effects of the 
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polymorphisms caused the analyses to reach statistical significance. The ‘additive’ 
explanation does not, however, account for the present finding that APOE ε2/BDNF Met 
carriers had the highest episodic memory function, as BDNF Met polymorphisms were 
hypothesised to be associated with decreased cognitive function.  
 
Interactions between APOE and BDNF have been previously investigated with mixed results. 
One study demonstrated a negative association between BDNF Met polymorphisms and 
working memory capacity, but found no influence of APOE on cognition, either 
independently or in combination with BDNF (Richter-Schmidinger et al., 2010). Another 
investigation showed an additive effect of APOE and BDNF on hippocampal activity during a 
memory encoding task: although reduced medial temporal lobe activation showed a dose-
dependent relationship with APOE ε4 and BDNF Met polymorphisms, the combined effect of 
both genes explained more variance than when they were considered individually (Kauppi et 
al., 2014). The researchers concluded that both genes exert converging, but independent, 
effects on memory function. Finally, a recent study identified an interaction between APOE 
and BDNF in the putative preclinical phase of AD associated with Aβ deposition in the brain 
(Adamczuk et al., 2013). In cognitively normal older adults, BDNF Met carriers showed a 
significantly higher amyloid load than BDNF Met non-carriers, but only if they were APOE 
ε4 carriers. Notably, variation in BDNF polymorphisms did not have an effect on amyloid 
load in APOE ε4 non-carriers. These investigators also found an inverse relationship between 
episodic memory and amyloid burden that was only present in APOE ε4/BDNF Met carriers. 
Similarly, in cognitively normal or MCI individuals with high Aβ, relative to BDNF Val 
homozygotes, BDNF Met carriers had a larger rate of decline in episodic memory (Lim et al., 
2013; 2014). Moreover, APOE and BDNF have been suggested to combine to affect the 
progression of pathological morphological AD-related changes in the preclinical phase (R. 
Hashimoto et al., 2009). Taken together, these findings suggest that the present data may 
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reflect a combination of an interaction of APOE and BDNF effects on medial temporal lobe 
activation, amyloid load, and atrophy, which culminate in cognitive outcomes. 
 
With interactions between APOE and BDNF reliably identified in previous research, 
knowledge of accurate population-based genotype frequencies is important for predicting the 
efficacy of possible future interventions. In the present sample, the BDNF Val66Met 
polymorphism influenced whether variation in APOE exerted cognitive effects. Consequently, 
as BDNF Met carriers comprised 33% of the sample, a third of the participants were exposed 
to the cognitive implications of polymorphic variation in APOE. A meta-analysis of 643 
subjects of varying ethnicities reported that 37% of their sample were BDNF Met carriers 
(Harrisberger et al., 2014). Similarly, a meta-analysis of 3322 subjects of majorly European 
descent reported that 36% of their sample were BDNF Met carriers (Brandys et al., 2013). 
The present data show that, in BDNF Met carriers, 6% of the variance in episodic memory 
performance was accounted for by variation in APOE genotype. Although initially a small 
effect, if an individual’s genetic makeup accounts for 50% of overall adult cognitive function 
(Bouchard & McGue, 1981), 12% of the genetically-derived episodic memory function in 
BDNF Met carriers is accounted for by the interaction identified in the present study. Overall, 
the genotype frequencies are consistent with those previously identified in the literature and, 
as a result, the present findings indicate that a large proportion of individuals in the greater 
population may show affected episodic memory due to variation in BDNF Val66Met and 
APOE. 
 
Increased understanding of complex gene-environment (Casey et al., 2009) and epigenetic 
(Egger, Liang, Aparicio, & Jones, 2004) interactions weakens the notion that simple risk 
alleles cause deterioration in cognitive function. In investigations that do find significant main 
effects for gene polymorphisms on cognitive function, the effect size is often very small. For 
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example, a meta-analysis of 77 studies comprising 40,942 cognitively normal adults identified 
an association of APOE ε4 with reduced episodic memory (d = -0.14), reduced global 
cognitive ability (d = -0.05), reduced executive function (d = -0.06), and slowed perceptual 
speed (d = -0.07; Wisdom et al., 2011). Similarly, Deary and colleagues found that the APOE 
ε4 polymorphism accounted for just 2% of the variance in verbal episodic memory 
performance (Deary et al., 2004). Investigations that examine single gene cognitive effects, 
and ignore environmental or gene product interactions, are unlikely to produce significant or 
translatable results. However, such studies can be useful in identifying potential targets for 
more complex investigations. In the present study, no cognitive effect was identified due to 
genetic variation unless genes were considered in combination. Large-scale investigations that 
utilize whole-genome sequencing may be best suited to answer questions relating to the 
genetics of human cognition (Davies et al., 2011), provided interpretations of any association 
identified take account of the magnitude of the effect size of the association rather than just 
statistical significance of an effect. 
 
A limitation of the present research is that physical activity and diet were not measured or 
controlled for. Specifically, the general linear models did not covary for such variables while 
detecting the cognitive effects of polymorphic variation. This is particularly important when 
investigating BDNF, as evidence from animal studies reliably describes elevated BDNF 
secretion in hippocampal regions of mice after exercise (Farmer et al., 2004). BDNF 
signalling may also mediate the protective effects of diet and exercise on neurodegeneration 
(Mattson et al., 2004). Moreover, the inhibition of BDNF action has been demonstrated to 
negate the cognitive and synaptic benefits of exercise (Vaynman et al., 2004). A recent study 
demonstrated that exercise provided protection against diet induced cognitive decline, an 
effect likely due to the increased presence of BDNF in hippocampal CA3 region (Noble et al., 
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2014). Future BDNF investigations should consider measures of physical activity in the 
design of their statistical analyses. 
 
In conclusion, the present study did not support the hypotheses that variation in APOE or 
BDNF is associated with cognitive function in healthy older adults. However, a significant 
APOE x BDNF interaction that was associated with episodic memory capacity was identified. 
This effect demonstrated that, in BDNF Val homozygotes, the cognitive implications of 
APOE genotype were minimal, whereas, in BDNF Met carriers, the hypothesised 
beneficial/detrimental association with APOE polymorphisms was found. The data show the 
effects of single genes on cognition are neither simple nor reliable, and that consideration of 
multiple genes and interactions is necessary. 
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Chapter 5 
The BDNF Val66Met polymorphism moderates the relationship between cognitive 
reserve and executive function 
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Abstract 
 
Cognitive reserve (CR) describes the inherent cognitive resilience and flexibility that an 
individual has. The level of CR an individual attains has been proposed to be due to a product 
of intrinsic (biologic) and extrinsic (environmental) factors, and may mitigate against risk of 
developing dementing illnesses such as AD. In 433 healthy older adults, aged 50-79 years, it 
was investigated whether common polymorphic variation in APOE or BDNF Val66Met 
influenced the association between a multivariate estimate of prior CR and healthy cognitive 
function in older adults. Results indicated that prior CR was positively associated with 
performance in each assessed cognitive domain (episodic memory, working memory, 
executive function, language processing), while age showed a negative association with each 
domain, excluding language processing. It was also found that BDNF Val66Met moderated 
the association between prior CR and cognitive function. Prior CR accounted for 8.5% of the 
variance in executive function in BDNF Val homozygotes, but prior CR was a non-significant 
predictor in BDNF Met carriers. APOE polymorphisms were not linked to the influence of 
prior CR on cognitive function. This result implicates BDNF in playing an important role in 
capacity for building or accessing CR, and may indicate that BDNF Met carriers have a 
reduced capacity to increase cognitive resilience due to participation in cognitively 
stimulating activities over their lifetime. 
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Introduction 
 
CR is a hypothetical construct of compensatory neurobiological processes that support 
cognitive function in the presence of cerebral lesions (Stern, 2002). Individuals with higher 
CR, generated by a lifetime of cognitive engagement, have lower risk for dementia despite 
having the same degree of AD pathology as individuals with lower CR (Valenzuela & 
Sachdev, 2006). Although CR is difficult to directly quantify, proxy variables used to 
estimate an individual’s CR include those factors found to display an inverse relationship with 
dementia risk, such as education (Basu, 2012); intelligence (Rentz et al., 2010); occupational 
attainment (Karp et al., 2009); and cognitively stimulating leisure activities (Wilson et al., 
2010). That individuals with higher CR display greater resistance to the effects of 
neuropathology is likely due to induced cortical plasticity caused by a prolonged mismatch 
between functional supply and task demands (Lövdén et al., 2010), resulting in more flexible 
and denser neural networks (Barulli & Stern, 2013). As adult cognitive function and cognitive 
ageing show significant heritability (Harris & Deary, 2011), research examining the 
interaction between genes and CR proxies are justified. The most likely candidate genes for 
CR are those that interact with environmental factors to induce effects on cognitive functions 
(Lee, 2003). 
 
One gene that potentially interacts with CR is apolipoprotein E (APOE). While it has been 
established that specific allelic variants in the APOE gene are associated with risk for late-
onset AD (Verghese et al., 2011), it is less clear whether allelic variants of the APOE gene 
impart healthy cognitive function (Foster et al., 2013). For instance, it was demonstrated in 
chapter 4 that variation in APOE was not independently associated with any of the assessed 
cognitive functions. However, APOE polymorphisms have been shown to exert divergent 
neuroprotective effects (Gokhale & Laskowitz, 2013; Liu et al., 2013a). For example, the 
! !!
!
109!
presence of APOE ε4 is associated with an increased rate of AD-related hippocampal atrophy 
(Manning et al., 2014), and impaired synaptic plasticity (Chen et al., 2010), when compared 
to APOE ε4 non-carriers. Lifestyle activities that require cognitive effort (e.g. completing 
puzzles, playing chess) predict verbal fluency and semantic memory recall in APOE ε4 non-
carriers but not in carriers (Runge et al., 2014). 
 
A second gene that may be associated with CR is brain-derived neurotrophic factor (BDNF). 
The encoded neurotrophin is crucial to neuronal survival, maintenance, neurogenesis, and 
synaptic plasticity (Bath & Lee, 2006; Mattson et al., 2004). The BDNF Val66Met 
polymorphism affects activity-dependent secretion of BDNF, with the Met allele associated 
with reduced depolarization-induced BDNF release into the synapse (Egan et al., 2003). 
BDNF Met alleles have been associated with reduced memory capacity (Egan et al., 2003; 
Hariri et al., 2003), but not consistently (Gong et al., 2012). In the present thesis, similar to 
APOE, it was demonstrated that variation in BDNF did not account for any significant 
variance in cognitive function (chapter 4). However, like APOE, impaired synaptic plasticity 
is a feature of BDNF Met alleles (Ninan et al., 2010; Pattwell et al., 2012). 
 
Synaptic plasticity is a key mechanism that facilitates the development of CR (Esiri & 
Chance, 2012). Research to date has examined CR in the presence of pathology; however, as 
CR is developmentally acquired through both intrinsic (biologic) factors such as genetic 
heritability as well as extrinsic (environmental) factors such as education, it is imperative to 
examine the development of CR prior to the onset of clinical symptomatology. It was aimed 
to use baseline data from the THBP and a previously developed model of prior CR (chapter 3) 
to investigate the relationship between CR, cognitive function, and APOE and BDNF 
Val66Met polymorphisms in healthy older adults (50-79 years). Two hypotheses were tested. 
First, that higher prior CR is associated with better cognitive performance. Second, that 
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BDNF Val66Met and APOE polymorphisms independently moderate the association between 
prior CR and cognitive performance, with carriers of the putative detrimental alleles (Met and 
ε4, respectively) showing a reduced influence of CR when compared to non-carriers. 
 
Method 
 
Study population 
 
The participants were the same 433 community-residing healthy older adults that were 
investigated in chapter 4. 
 
Materials 
 
A comprehensive test battery was completed by subjects as described in detail elsewhere 
(Summers et al., 2013). Multiple objective measures were used to screen participants for: 
symptoms of dementia, clinically significant symptoms of depression or anxiety, general 
health, medical conditions, prescription medication use, drug and alcohol use, handedness, 
height, weight, marital status, educational and occupational history. 
 
Neuropsychological assessment battery 
 
Cognitive functions were assessed using tests that measured learning and memory, working 
memory, executive function, and language processing, and are described in detail in chapter 
2.  
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Assessment of cognitive reserve 
 
To generate an estimate of CR, the prior CR equation that had been developed in chapter 3 
was used. 
 
Genotyping 
 
DNA samples were collected with Oragene DNA self-collection kits (DNA Genotek Inc., 
n.d.). APOE and BDNF genotypes were determined through the methods outlined in chapter 
2. 
 
Procedure 
 
Trained assessors carried out the neuropsychological testing as part of the baseline THBP 
assessments (Summers et al., 2013). The assessment process took approximately four hours to 
complete and was undertaken in a quiet room. Subjects were encouraged to take 10-minute 
breaks when required to reduce fatigue. 
 
Data analysis 
 
Prior to the main analyses, variables of prior CR and cognitive function were generated. To 
represent CR, a previously developed prior CR equation was used to create a comprehensive 
single-point measure of the construct (chapter 3). Standardised scores of prior CR variables 
(Table 5.1) were entered into the prior CR equation to yield total CR for each subject. 
Composite cognitive domain variables were also computed through the method of factor 
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analysis employed in chapter 4. The extracted factor that explained the highest proportion of 
variance was retained to represent each cognitive domain (Table 5.2). The APOE and BDNF 
predictor variables were coded as carriers or non-carriers of the detrimental allele, ε4 and 
Met, respectively. To assist in interpretation, subjects with the APOE ε2/ε4 polymorphism 
were excluded from the analysis.  
 
The primary analyses used PROCESS v2.11 (Hayes, 2013) to test whether CR was associated 
with cognitive function, either independently or through CR x APOE/CR x BDNF interaction. 
PROCESS is a computational tool for path analysis-based moderation and mediation analysis 
that provides coefficient estimates for total, direct, and indirect effects of variables using OLS 
regression. Prior to analysis, the continuous independent predictor (CR) was mean-centred to 
reduce potential multicollinearity. Subsequent analyses involved testing for direct effects of 
predictors (CR, APOE, BDNF) and indirect effects of possible CR moderators (APOE, 
BDNF) on cognitive function domains while covarying for age. First, regression equations 
were fitted to cognitive domain data and the predictive capacity of age and CR were assessed. 
Second, APOE/BDNF data and corresponding CR-gene product variables were entered to test 
for CR moderation in separate models. An alpha value of .05 was used for all statistical tests 
and all data were analysed in SPSS v21. 
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Table 5.1. Descriptive statistics for study population stratified by APOE and BDNF genotype 
Characteristic N 
APOE status  BDNF status 
ε4- ε4+ p. Met- Met+ p. 
Demographics        
    Age (years) 422 62.31 (6.83) 61.67 (6.69) .53 62.16 (6.85) 61.99 (6.68) .81 
    Gender (male/female %) 422 31.9/68.1 35.8/64.2  31.6/68.4 36.4/63.6  
    Genotype (%) 422 67.5 32.5  66.8 33.2  
Screening        
    DRS-2 AEMSS 422 11.93 (2.12) 12.16 (2.03) .56 12.04 (2.10) 11.93 (2.08) .61 
    HADS anxiety 421 5.21 (3.12) 5.35 (2.97) .39 5.35 (3.19) 5.07 (2.80) .38 
    HADS depression 421 2.36 (2.14) 2.58 (2.34) .24 2.42 (2.26) 2.45 (2.10) .91 
Prior cognitive reserve         
    WTAR Est. FSIQ 421 112.57 (5.39) 112.16 (5.94) .86 112.40 (5.49) 112.51 (5.76) .85 
    Prior education (years) 422 14.13 (2.81) 13.61 (2.59) .19 13.73 (2.72) 14.44 (2.75) .01 
    LEQ Young Adulthood Specific 421 16.19 (7.93) 15.51 (7.65) .41 15.56 (7.61) 16.78 (8.25) .13 
    LEQ Young Adulthood 
Nonspecific 
421 24.71 (5.54) 24.93 (5.11) .19 24.42 (5.45) 25.52 (5.23) .05 
    LEQ Midlife Specific 420 19.07 (5.01) 19.06 (4.93) .45 19.09 (4.82) 19.02 (5.28) .90 
    LEQ Midlife Nonspecific 420 24.37 (5.55) 24.36 (5.60) .46 24.08 (5.72) 24.93 (5.20) .14 
    LEQ Continuing Education 
Bonus 
418 10.22 (8.79) 9.38 (8.01) .46 9.95 (8.45) 9.94 (8.75) .99 
Note: Data represented are mean values (SD) for continuous variables and proportions for categorical variable. 
DRS-2 = Dementia Rating Scale-2; AEMSS = Age- and education-corrected Mayo Older American normative 
Studies (MOANS) scaled score; HADS = Hospital Anxiety and Depression Scale; WTAR = Wechsler Test of 
Adult Reading; FSIQ = Full-scale IQ; LEQ = Lifetime of Experiences Questionnaire; ε4-/Met- = participants 
not carrying the APOE ε4/BDNF Met alleles; ε4+/Met+ = participants carrying at least one copy of the APOE 
ε4/BDNF Met alleles. 
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Results 
 
Study population 
 
The sample comprised 433 participants with a mean age of 62.16 years (SD = 6.81) and an 
above average estimated full-scale IQ (M = 112.47, SD = 5.52). Participants were mostly 
female (66.7%) and had completed an average of 13.97 (SD = 2.73) years of formal 
education. To assist in interpretation, 11 participants were excluded due to possessing the 
APOE ε2/ε4 genotype. The characteristics of the remaining participants are presented in Table 
5.1. The APOE (χ2(1, N = 422) = 0.02, p. = 0.90) and BDNF Val66Met (χ2(1, N = 422) = 0.31, p. = 
0.58) genotype distributions did not differ significantly from Hardy-Weinberg equilibrium. 
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Table 5.2. Factor analysis results for composite cognitive domain variables 
Cognitive domain Initial 
eigenvalue 
Variable N Mean SD Loading 
Episodic memory 2.50 (62.46%) RAVLT 1-5 total 407 52.96 8.92 .76 
  LM I immediate recall 
total 
407 48.43 8.07 .89 
  LM II delayed recall total 407 30.29 6.28 .86 
  PAL first trial memory 
score 
407 18.35 3.46 .63 
Working memory 2.04 (50.93%) Digit span 407 18.63 3.90 .76 
  Letter-number sequencing 407 11.59 2.40 .79 
  SWM between errors 407 25.36 18.64 -.63 
  SSP length 407 5.75 1.20 .66 
Executive function 1.80 (59.83%) Stroop trial C 403 26.26 7.63 .76 
  RVP A’ 403 0.91 0.05 -.81 
  TMT trial B 403 59.09 18.82 .75 
Language 
processing 
1.88 (62.81%) WAIS Vocabulary 421 56.62 6.23 .88 
  WAIS Comprehension 421 26.21 3.33 .77 
  Boston Naming Test 421 57.49 3.42 .72 
Note: Data in parentheses represent the proportion of variance (%) explained by the resulting factor. 
RAVLT = Rey Auditory Verbal Learning Test; LM = Logical Memory; SWM = Spatial Working 
Memory; SSP = Spatial Span; RVP = Rapid Visual Processing; TMT = Trail Making Test; WAIS = 
Wechsler Adult Intelligence Scale. 
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Cognitive reserve and age 
 
PROCESS was used to fit linear regression models to the cognitive domain data. With the age 
and CR predictors entered, significant models were produced for all assessed cognitive 
functions: episodic memory (F(2, 398) = 22.15, p < .01, R2 = .10); working memory (F(2, 398) = 
28.96, p < .01, R2 = .13); executive function (F(2, 394) = 52.88, p < .01, R2 = .21); and language 
processing (F(2, 412) = 34.15, p < .01, R2 = .14). The CR variable had a significant positive 
association with each cognitive domain (p < .05) while the age variable had a significant 
negative association with each cognitive domain (p < .01), excluding language processing (p 
= .62). The individual contribution that each predictor made to the model is detailed in Table 
5.3. 
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Table 5.3. Results of the regression analyses for cognitive domain data 
 !  
Cognitive domain Predictor N B SE t p. 
R2 
change 
F 
Episodic memory Age 401 -0.05 0.01 -6.51 < .01   
 CR 401 0.04 0.02 2.01 .05   
 APOE 401 -0.08 0.10 -0.84 .40   
 BDNF 401 -0.03 0.10 -0.25 .80   
 CR x APOE 401 -0.02 0.05 -0.35 .72 0.00 0.12 
 CR x BDNF 401 -0.06 0.04 -1.41 .16 0.00 1.99 
Working memory Age 401 -0.05 0.01 -7.11 < .01   
 CR 401 0.07 0.02 3.37 < .01   
 APOE 401 0.07 0.10 0.70 .48   
 BDNF 401 -0.11 0.10 -1.12 .26   
 CR x APOE 401 0.04 0.04 0.99 .32 0.00 0.99 
 CR x BDNF 401 0.04 0.04 0.99 .32 0.00 0.98 
Executive function Age 397 -0.06 0.01 -9.40 < .01   
 CR 397 0.10 0.02 5.23 < .01   
 APOE 397 0.12 0.10 1.25 .21   
 BDNF 397 -0.02 0.10 -0.17 .86   
 CR x APOE 397 0.02 0.04 0.40 .69 0.00 0.16 
 CR x BDNF 397 -0.08 0.04 -1.98 .05 0.01 3.94 
Language 
processing 
Age 
415 0.00 0.01 0.49 .62   
 CR 415 0.16 0.02 8.15 < .01   
 APOE 415 0.08 0.10 0.87 .38   
 BDNF 415 -0.07 0.10 -0.69 .49   
 CR x APOE 415 0.03 0.04 0.62 .54 0.00 0.38 
 CR x BDNF 415 -0.05 0.04 -1.30 .19 0.00 1.70 
Note: Apolipoprotein E and Brain-derived neurotrophic factor main and interaction effects were 
tested in separate models. CR = Prior cognitive reserve; APOE = Apolipoprotein E; BDNF = Brain-
derived neurotrophic factor. 
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Gene-cognitive reserve interactions 
 
It was then assessed whether the inclusion of APOE/BDNF Val66Met allelic carrier data 
significantly improved the fit of the models. Notably, no significant main effects of genetic 
predictors, APOE or BDNF Val66Met, were identified for any cognitive domain. A 
moderation analysis (PROCESS) was then conducted examining whether the inclusion of CR 
x APOE or CR x BDNF interaction terms significantly improved the fit of regression models. 
Results indicated that a single genetically based moderation effect on CR was present (Table 
5.3). Specifically, inclusion of the CR x BDNF Val66Met interaction term led to a significant 
increase in the amount of variance in executive function explained by the model (ΔR2 = .01, p 
=.05). Simple slopes analysis was conducted in order to determine the basis of the moderation 
effect of BDNF polymorphism on the conditional effect between CR and executive function 
and tested whether the slopes statistically differed from zero for BDNF Met carriers and non-
carriers, separately. These analyses indicate that a significant positive relationship between 
CR and executive function was identified in BDNF Val homozygotes (B = 0.13, t = 5.44, SE 
= 0.02, p < .01), but was not evident in BDNF Met carriers (B = 0.05, t = 1.41, SE = 0.03, p = 
.16). In BDNF Val homozygotes, CR accounted for a significant 8.5% of variance in 
executive function performance. In BDNF Met carriers, CR accounted for a non-significant 
1.2% of variance in executive function performance. Simple slopes are presented in Figure 
5.1.  
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Figure 5.1. BDNF Val66Met moderates the relationship between CR and executive function 
scores. Plot represents age-adjusted executive function performance as predicted by the 
composite CR proxy variable for those with low CR (CR scores less than the mean – 1 
standard deviation) and high CR (CR scores greater than the mean + 1 standard deviation) for 
BDNF Met carriers and Val homozygotes, separately. 
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Discussion 
 
This chapter was designed to investigate whether a composite measure of CR was associated 
with healthy cognitive function, either independently or through an interaction with genetic 
APOE/BDNF Val66Met polymorphic data, in participants of the THBP. The first hypothesis, 
that higher CR is associated with better cognitive performance, was supported. The sample 
showed significant positive relationships between CR and cognitive function across all 
cognitive domains, after accounting for the effects of age. The second hypothesis, that BDNF 
Met carriers and APOE ε4 carriers would display a lower relationship between CR and 
cognitive function when compared to their respective non-carriers, was partially supported. 
The analyses revealed a single significant CR x BDNF interaction in predicting age-adjusted 
executive function performance. In this regard, the relationship between CR and executive 
function was moderated by BDNF genotype, with a positive association between the variables 
present in BDNF Val homozygotes that was absent in BDNF Met carriers.  
 
CR is of interest due to its potential role in varying the age at which an individual develops 
dementia and the subsequent rate of dementia progression experienced (Barulli & Stern, 
2013), as well as mitigating against the effect of other CNS insults. However, while previous 
research frequently highlights the relationship between increased CR and reduced dementia 
incidence (Brayne et al., 2010), other investigations have suggested that CR is also involved 
in non-pathological cognitive function. For instance, during a memory task, higher functional 
connectivity, indicative of heightened cognitive effort, is found in subjects with lower CR, 
despite achieving the same level of performance as those with higher CR (Lopez et al., 2014). 
Similarly, CR was positively associated with brain volume but negatively associated with 
cortical activity during a visual encoding task (Solé-Padullés et al., 2009). Such findings are 
consistent with the CR hypothesis, which posits that CR is implicated in non-pathological 
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cognitive function (Stern, 2002), particularly in relation to cerebral network efficiency (Stern, 
2012). The finding from the present investigation, that CR was positively associated with all 
four assessed cognitive domains, adds further evidence that CR accounts for healthy cognitive 
function and that cognitive associations with CR are not limited to protection from the clinical 
expression of pathological processes. At the very least, higher scores on CR proxy variables 
would result in a delayed onset of dementia due to the pre-existing cognitive advantage 
afforded to high CR individuals through greater education, occupational attainment, 
intelligence, and participation in cognitively stimulating lifestyle activities. In high CR 
individuals a greater loss of cognitive function, resulting from greater levels of 
neuropathology, would be required to produce functional deficits of sufficient severity to 
meet diagnostic criteria for dementia.  
 
A comprehensive review of the evidence for genetic contributions to CR noted that those 
genes that interact with environmental factors to produce a cognitive effect are the most likely 
candidates (Lee, 2003). In this study, a significant moderating influence of BDNF Val66Met 
polymorphism on the relationship between CR and executive function was identified. In those 
individuals who were BDNF Val homozygotes, a one point increase in CR was associated 
with a 0.13 point of increase in executive function. Comparatively, in those individuals who 
were BDNF Met carriers, a one point of increase in CR was associated with a non-significant 
0.05 point increase in executive function. This finding is of particular importance due to the 
overlap between CR and executive function (Siedlecki et al., 2009). Both executive function 
and CR have an underlying reliance on cognitive flexibility (Miyake, 2000; Stern, 2002) and 
resources associated with frontal lobe activity (Alvarez & Emory, 2006), with a positive 
association of education and frontal engagement present in older adults that is not seen in 
younger adults (Springer et al., 2005). Clinical studies confirm that there is an age-related 
decline in executive function (Deary et al., 2009), and that the onset of dementia is often 
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characterised by early impairment of executive function (Silveri, Reali, Jenner, & Puopolo, 
2007). Overall, the present findings indicate that while BDNF Val homozygotes show normal 
positive associations between CR and executive function, BDNF Met carriers have a reduced 
influence of CR on executive function. 
 
No CR-APOE interaction was found in the current study. Previous longitudinal investigations 
have reported interactions between APOE ε4 alleles, education, and the rate of age-related 
cognitive decline (Seeman et al., 2005; Shadlen et al., 2005). However, a recent study found 
an interaction of CR and APOE polymorphism in cross-sectional but not longitudinal data 
(Runge et al., 2014). This investigation found that verbal fluency and semantic memory recall 
performance was predicted by participation in cognitively stimulating lifestyle activities in 
APOE ε4 non-carriers but not in carriers (Runge et al., 2014). The discrepancy between the 
results of the present study and those of Runge and colleagues may reflect differences in the 
method used to quantify lifetime cognitive stimulation. They assessed low (e.g. singing, 
traveling) and high (e.g. puzzles, viewing educational television) cognitive demand lifestyle 
activities, whereas the present study took into account a wider range of CR measures, 
including years of formal education and occupational attainment (chapter 3). 
 
One explanation for the significant moderation of CR by BDNF Val66Met lies within 
differences in biochemical responses to cognitively stimulating environments. Namely, 
individuals with BDNF Met alleles may receive a lesser impact on neurological function of 
exposure to environmental activities that contribute to CR, whereas, for Met non-carriers 
there is a greater beneficial effect of exposure to environmental activities on neurological 
function. Previous research has demonstrated that long-term exposure to cognitively 
stimulating environments is associated with a widespread increase in BDNF expression in the 
brain (Ickes et al., 2000), but BDNF Met carriers have both reduced activity-dependent 
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secretion of BDNF (Egan et al., 2003) and impaired synaptic capacity for long term 
potentiation/depression (Cheeran et al., 2008). Consequently, for two individuals exposed to 
the same level of extrinsic environmental stimulation, the individual who carries the BDNF 
Met polymorphism exhibits reduced synaptic plasticity and neuronal restructuring subsequent 
to environmental stimulation and consequently displays lowered functional capacity due to 
the negative intrinsic effect of BDNF Met polymorphism on development of CR. Studies 
examining the influence of environmental enrichment in rodents report that EE only confers 
benefits in the presence of BDNF protein. For example, environment-induced hippocampal 
neurogenesis occurs only in the presence of BDNF (Rossi et al., 2006) and upregulation of 
BDNF by stimulating environments promotes neural plasticity (van Praag et al., 2000). 
Although environmental enrichment in experimental animals and measures of CR in humans 
are unlikely to be analogous, a comprehensive review concluded that, as with human 
educational and occupational attainment, environmental enrichment develops reserve that can 
be used to offset the impact of cortical lesions (Petrosini et al., 2009). 
 
The results of the present study have several implications. First, as higher CR was associated 
with higher overall cognitive function, CR exerts an impact on healthy cognitive function, 
independent of dementia. While the cross-sectional analyses employed in the present study do 
not allow comment on the relationship between CR and rate of age-related cognitive decline, 
the results indicate that, at the very least, CR may benefit cognitive function in older age due 
to the persistent effects of improved cognitive function. Second, the results of the present 
study demonstrate that a genetic factor moderates the effect that CR has on cognitive 
function. Specifically, BDNF Met carriers showed a reduced relationship between CR and 
executive function when compared to non-carriers. This result provides evidence that BDNF 
Met carriers have a partial ‘disconnect’ between CR and cognitive function, and future 
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longitudinal analyses will examine whether BDNF Val66Met mediates environmentally 
generated protection from dementia. 
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Chapter 6 
Discussion 
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CR describes the ability of an individual to compensate for disruptions to neural networks 
caused by pathological processes and, potentially, age-related neural changes (Stern, 2002). 
To achieve this, it is proposed that two complementary neural processes mediate the benefits 
of higher CR: neural reserve and neural compensation (Stern et al., 2005). Although further 
research into the construct has increased our understanding of what increases CR (Valenzuela 
& Sachdev, 2006), conceptual aspects of CR (Barulli & Stern, 2013), and how CR may be 
implemented into brain networks (Bozzali et al., 2014; Lopez et al., 2014), CR remains a 
nebulous concept. Similarly, inconsistent associations between variation in single genes and 
cognitive function are reported in the literature, despite strong evidence for the heritability of 
healthy cognitive function (Harris & Deary, 2011). The most ambiguity, however, is present 
in relation to genes that may be involved in CR (Lee, 2003), either through their effect on the 
development of CR or their effect on the ability to use CR. 
 
Thesis aims 
 
Overall, the present thesis had four overarching aims. First, to elucidate and provide 
specificity to the CR theory by operationally defining factor-supported prior and current CR 
constructs. Second, to determine whether common genetic variation in APOE or BDNF 
Val66Met is associated, either independently or through gene-gene interaction, with cognitive 
function. Third, to quantify the premorbid associations between CR and cognitive function. 
Fourth, to investigate APOE and BDNF Val66Met polymorphisms for potential genetic 
interactions with CR. 
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Modelling cognitive reserve in healthy older adults (chapter 3) 
 
The aim of the first study was to explore the inter-relationships between CR proxy variables 
and to develop two operational factor-supported measures of CR: prior and current. This was 
an essential first step in the investigation of the CR theory, as future investigations (i.e. 
chapter 5) relied upon an estimate of CR to allow for tests of genetic associations. To achieve 
this aim, a multivariate latent approach was adopted for the development of both prior and 
current CR variables. Two hypotheses were proposed. First, traditional CR proxy variables 
(education, occupational attainment, intelligence, cognitively stimulating leisure activities) 
can be combined through factor analysis to provide a comprehensive operational factor-
supported estimate of CR prior to entering the THBP. Second, flexible measures of cognitive 
ability that approximate traditional CR proxy variables (intelligence, academic ability) can be 
combined through factor analysis to provide an estimate of change in CR due to new life 
experiences. 
 
A sample of 467 healthy older adults that had completed their baseline assessment for the 
THBP (Summers et al., 2013) participated in the present study. Participants were aged 50-79 
years old and were mostly female (68.3%). They were cognitively normal and had undergone 
screening for symptoms of anxiety, depression and dementia. To develop a model of prior 
CR, data were used from seven items: WTAR Est. FSIQ; Prior education (years); LEQ young 
adulthood specific; LEQ young adulthood non-specific; LEQ midlife specific; LEQ midlife 
non-specific; LEQ midlife continuing education. To develop a model of current CR, data 
were used from five items: WAIS-III-SF1 FSIQ; WRAT-4-PMV spelling LES; WRAT-4-
PMV math computation LES; WRAT-4-PMV word reading; WRAT-4-PMV sentence 
comprehension. Statistical analyses involved principal components analysis (PCA) with 
Varimax rotation to combine variables into separate models of prior and current CR. A further 
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PCA was used that included all CR variables in an attempt to differentiate contributors to 
prior from current CR models. 
Key findings 
 
These results suggest that multiple CR proxies can be combined to provide an estimate of 
reserve that likely better reflects the CR theory than the use of a single indicator (Stern, 2002). 
For the prior CR model, PCA was successful in combining measures of intelligence, 
education, occupational attainment, and participation in cognitively stimulating leisure 
activities. In this analysis, a four-factor prior CR model was extracted, which produced a 
factor structure independent of the effects of age and employment status. The clustering of the 
variables suggested that factor 1 represented education and intelligence, factor 2 represented 
cognitive activities, factor 3 represented midlife education, and factor 4 represented 
occupational attainment. In combination, these factors explained 77.10% of the variance in 
the dataset. The final equation for prior CR = 0.370 (WTAR FSIQ) + 0.408 (Prior education 
in years) + 0.567 (LEQ Young Adulthood Specific) + 0.565 (LEQ Young Adulthood Non-
specific) + 0.630 (LEQ Midlife Non-specific) + 0.875 (LEQ Midlife Continuing Education 
Bonus) + 1.004 (LEQ Midlife Specific). 
 
For the current CR model, PCA was successful in combining measures of intelligence and 
academic ability. However, in this analysis, two of the proposed contributors to the model 
were removed prior to finalising the current CR equation. WRAT-4-PMV reading was 
removed due to its potential for confounding with the WTAR, which contributes to prior CR; 
a previous version of the WRAT (WRAT-R) has been shown to correlate highly (r = 0.73) 
with the WTAR (Strauss et al., 2006). WRAT-4-PMV sentence comprehension was also 
removed from the model due to a very low extracted communality value in a preliminary 
PCA (0.31). The final PCA extracted a one-factor current CR model, with the factor 
explaining 59.87% of the variance in the dataset. The final equation for current CR = 0.454 
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(WAIS-III-SF1 FSIQ) + 0.369 (WRAT-4-PMV spelling LES) + 0.463 (WRAT-4-PMV math 
computation LES). 
 
To validate the prior and current models of CR, a third PCA was conducted that attempted to 
statistically differentiate the two models. This analysis included the ten variables that 
comprised both prior and current CR models. Results indicated that the PCA was partially 
successful in differentiating the models; three underlying factors were extracted: current CR, 
education and occupation, and cognitive activities. Of importance, the variables in both 
hypothesised models were successfully separated, with the exception of WTAR FSIQ, which 
loaded on the current CR factor that contained other intelligence- and academic-related 
variables. Participant scores for prior and current CR were significantly correlated (r = 0.40, p 
< 0.01). 
 
Genetic associations with cognitive function in healthy older adults (chapter 4) 
 
The aim of the second study was to determine whether common genetic variation in APOE or 
BDNF Val66Met is associated, either independently or through gene-gene interaction, with 
cognitive function. In addition to CR, genetic variation has been proposed to account for 
differences in age-related cognitive decline (Harris & Deary, 2011) and risk for dementia 
(Verghese et al., 2011). However, earlier studies that reported differences in cognitive 
performance due to variation in APOE (Small et al., 2004) and BDNF Val66Met (Egan et al., 
2003) were not supported by more recent work (Foster et al., 2013; Mandelman & 
Grigorenko, 2011). In order to provide clarity to these discrepancies, three hypotheses were 
proposed. First, APOE ε2 alleles are associated with better cognitive function and ε4 alleles 
are associated with worse cognitive function when compared to ε3 homozygotes. Second, 
BDNF Val homozygotes are associated with better cognitive function when compared to Met 
carriers. Third, a cumulative effect of the cognitive consequences associated with APOE and 
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BDNF alleles results in the highest cognitive function in APOE ε2/BDNF Val homozygotes 
and the lowest cognitive function in APOE ε4/BDNF Met carriers. 
 
The participants who were included in chapter 4 were a subgroup of 433 members of the 
larger THBP cohort who had consented to genetic analysis. The health of the participants was 
particularly important, as this study aimed to investigate genetic associations with healthy, 
non-pathological, cognitive function. In this regard, it has been suggested that previously 
identified associations between APOE ε4 and reduced cognitive function were due to 
prodromal dementia onset (Foster et al., 2013). The sample’s APOE allele frequencies were 
11.11% ε2 carrier, 56.4% ε3 homozygote, and 32.5% ε4 carrier; BDNF Val66Met allele 
frequencies were 67% Val homozygote and 33% Met carrier. Allele frequencies for both 
genes did not differ significantly from Hardy-Weinberg equilibrium and were consistent with 
those previously reported (Egan et al., 2003; Small et al., 2004; Vickers et al., 2002). Prior to 
investigating associations between polymorphisms and cognitive function, PCA was used to 
compute cognitive domain variables from multiple tests of separate cognitive processes that 
assessed a similar domain. General linear models were fitted to each composite cognitive 
domain variable, using APOE and BDNF polymorphic data as predictors, while covarying for 
age and education. 
 
Key findings 
 
The results of this study, in combination with previous investigations into the genetic 
associations of healthy cognitive function (Foster et al., 2013; Gong et al., 2012; Houlihan et 
al., 2009; Quintas et al., 2013; Stuart et al., 2014), indicate that specific genes that account for 
the heterogeneity of cognitive function are elusive. This is despite evidence that shows the 
substantial heritability of cognitive function (Haworth et al., 2010; Plomin et al., 2013). The 
analysis first examined whether variation in APOE or BDNF Val66Met was independently 
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associated with variation in episodic memory, working memory, executive function, or 
language processing. The results indicate that variation in neither APOE nor BDNF 
polymorphisms influenced cognitive performance in any domain. This data adds to the 
growing body of evidence suggesting that variation in APOE or BDNF Val66Met does not 
independently cause differences in healthy adult cognitive function. 
 
Although independent effects of the genes were not found in the present study, a significant 
APOE x BDNF effect was detected in the episodic memory domain. Follow-up analysis of 
age- and education-adjusted episodic memory scores revealed that, for BDNF Val 
homozygotes, no differences in function were identified as a result of variation in APOE. 
However, for BDNF Met carriers, APOE genotype was associated with significant variation 
in function. For BDNF Met carriers, APOE ε2 carriers had significantly higher episodic 
memory performance than APOE ε3 homozygotes and APOE ε4 carriers. Despite APOE ε3 
carriers displaying better episodic memory performance than APOE ε4 carriers, the difference 
did not reach significance. This finding is consistent with previous work identifying 
significant cumulative effects of these genes on hippocampal function (Kauppi et al., 2014), 
amyloid deposition (Adamczuk et al., 2013), and the progression of AD-related 
morphological changes (Hashimoto et al., 2009). In all cases, including the present study, it 
was found the largest detrimental effects were present in carriers of both the APOE ε4 and 
BDNF Met alleles. 
 
Genetic interactions with cognitive reserve in healthy older adults (chapter 5)  
 
The third study was undertaken with two aims in mind, both of which involved the use of the 
prior CR equation that was developed in chapter 3. The first aim was to quantify the 
premorbid associations between CR and cognitive function. The CR theory posits that 
differences in neural efficiency exist in non-pathological functioning (Stern, 2002), with 
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recent data supporting this notion (Lopez et al., 2014; Solé-Padullés et al., 2009). It was 
hypothesised that higher prior CR is associated with better cognitive performance in healthy 
individuals. The second aim was to investigate APOE and BDNF Val66Met polymorphisms 
for potential genetic interactions with CR. Both of these genes have shown previous 
associations with cognitive function and play important roles in the process of synaptic 
reorganisation (Cheeran et al., 2008; Chen et al., 2010). Here, it was hypothesised that BDNF 
Val66Met and APOE polymorphisms independently moderate the association between CR 
and cognitive performance, with carriers of the putative detrimental alleles (Met and ε4, 
respectively) showing a reduced influence of CR when compared to non-carriers. 
 
The participants who provided data for this chapter were the same healthy 433 THBP 
participants who had consented to genetic analysis in chapter 4. In contrast to the analysis in 
chapter 4, however, the potential benefit of the APOE ε2 allele was not examined in this 
investigation; subjects were coded as carriers or non-carriers of the detrimental alleles. To test 
the hypotheses, an estimate of CR was calculated by entering standardised scores of CR 
variables into the prior CR equation (chapter 3). Composite cognitive domain variables of 
episodic memory, working memory, executive function, and language processing (developed 
in chapter 4) were used as the dependent variables. The primary analyses used PROCESS 
v2.11 (Hayes, 2013) to test whether CR was associated with cognitive function, either 
independently or through CR x APOE/CR x BDNF interaction. 
 
Key findings 
 
The first hypothesis, that higher prior CR is associated with better cognitive performance in 
healthy individuals, was supported. When the predictors of age and CR were entered, 
significant models were produced for all assessed cognitive functions. Age was negatively 
correlated with each ageing-susceptible cognitive domain, consistent with previous literature 
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demonstrating age-related cognitive declines in episodic memory, working memory, and 
executive function/processing speed (Craik, 1994; Park et al., 2002; Schaie, 1996). However, 
a noteworthy finding was that each point of prior CR was associated with increases in 
performance in all assessed cognitive domains, after accounting for the effects of age. Given 
the clear cognitive benefits of participation in activities said to increase CR, in particular 
education (Brinch & Galloway, 2012; Ceci, 1991), this effect was not surprising. Other lines 
of evidence have also implicated CR in healthy neurological functioning, such as those that 
have demonstrated higher neural efficacy due to CR proxy variables (Lopez et al., 2014; Solé-
Padullés et al., 2009). However, the present investigation was one of the first to quantify the 
premorbid cognitive effects of an operationally defined factor-supported variable of reserve 
that is consistent with the CR theory. 
 
The second hypothesis, that BDNF Val66Met and APOE polymorphisms independently 
moderate the association between CR and cognitive performance, was then tested. Here, 
partial support was found, as a significant interaction between CR and BDNF Val66Met was 
present only in the executive function domain. Specifically, the expected significant positive 
relationship between CR and executive function that was present in BDNF Val homozygotes 
was not evident in BDNF Met carriers. In BDNF Val homozygotes, CR accounted for a 
significant 8.5% of variance in executive function performance; however, in BDNF Met 
carriers, CR accounted for a non-significant 1.2% of the variance in executive function 
performance. This result indicates that individuals with the most common BDNF 
polymorphism (Val/Val) demonstrate the normal benefits of CR on cognitive function, 
whereas individuals who carry a BDNF Met allele have a weakened association between CR 
and cognitive function. 
  
! !!
!
134!
General discussion 
 
Modelling prior cognitive reserve 
 
CR provides one explanation as to how two individuals with a similar level of neuropathology 
can express very different levels of clinical impairment (Stern, 2002; 2006). The 
conceptualisation of the CR theory, as well as the brain reserve capacity theory (Satz, 1993), 
was prompted by an early autopsy investigation that identified a subset of subjects who, prior 
to death, had significant AD pathology despite no clinical impairments to cognitive function  
(Katzman et al., 1988). Since CR was proposed, many investigations have reported that 
participation in activities that involve complex cognitive stimulation protects and preserves 
cognitive function after stroke (Glymour, Weuve, Fay, Glass, & Berkman, 2008; Ojala-
Oksala et al., 2012; Sachdev, Brodaty, Valenzuela, Lorentz, & Koschera, 2004) and traumatic 
brain injury (Fay et al., 2010; Kesler, Adams, Blasey, & Bigler, 2003). The major disability 
that CR has been implicated in is dementia stemming from neurodegenerative diseases (e.g. 
Andel et al., 2005; Bickel & Kurz, 2009; Brayne et al., 2010; Fritsch et al., 2002; Ngandu et 
al., 2007; Ravaglia et al., 2002; Valenzuela & Sachdev, 2006). However, most of these 
investigations have large variations in their methods of measuring CR and, as such, it is 
difficult to equate the conclusions of one investigation with another. 
 
Numerous methods of assessing CR have been suggested. One is to estimate 
neurocomputational factors, such as network efficiency, redundancy, and dynamic range 
(Valenzuela, 2008). Other methods involve the measurement of the discrepancy between 
expected cognitive outcome and actual cognitive outcome due to the presence of pathology 
(Reed et al., 2011). However, for practicality reasons, an estimate of CR can be established by 
determining how cognitively engaged an individual has been over their lifespan. It follows 
then, that a comprehensive estimate of CR should examine multiple lifetime factors that 
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involve complex cognitive stimulation (Sánchez et al., 2011), particularly since these different 
lifetime factors contribute independently to reserve capacity (Foubert-Samier et al., 2012; 
Reed et al., 2011). However, this is, more often than not, not the case, and many 
investigations have used just education (Batterham, Mackinnon, & Christensen, 2011; Bozzali 
et al., 2014; Brayne et al., 2010; Duda, Puente, & Miller, 2014; Guzzetti & Daini, 2014; 
Kesler, Tanaka, & Koovakkattu, 2010; Liu, Cai, Xue, Zhou, & Wu, 2013b), occupation 
(Ghaffar, Fiati, & Feinstein, 2012; Karp et al., 2009; Kröger et al., 2008; Potter, Helms, 
Burke, Steffens, & Plassman, 2007; Suo et al., 2012), intelligence (Albanese et al., 2012; 
Galioto et al., 2013; Koerts, Tucha, Lange, & Tucha, 2012; Vemuri et al., 2011), or cognitive 
activities (Booth et al., 2013; Wilson et al., 2007; 2010; Wilson, Barnes, & Bennett, 2003; 
Wirth, Haase, Villeneuve, Vogel, & Jagust, 2014) as an estimate of CR. 
 
Although the use of single proxy variables to represent CR is common (e.g. education), this 
may not be the best method. In this regard, multiple indicators should be taken into account 
when calculating an estimate of an individual’s CR (Sánchez et al., 2011). In support, one 
meta-analysis found that the combined protective effect of multiple CR indicators reduced 
risk for dementia by approximately 50% (Valenzuela & Sachdev, 2006). Reserve is a 
hypothetical construct that, at this point, cannot be directly measured (Stern, 2002). This is 
due to the fact that CR is not tied to any one of these CR proxy variables – it is a latent 
variable (Stern, 2006). Until a direct measure of CR is identified, it has been suggested that 
latent variable approaches be implemented to test CR hypotheses (Jones et al., 2011). Here, 
some important theoretical considerations have been proposed. Mainly, the a priori 
conceptualisation of CR factor models should be avoided (Jones et al., 2011; Satz et al., 
2011). Instead, data-driven approaches should be implemented to decide how CR indicators 
should be grouped (Satz et al., 2011). Statistically, principal components analysis (PCA) is 
preferable for grouping CR indicators than a true factor analysis (e.g. maximum likelihood), 
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as PCA may be better suited to handle issues of shared covariance among predictors (Jones et 
al., 2011). 
 
In line with such recommendations (Jones et al., 2011; Satz et al., 2011), the present 
investigation took a multivariate approach to constructing latent models of prior CR and 
current CR. For prior CR, quantifying previous educational, occupational, and cognitive 
activity, as well as including an estimate of premorbid intelligence, gave an estimate of an 
individual’s existing CR. For current CR, a model that could reflect change in CR was 
constructed through the quantification of current intellectual and academic ability. For both 
models, the variables were combined using exploratory factor analysis (EFA) with the PCA 
method, which allowed us to use both shared and unique variance to construct new latent 
variables of reserve (Jones et al., 2011). 
 
Other investigations have implemented similar approaches when investigating the predictive 
capacity of a CR variable that reflects data from multiple proxy variables. Most similar to the 
method used in the present investigation, one study used EFA using PCA to combine data of 
premorbid IQ, education-occupation history, and a measure of lifetime participation in leisure 
and cognitive activities (Arenaza-Urquijo et al., 2011). The total variance explained by the 
extracted latent variables in combination was also similar: 62.3% in their investigation 
compared to 77.10% in the present study’s. In the study by Arenaza-Urquijo and colleagues, 
their multivariate estimation of CR correlated significantly with a number of different 
anatomic white matter areas in healthy older adults and patients with amnestic MCI, 
indicating an increased resilience of white matter in individuals with more CR. 
 
In contrast to the data-driven, post hoc, approach recommended by Jones et al. (2011) and 
Satz et al. (2011), which was implemented in the present study and in the Arenaza-Urquijo et 
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al. (2011) study, some researchers have used an a priori approach to developing multivariate 
models of CR. For example, one study, which investigated whether CR predicted longitudinal 
cognitive performance in children and adolescents with schizophrenia, used confirmatory 
factor analysis (CFA) to test a three factor model of CR (la Serna et al., 2013). Here, the CR 
model comprised estimates of premorbid IQ, education-occupation history, and lifetime 
leisure activities; the results of the CFA indicating a good fit between the model and the 
observed data. Similarly, CFA has been used to test a four factor model of CR, comprising 
factors of memory-language, processing speed/executive function, attention, and CR factors 
(Mitchell, Shaughnessy, Shirk, Yang, & Atri, 2012). Again, support was found for the 
hypothesised model in both cognitively normal and cognitively impaired older adults. In 
contrast to Mitchell et al. (2012), others have tested and found support for two factor models 
(Lojo-Seoane, Facal, Guardia-Olmos, & Juncos-Rabadan, 2014) and three factor models 
(Giogkaraki, Michaelides, & Constantinidou, 2013). 
 
Large variability is evident in the CR factor models that have resulted from multivariate 
estimations, regardless of the method of factor analysis used (i.e. EFA or CFA). Given the 
heterogeneity of datasets that were used to develop these models, such discrepancies are not 
surprising. In order to resolve potential inconsistencies in CR models, it is recommended that 
a data-driven exploratory approach should be applied. This method would avoid erroneous a 
priori groupings of CR indicators and allows the dataset to determine how CR indicators 
should be grouped (Jones et al., 2011; Satz et al., 2011). 
 
Interventions and current cognitive reserve 
 
Recent investigations have examined the consequences of CR in dementia (Andel et al., 2005; 
Bickel & Kurz, 2009; Brayne et al., 2010; Fritsch et al., 2002; Ngandu et al., 2007; Ravaglia 
et al., 2002; Valenzuela & Sachdev, 2006) or brain trauma (Fay et al., 2010; Glymour et al., 
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2008; Kesler et al., 2003; Ojala-Oksala et al., 2012; Sachdev et al., 2004), but it is important 
to model CR and investigate the associations of CR and cognitive function in healthy midlife. 
This is the phase of life where prolonged participation in cognitively demanding activities can 
occur, the like of which is theorised to be responsible for the development of CR’s beneficial 
compensatory neurological effects (Lövdén et al., 2010; Stern, 2002). In addition, healthy 
midlife is also the life phase where cognition-preserving interventions based on cognitive 
stimulation can readily occur. 
 
Interventions aimed at providing a cognitive advantage, or buffer, to negate or protect from 
age-related cognitive decline or dementia usually take the form of randomised controlled 
trials (RCT). These trials typically involve exposing an experimental group of participants to 
an intervention of on-going computer-based cognitive training for the duration of the trial. 
The benefit of such a design is the ability to reduce allocation bias due to the randomisation of 
participants to treatment groups, allowing strong inferences about cause and effect to be made 
(Moher et al., 2010). However, one of the major criticisms directed at cognitive training 
interventions relates to the limited generalisability and longevity of the cognitive gains (La 
Rue, 2010), and evidence indicating that this form of mental exercise results in increased CR 
is weak (Gatz, 2005). This may relate to the distinction between specific training aimed at 
individual cognitive processes and the complex, multifaceted, stimulation obtained from 
education and demanding occupations. 
 
Another trial that is currently on-going that aims to increase CR due to participation in an 
intervention is the THBP (Summers et al., 2013). The THBP has the advantage of using an 
intervention that involves complex cognitive stimulation; university study involves social, 
educational, and intellectual components. This more complex brand of cognitive stimulation, 
when compared to that used in RCTs, fits within the framework proposed by Loveden et al. 
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(2010), in which a prolonged mismatch between supply and demand must occur before plastic 
changes take place within the brain. However, a related disadvantage is the inability to use 
randomisation of participants, introducing a possible confounder to the intervention outcome 
(Moher et al., 2010). 
 
One of the major problems with prospective investigations is the lack of an estimate of 
intervention efficacy prior to the end point – particularly with interventions that aim to reduce 
dementia risk. In this regard, it is in the interest of the CR hypothesis that an operationalised 
estimate of current/change in CR be developed (Tucker & Stern, 2011). The present study 
aimed to fill this gap by developing a model of CR comprised of variables that approximate 
traditional CR indicators, but can change dynamically to reflect change in cognitive function 
due to exposure to new CR-building activities. To achieve this, estimates of current 
intellectual and academic ability were combined using PCA, producing a latent current CR 
variable that accounted for 59.87% of the variance in the dataset. Notably, this current CR 
model demonstrated a moderate-strong correlation with the model of prior CR, indicating that 
both models assessed a similar underlying construct. 
 Although!the!model!of!current!CR!has!the!potential!to!reflect!change!in!function!due!to!participation!in!CRCrelated!activities,!it!also!reflects!longCacquired!cognitive!capacity.!In!this!regard,!it!is!unlikely!that!any!cognitive!measure!of!current/change!in!CR!will!be!unaffected!by!previous!function,!generated!by!prior!lifetime!exposures.!As!is!the!nature!of!CR,!even!estimates!of!change!in!network!efficiency!or!redundancy!(Valenzuela,!2008)!would!be!tempered!by!the!preCexisting!individual!differences!in!these!factors.!One!of!two!approaches!may!allow!for!the!capture!of!a!‘pure’!measure!of!change!in!CR.!First,!if!a!cognitive!approach!is!adopted,!researchers!may!consider!entering!prior!CR!as!a!covariate!to!control!for!the!influence!of!preCexisting!activity/function.!Second,!
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Genetic factors in healthy adult cognitive function 
 
The notion that an individual’s genetic makeup contributes to the capacity of cognitive 
function as an adult is recognised, but the exact genes that account for the heritability are 
elusive. One review of 111 studies that examined the familial basis of cognitive function 
concluded that approximately 50% of the variability in adult cognitive function is inherited 
(Bouchard & McGue, 1981). In addition, the heritability of cognitive function seems to 
increase with age, rather than decline (Davis et al., 2009; Haworth et al., 2010). For example, 
one study demonstrated linear increases in the heritability of general cognitive ability from 
41% in childhood, to 55% in adolescence, to 66% in young adulthood (Haworth et al., 2010). 
Recent genome wide association studies have provided further evidence that genetic variation 
affects cognitive processing, with an estimated 40% of crystallised intelligence and 51% of 
fluid intelligence accounted for by both common SNP markers and unknown causal variants 
(Davies et al., 2011). Despite this, the replication of single gene effects on cognitive function 
is rare (Houlihan et al., 2009). 
 
The first gene that was examined in the present study for effects on cognitive function was 
APOE. APOE ε4 has been associated with a faster age-related cognitive decline (Wilson et al., 
2002c), and ε2 a slower decline (Wilson et al., 2002a), when compared to ε3 homozygotes. 
However, cross-sectional differences are also found. After adjusting for sex and childhood IQ, 
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ε4 was associated with reduced, and ε2 increased, verbal episodic memory, when compared to 
ε3 homozygotes at age 79 years (Deary et al., 2004). At age 56 years, ε4 has also been related 
to slower performance on an executive function and processing speed measure (Ready et al., 
2011). Two meta analyses have identified converging results of impaired episodic memory, 
executive functioning, and overall global cognitive ability due to ε4 (Small et al., 2004; 
Wisdom et al., 2011). In line with such findings, it was hypothesised that APOE ε2 alleles are 
associated with better cognitive function and ε4 alleles are associated with worse cognitive 
function when compared to ε3 homozygotes. 
 
In the present investigation, no evidence was found to support premorbid effects of APOE on 
cognitive function. Here, variation in APOE genotype was not associated with performance in 
any of the assessed cognitive domains (episodic memory, working memory, executive 
function, language processing). However, this finding is not novel, as more recent data have 
refuted the notion that APOE exerts a specific non-pathological cognitive phenotype (Quintas 
et al., 2013). For instance, no baseline differences and only greater negative 3-year change in 
recognition memory for faces and words were found in an earlier investigation of 74 very old 
adults without dementia (Small et al., 1998). Another investigation found no APOE-related 
differences in cognitive function in multiple age groups: 20-24, 40-44, and 60-64 years (Jorm 
et al., 2007). One recent study found APOE ε4-related cognitive deficits when MCI and 
healthy controls were examined concurrently; however, when the 764 healthy controls were 
tested separately, no significant APOE effects were found (Foster et al., 2013). 
 
Overall, if variation in APOE is found to be associated with cognitive functions, it is likely 
that this is due to prodromal dementia. Support for this opinion is provided by the lack of 
significant APOE-related cognitive effects in investigations that implemented strict cognitive 
screening procedures (Foster et al., 2013). In the present study, all participants underwent 
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comprehensive screening before being invited to participate in the THBP and were excluded 
if they had a history of any condition independently associated with impairments to cognitive 
function. In addition, an experienced neuropsychologist reviewed performance on the Mattis 
Dementia Rating Scale-2 (DRS-2; Jurica et al., 2001), the Hospital Anxiety and Depression 
Scale (HADS; Zigmond & Snaith, 1983) and the Medical Health Status questionnaire 
(Summers et al., 2013) to determine participant inclusion. In this regard, the accidental 
inclusion of individuals with MCI into samples of otherwise healthy participants could lead to 
the detection of emerging prodromal AD attributable to the increased risk for AD associated 
with APOE ε4 (Verghese et al., 2011). 
 
The second gene that the present study investigated was BDNF. The Val66Met 
polymorphism, characterized by a Val to Met substitution at position 66 in the pro-domain of 
the gene (Mizuno et al., 2000), has been extensively researched for potential effects on adult 
cognitive function, with mixed results. However, due to previously reported associations 
between variation in BDNF Val66Met and cognitive functions, it was hypothesised that 
individuals that are BDNF Val homozygotes have superior cognitive function compared to 
Met carriers. For example, Met alleles were associated with poorer memory function within 
641 subjects tested on the Wechsler Memory Scale (Egan et al., 2003). In a smaller sample of 
64 subjects, Val homozygotes were significantly more accurate than Met carriers at 
recognising both ‘new’ and ‘old’ scenes during the retrieval phase of a declarative memory 
paradigm (Hariri et al., 2003). Even in a younger sample of 135 healthy individuals with a 
mean age of 24.6 years, Met carriers have displayed significantly lower working memory 
function (Richter-Schmidinger et al., 2010). In addition to BDNF effects on memory 
processing, Met alleles have also been associated with reduced speed of processing (Laing et 
al., 2011; Raz et al., 2009). 
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Despite evidence that supports the link between BDNF Met alleles and reduced performance 
on tests of cognitive function, the analysis from the present investigation failed to identify any 
effect of variation in BDNF Val66Met on cognitive function. In the present study, the BDNF 
Val homozygote group performed similarly to the BDNF Met carrier group in all four 
assessed cognitive domains. Again, this finding is not unusual, as others have also reported 
negative findings (Gong et al., 2012; Houlihan et al., 2009; Stuart et al., 2014). In 1,063 
Scottish individuals of mean age 70 years, variation in the polymorphism did not account for 
any of the variance in cognitive function variables (Houlihan et al., 2009). Similarly, in 700, 
19-21 year olds, BDNF Val66Met had no observable effects on either semantic or episodic 
memories (Gong et al., 2012). One recent meta-analysis of 23 publications encompassing 
7,095 subjects found no association of the polymorphism with any cognitive domain 
(Mandelman & Grigorenko, 2011). 
 
While the results of the present investigation did not support a role for BDNF Val66Met in 
memory function, it is widely accepted that the gene and, specifically, the polymorphism, 
critically alters the neural networks that support memory processing (Lu et al., 2013). In 
particular, the memory encoding process, which is dependent on the presence of BDNF in the 
hippocampus (Ying et al., 2002), may be disrupted due to the Met variant’s impaired activity-
dependent secretion of BDNF in hippocampal neurons (Egan et al., 2003). Met alleles are also 
associated with reduced hippocampal volume (Frodl et al., 2007; Kauppi et al., 2014), even in 
young adults (Pezawas et al., 2004), when compared to Val homozygotes. In addition, 
reduced activity in the medial temporal lobe and hippocampus during the encoding of 
information, indicative of subsequently forgotten memories (Eichenbaum et al., 2007), has 
been found in Met carriers (Kauppi et al., 2013; 2014). Such evidence strongly supports an 
association of BDNF Val66Met and memory function, and discrepancies in results are likely 
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due to the profound differences in the effects that variation in BDNF exerts across the lifespan 
(Casey et al., 2009). 
 
Interactive effects of APOE and BDNF on episodic memory 
 
As the detrimental cognitive effects of the putative negative alleles could combine to produce 
a larger decrease in cognitive function in carriers of both APOE ε4 and BDNF Met, a third 
hypothesis was proposed. Specifically, it was expected that the highest cognitive function 
would be observed in APOE ε2 and BDNF Val homozygote carriers and the lowest cognitive 
function in APOE ε4 and BDNF Met carriers. Previous investigations have examined 
interactions between APOE and BDNF Val66Met in terms of brain morphology and function 
(Adamczuk et al., 2013; Hashimoto et al., 2009; Kauppi et al., 2014; Richter-Schmidinger et 
al., 2010), with mixed results. Such reports underline the importance of investigating the 
cognitive consequences of variation in both genes concurrently. 
 
Partial support was found for the hypothesis of an APOE x BDNF interaction. For BDNF Met 
carriers, the expected beneficial and detrimental effects of APOE ε2 and ε4 alleles, with 
relation to APOE ε3 homozygotes, were found for episodic memory performance. For BDNF 
Val homozygotes, no differences were found for episodic memory due to APOE groups. In 
relation to the hypothesis, the lowest episodic memory was found to be associated with 
inheritance of both BDNF Met and APOE ε4, consistent with the hypothesis; but, 
unexpectedly, the highest episodic memory performance was associated with inheritance of 
BDNF Met and APOE ε2. That the lowest episodic memory function was found in BDNF 
Met/APOE ε4 can be attributed to an additive effect of both genetic variants. By comparison, 
the finding that the highest episodic memory function was found in BDNF Met/APOE ε2 is 
unable to be accounted for by an additive effect, as previous reports have implicated BDNF 
Met with reduced memory function across a range of age groups (Egan et al., 2003; Hariri et 
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al., 2003; Raz et al., 2009; Richter-Schmidinger et al., 2010). However, in the present study, 
the BDNF Met/APOE ε2 group comprised the lowest number of participants (N = 13), due to 
uncommon allele occurrence rates (Egan et al., 2003; Farrer et al., 1997). As a result, this 
result should be interpreted with caution, due to the high intra-group variance in the BDNF 
Met/APOE ε2 group. 
 
Interactions, both additive and non-additive, have been identified between APOE and BDNF 
Val66Met in previous work. In one investigation into hippocampal activation during a 
memory task in healthy older adults, decreased activation in the bilateral hippocampus and 
parahippocampus was identified as a function of the number of APOE ε4 and BDNF Met 
alleles (Kauppi et al., 2014). An additive effect meant that, in this study, the combined effect 
of both genes was stronger than either of the individual effects. Similarly, a study of the 
morphological changes associated with preclinical AD found that, in addition to the 
commonly occurring atrophy in the medial temporal areas, the presence of either APOE ε4 
and BDNF Met was associated with additional atrophy in the precuneus, and anterior and 
posterial cingulate cortices (Hashimoto et al., 2009). In cognitively normal older adults, 
individuals carrying BDNF Met have shown a higher amyloid load than individuals who are 
BDNF Val homozygotes, but only in the presence of the APOE ε4 allele (Adamczuk et al., 
2013). In this study, variation in BDNF Val66Met was not associated with amyloid load in 
APOE ε4 non-carriers. Furthermore, the authors identified a significant inverse relationship 
between amyloid load and episodic memory function, but only in the BDNF Met group/APOE 
ε4 group. 
 
The finding from the present investigation, that APOE-related variation in episodic memory 
function occurs only in the presence of a BDNF Met allele, appears novel but consistent with 
previous research. The present data likely reflect a combination of an interaction of APOE 
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and BDNF effects on medial temporal lobe activation (Kauppi et al., 2014), atrophy 
(Hashimoto et al., 2009), and amyloid load (Adamczuk et al., 2013), which culminate in 
differential cognitive outcomes. One of the most likely explanations involves the negative 
impact of amyloid load on healthy episodic memory function only in the presence of both 
BDNF Met and APOE ε4 alleles (Adamczuk et al., 2013). The presence of APOE ε2 is 
associated with reduced amyloid deposition and more efficient clearance (Castellano et al., 
2011; Suri et al., 2013; Tiraboschi et al., 2004), whereas APOE ε4 is associated with 
increased amyloid deposition and less efficient clearance (Castellano et al., 2011; Deane et 
al., 2008; Kok et al., 2009), when compared to APOE ε3 homozygotes. In the present study, 
BDNF Met may have conferred a vulnerability to the differential amyloid-related effects of 
variation in APOE. 
 
Cognitive reserve and premorbid cognitive function 
 
Evidence has consistently demonstrated that the clinical symptoms of AD can be delayed due 
to increased CR (Amieva et al., 2014; Brayne et al., 2010; Valenzuela & Sachdev, 2006); 
however, few investigations have examined the premorbid impact of CR on cognitive 
function. Such investigations are important to the CR theory, as a main conceptualisation of 
CR involves the presence of neural reserve in healthy adult brain networks (Stern, 2002; Stern 
et al., 2005). Stern (2002) noted a distinction between neural reserve, the ability to optimise 
non-pathological function, and neural compensation, the ability to recruit additional brain 
structures or networks to maximise function in the presence of pathology. Consequently, 
variation in CR should result in changes to performance in cognitive processing. A primary 
aim of this thesis was to quantify the premorbid associations between prior CR and cognitive 
function. 
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Multiple behavioural investigations have suggested that engagement in CR-building activities 
is associated with higher baseline cognitive function (Gottesman et al., 2014; Singh-Manoux 
et al., 2011; Zahodne et al., 2011), despite little to no protective effects of education on age-
related cognitive decline (Christensen et al., 2009; Van Dijk et al., 2008; Zahodne et al., 
2011). In addition, neuroimaging studies have identified morphological (Foubert-Samier et 
al., 2012; Liu et al., 2012; Suo et al., 2012) and neural (Lopez et al., 2014; Morbelli & Nobili, 
2014; Solé-Padullés et al., 2009) benefits associated with life experience in healthy 
individuals. As such, it was hypothesised that higher CR is associated with better premorbid 
cognitive performance. To test this hypothesis, a prior CR equation (developed in chapter 3) 
was used to compute an estimate of CR for each participant. This was subsequently regressed 
against age-adjusted composite cognitive domain variables (episodic memory, working 
memory, executive function, language processing), which were developed in chapter 4. 
 
In the present study, compelling evidence was found implicating CR in cognitive functioning 
in healthy older adults; the sample showed significant positive relationships between CR and 
cognitive function across all assessed cognitive domains, after accounting for the effects of 
age. This finding is consistent with previous literature that has reported that increased 
participation in cognitively stimulating activities is accompanied by better cognitive 
processing (Gottesman et al., 2014; Singh-Manoux et al., 2011; Zahodne et al., 2011). For 
instance, in a 20-year longitudinal analysis of 14,020 individuals, aged 48-67 years at 
baseline, higher education was associated with substantial persistent increases in global, 
episodic memory, processing speed, and language processing function (Gottesman et al., 
2014). Similarly, more education was related to increased function in a range of cognitive 
domains in 1,014 participants aged 54-95 years (Zahodne et al., 2011). Another study 
examined the 10-year effect of three markers of reserve (height, education, and occupation) 
on cognitive change in 7,454 individuals (Singh-Manoux et al., 2011). Although the authors 
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reported that reserve did not alter the rate of cognitive decline, they found that cognitive 
performance was remarkably higher in the high reserve groups. 
 
Whether the finding of a positive relationship between CR and healthy cognitive function is 
consistent with the neural implications of the CR theory (Stern, 2002), or simply a reflection 
of the cognitive benefits associated with living a mentally engaged lifestyle, remains 
unknown. Without functional neuroimaging data, it is not possible to test whether the 
relationship between CR and cognitive function is mediated by differences in neural 
efficiency, which would be consistent with CR theory (Stern et al., 2005). However, due to 
evidence reported by other groups, it is plausible that CR-related differences in neural 
network recruitment and efficiency are present in this dataset (Morbelli & Nobili, 2014). In 
this regard, functional MRI and PET investigations have identified altered patterns of neural 
activation associated with CR proxy variables (Barulli & Stern, 2013), even in younger adults 
(Stern et al., 2003). For example, in older adults with greater levels of education, it has been 
found that there is greater recruitment of the frontal cortex during performance on a memory 
task (Springer et al., 2005). Individuals with more years of education and occupational 
experience also show lowered functional connectivity during a memory task, indicative of 
more efficient networks, despite no difference in behavioural accuracy (Lopez et al., 2014). 
 
Another explanation for the increased cognitive function associated with more CR relates to 
possible morphological and pathological effects. Previous studies indicate that individuals 
with greater CR have larger regional cortical thickness in transverse temporal cortex, insula, 
and isthmus of cingulate cortex (Liu et al., 2012), more grey and white matter brain volumes 
(Foubert-Samier et al., 2012), better integrity of white matter tracts (Teipel et al., 2009), and 
less 3-year hippocampal atrophy (Valenzuela et al., 2008), when compared to those with less 
CR. More CR may also alter the rate at which AD pathology is accumulated (Jagust & 
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Mormino, 2011). For instance, higher levels of early- and mid-life engagement in cognitive 
activities is associated with a significantly reduced Aβ deposition in later life (Landau et al., 
2012). 
 
Genetic interactions with cognitive reserve 
 
Although the development of CR is mainly achieved through sustained participation in 
activities that involve complex cognitive engagement (Lövdén et al., 2010; Stern, 2002; 
2009), it is likely that genetic makeup impacts upon either the development or use of CR 
(Lee, 2003). This is assumed due to the large heritability of cognitive function in adult life 
(Bouchard & McGue, 1981; Plomin et al., 2013) and the significant impact that variation in 
genes can have on processes vital to CR, such as synaptic plasticity (Esiri & Chance, 2012). 
Two genes that show polymorphisms that impact upon both cognitive function and synaptic 
plasticity are APOE and BDNF Val66Met (Cheeran et al., 2008; Chen et al., 2010; Egan et al., 
2003; Levi et al., 2005). Consequently, an aim of the present study was to investigate the 
relationship between CR, cognitive function, and APOE and BDNF Val66Met 
polymorphisms. It was hypothesised that BDNF Val66Met and APOE polymorphisms 
independently moderate the association between CR and cognitive performance, with carriers 
of the putative detrimental alleles (Met and ε4, respectively) showing a reduced influence of 
CR when compared to non-carriers. 
 
To test this hypothesis, PROCESS (Hayes, 2013) was used to examine whether CR x APOE 
or CR x BDNF interaction terms explained significant variance in cognitive domain variables, 
after controlling for CR, age, and corresponding genetic main effects. The results indicate 
partial support for the hypothesis, as a significant CR x BDNF interaction was present for 
executive function. This result indicates that the relationship between CR and executive 
function was moderated by the BDNF Val66Met polymorphism, with a positive association 
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between the variables present in BDNF Val homozygotes and absent in BDNF Met carriers. 
However, no evidence was found to implicate variation in APOE in altering the relationship 
between CR and cognitive function. 
 
Although investigations that attempt to quantify the impact of genetic variation on CR are 
rare, some APOE-related interactions have been previously reported. In most of the cases, the 
basis for the CR x APOE interactions were that higher education seemed to reduce the 
increased risk of dementia associated with APOE ε4 (Ferrari et al., 2013; Shadlen et al., 2005; 
Wang et al., 2012). For example, a steeper 6-year age-related decline in cognitive function 
due to the presence of two APOE ε4 alleles was reduced due to greater education in 2,168 
non-demented elderly (Shadlen et al., 2005). Other studies have demonstrated a reduced 
association between CR and cognitive function in the presence of APOE ε4 (Runge et al., 
2014; Seeman et al., 2005), potentially due to the allele-specific impaired synaptic plasticity 
(Chen et al., 2010; Levi et al., 2005). For instance, cognitively stimulating lifestyle activities 
was found to impact on verbal fluency and semantic memory recall in APOE ε4 non-carriers 
but not in APOE ε4 carriers (Runge et al., 2014). In any case, the present study does not 
provide evidence of such associations. 
 
Surprisingly, few studies have examined the effect of variation in BDNF Val66Met on the 
relationship between CR and cognitive function, despite the clear and vital role the 
neurotrophin plays in many developmental processes and adult plasticity (Casey et al., 2009). 
However, it has been theorised that the increased neuronal plasticity associated with cognitive 
stimulation is mediated by the upregulation of BDNF (Stern, 2009; 2012). In this case, it 
follows that a polymorphism associated with reduced trafficking of BDNF into the regulated 
secretory pathway (Egan et al., 2003), leading to impairments in activity-dependent release of 
BDNF, may affect the association between lifetime cognitive activities and cognitive 
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function. In the present study, it was determined that the normal relationship between CR and 
executive function was present in BDNF Val homozygotes but absent in BDNF Met carriers. 
Such a result supports a role of BDNF in mediating the benefits associated with more CR, 
potentially due to reduced synaptic restructuring following participation in cognitively 
stimulating activities associated with inheritance of BDNF Met. 
 
The finding that BDNF Val66Met moderated the association between CR and executive 
function is particularly important, given the overlap between these constructs. Overall, both 
CR and executive function have an underlying reliance on cognitive flexibility (Miyake, 
2000; Stern, 2012) and a reliance on frontal lobe activity (Alvarez & Emory, 2006; Springer 
et al., 2005). For instance, although frontal activity was negatively related to education in 
young adults, frontal lobe activity was increased in highly educated older adults, potentially 
serving as an alternative network that may be engaged to aid cognitive function (Springer et 
al., 2005). One investigation examined whether CR was a distinct construct, separate from 
other cognitive domains, using structural equation modelling (Siedlecki et al., 2009). Here, 
the authors found evidence to suggest that CR was separate to other cognitive variables, but 
that CR was closely related to executive function. This may have been due to their approach 
to estimating CR, as only intellectual variables (reading ability, vocabulary, and years of 
education) comprised their model of CR, rather than variables of lifetime cognitive 
stimulation (e.g. occupation, leisure activities). Executive function is also clinically relevant, 
as reductions in executive function are found in response to ageing (Deary et al., 2009) and 
characterise early dementia onset (Silveri et al., 2007). 
 
Effects of BDNF on the frontal lobe, a structure vital to cognitive processes associated with 
executive function (Kane & Engle, 2002), may also account for the gene-CR interaction 
witnessed in the present study. BDNF is expressed in significant quantities within the 
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prefrontal cortex, with reduced levels of BDNF and trkB protein in this region occurring due 
to the presence of AD (Allen, Wilcock, & Dawbarn, 1999; Ferrer et al., 1999). Recent 
investigations have also found an effect of the Val66Met polymorphism on frontal 
functioning. For instance, inheritance of BDNF Met leads to impairments to NMDA and 
GABA receptor transmission and plasticity in the infralimbic medial prefrontal cortex 
(Pattwell et al., 2012). Met alleles are also associated with a higher resting-state functional 
connectivity between the anterior insular and the dorsolateral prefrontal corticies (Wang et al., 
2014). As lower resting-state metabolic activity in the default-mode network is present in 
individuals with higher CR (Bastin et al., 2012), the finding of Wang and colleagues may be 
explained through less efficient neural networks, indicative of lower CR (Morbelli & Nobili, 
2014; Stern, 2002), in Met carriers. 
 
Integration of results 
 
This thesis has identified a biological target for the basis of individual differences in cognitive 
resilience. Overall, the data presented in this thesis are consistent with the suggestion that 
inheritance of BDNF Met is associated with a vulnerability of cognitive function to 
pathology, probably through the genetic modulation of an individual’s CR. Although this 
hypothesis is yet to be tested, the results of the present investigation, in conjunction with 
previous literature, suggest that this may be the case. In order to support this theory, two 
criteria must be met. First, that BDNF Met is associated with a reduced influence of CR on 
cognitive function, when compared to BDNF Val homozygotes. Second, that BDNF Met is 
associated with a poorer cognitive outcome in the presence of neuropathology that CR is 
unable to buffer against, when compared to BDNF Val homozygotes.  
 
The first criterion, that BDNF Met is associated with a reduced influence of CR on cognitive 
function, was demonstrated in this study. It was shown that a multivariate estimate of prior 
! !!
!
153!
CR had a positive association with all four assessed cognitive domains. However, when the 
impact of BDNF Val66Met on this association was examined, it was found that BDNF Met 
carriers lacked an association between CR and executive function, whereas the association 
was preserved in BDNF Val homozygotes. One possible explanation for this finding is that 
the impaired synaptic plasticity associated with BDNF Met (Cheeran et al., 2008; Ninan et al., 
2010; Pattwell et al., 2012) led to a reduced neurological impact imparted due to participation 
in cognitively stimulating leisure activities. 
 
The second criterion, that BDNF Met is associated with a poorer cognitive outcome in the 
presence of neuropathology, indicative of low CR, when compared to BDNF Val 
homozygotes, has been demonstrated by previous recent research (Adamczuk et al., 2013; 
Lim et al., 2013; 2014). In 165 healthy adults enrolled in the Australian Imaging, Biomarkers 
and Lifestyle (AIBL) study, BDNF Val66Met was found to interact with amyloid load 
resulting in an alteration of cognitive function (Lim et al., 2013). In the AIBL study, 
individuals with high Aβ and BDNF Met showed moderate-to-large declines in episodic 
memory, executive function, and language processing when compared to Val homozygotes; 
in comparison, BDNF Val66Met did not alter rates of cognitive change in individuals with 
low Aβ. Similarly, another investigation of 34 adults with aMCI recruited from the AIBL 
study found that, in individuals with high Aβ, BDNF Met carriers had larger declines in 
episodic memory and hippocampal volume at three-year follow-up than non-carriers (Lim et 
al., 2014). In a different study of 64 cognitively intact older adults, a detrimental effect of 
amyloid burden on episodic memory function was present only in the participants who carried 
both APOE ε4 and BDNF Met alleles (Adamczuk et al., 2013). In these studies, inheritance of 
BDNF Met conferred a vulnerability of cognitive function to the detrimental effects of AD-
like pathology. 
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Overall, it may be that reduced functional CR is present in BDNF Met carriers, causing an 
inability to compensate for amyloid accumulation. This explanation accounts for the data that 
describe a poorer cognitive outcome associated with increased amyloid deposition only in the 
presence of BDNF Met (Adamczuk et al., 2013; Lim et al., 2013; 2014). It may also partially 
account for the finding of the present study that the lowest episodic memory function was 
present in APOE ε4/BDNF Met carriers: the increased rate of amyloid accumulation 
associated with APOE ε4, in conjunction with a reduced ability to compensate for pathology 
due to BDNF Met, culminates in reduced memory function.  
 
Limitations 
 
The present investigation possessed a number of limitations, which should be considered 
when interpreting the reported results. Although a model of prior CR comprised from only 
variables that were prospectively assessed would have been preferable, the LEQ and Medical 
Health Status questionnaire collected retrospective data. As such, the accuracy of the 
information that was obtained cannot be verified (Bernard et al., 1984) and the prior CR 
model may possess slight inaccuracies as a result. Another limitation of the prior CR estimate 
is that, even though the variables that were entered into the model were predominantly static, 
some variability in the items is expected. This is particularly the case for those participants 
who completed their baseline THBP assessment prior to being aged 65 years, as LEQ data for 
midlife subscales would have been incomplete. One of the limitations of the current CR 
model is that longitudinal changes in this measure may be particularly prone to reflecting 
change in CR due to exposure to education, but less likely to reflect change in CR due to 
participation in other cognitive activities, such as playing a music instrument or learning a 
second language. This is due to the current CR model comprising cognitive variables that 
assess mainly intelligence and academic ability. However, it must be noted that there are 
inherent significant barriers to quantifying and then developing reliable and valid objective 
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measures of lifestyle factors associated with lifetime cognitive stimulation (e.g. playing 
music, social conversation, learning a language, etc.). 
 
When evaluating the cognitive implications of variation in APOE and BDNF Val66Met 
polymorphisms, previous education and age were controlled for in the analysis; however, 
other covariates, such as physical activity and diet, were not. These covariates are particularly 
important when investigating BDNF, a gene that has shown associations with such lifetime 
variables in previous investigations. For instance, the secretion of BDNF in the hippocampus 
of mice is elevated after participation in voluntary exercise (Farmer et al., 2004) and the 
inhibition of BDNF action in the hippocampus has been shown to negate the cognitive and 
synaptic benefits of exercise (Vaynman et al., 2004). Overall, it has been suggested that 
BDNF signalling mediates the protective effects of diet and exercise on neurodegeneration 
(Mattson et al., 2004). In support of this notion, a recent investigation showed that the 
alleviation of diet-induced cognitive decline by exercise was likely due to the increase 
presence of BDNF in the hippocampus (Noble et al., 2014). Future investigations should 
control for diet and exercise when examining the effects of BDNF on cognitive or 
neurological function.    
 
The aforementioned limitations may have had slight impacts upon the accuracy or reliability 
of the respective investigations, but the strength of the findings in this thesis would have been 
considerably increased by the availability of a subgroup of dementia patients and longitudinal 
data. The compensatory effect of CR to delay clinical dementia is well documented (Stern, 
2013), and the inclusion of participants with symptoms of dementia to test and validate the 
two models of CR would have been a major benefit. If longitudinal data were available at the 
time of analysis, hypotheses could have examined whether the models of CR or variation in 
APOE or BDNF Val66Met predicted age-related change in cognitive function. The ability to 
! !!
!
156!
test whether BDNF Val66Met moderated the association of CR on the rate of age-related 
cognitive decline would have been advantageous. 
 
Overall, CR is a hypothetical construct that is mainly applied to samples experiencing 
traumatic brain injury or neurodegenerative disorders (Stern, 2002). In this investigation, the 
CR theory was examined in a sample of healthy, extensively screened, older adults. This may 
reduce the applicability of these results to less healthy samples, particularly those 
experiencing symptoms of dementia.  
 
Clinical implications 
 
In examining the association between prior CR and the four assessed cognitive domains in 
this study, positive correlations were identified for all cognitive processes. This indicates that 
a history of higher involvement in the lifetime factors that comprised prior CR is associated 
with better global cognitive ability. Previously, research has investigated whether higher CR 
protects from symptoms of dementia (e.g. Basu, 2012; Norton et al., 2012; Vemuri et al., 
2011), however, the results of this thesis imply that CR exerts an impact on healthy cognitive 
function, independent of dementia. This finding is consistent with longitudinal investigations 
that have shown higher baseline cognitive function associated with more years of education 
(Gottesman et al., 2014; Singh-Manoux et al., 2011; Zahodne et al., 2011). Due to the nature 
of the cross-sectional design used in the present thesis, there is no opportunity to examine 
whether CR exerts a protective effect on the rate, or time of onset, of age-related cognitive 
decline. However, previous research has found negative results in relation to the hypothesis 
that CR protects from normal age-related declines in cognitive function (Christensen et al., 
2009; Van Dijk et al., 2008; Zahodne et al., 2011). Regardless, these results indicate that, at 
the very least, CR may benefit cognition and delay dementia onset in older age due to the 
persistent effects of higher premorbid cognitive function. 
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A second clinical implication of the present data is that the effects of single genes on 
cognitive function are minimal and that previous positive associations of APOE (Boardman et 
al., 2012; Deary et al., 2004; Ready et al., 2011) or BDNF (Egan et al., 2003; Hariri et al., 
2003; Raz et al., 2009) are not easily replicable, even with a substantial sample size. 
Investigations into single genes are unlikely to produce translatable results; however, they can 
be used as preliminary investigations to identify potential targets for follow-up studies. 
Despite this, an APOE x BDNF interaction was identified in the present study, which 
accounted for 6% of the variance in episodic memory. If 50% of adult cognitive function is 
inherited (Bouchard & McGue, 1981), then potentially 12% of the genetically-determined 
episodic memory is accounted for by this interaction. This effect size is likely a result of the 
cumulative effects of APOE and BDNF polymorphisms on cognitive function and the notion 
of simple risk alleles that have clinical importance for healthy adult cognitive function is 
unlikely; particularly with consideration of the increased understanding of complex gene-
environment (Casey et al., 2009) and epigenetic (Egger et al., 2004) interactions. Overall, the 
results of the present investigation suggest that individuals who carry both APOE ε4 and 
BDNF Met alleles are at a higher risk for cognitive impairment and decline. 
 
Perhaps the most important and clinically relevant finding from the present study was the 
identification of a genetic moderator of the influence that CR has on cognitive functioning. 
Although previous reports have identified genetic interactions between APOE and CR (Ferrari 
et al., 2013; Runge et al., 2014; Shadlen et al., 2005; Wang et al., 2012), no evidence of such 
an effect was found in the present thesis. Rather, the data demonstrated a significantly 
different relationship between CR and executive function for BDNF Met carriers compared to 
that observed in BDNF Val homozygotes. This implies that, in healthy older adults, BDNF 
Met carriers have reduced cognitive benefit from participation in cognitively stimulating 
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activities. Moreover, highly educated BDNF Met carriers may not develop the additional 
neurological resources associated with more CR to the same extent as BDNF Val 
homozygotes, and may be at a similar risk of dementia to those Met carriers who have not 
engaged in such CR-related activities. 
  
Experimental design recommendations 
 
That an estimate of prior CR that combines multiple independent proxy variables was 
successfully developed in this study has implications for the CR theory. Previously, single 
indicators (e.g. education) have been used to represent an individual’s CR (Basu, 2012; 
Brayne et al., 2010; Meng & D'Arcy, 2012; Ott et al., 1995), but the results of the present 
thesis indicate that this may not be the best method. Indeed, an estimation of CR that takes 
into account several indicators may supply the researchers with a more precise estimate 
(Jones et al., 2011), particularly as the proxy variables of education, occupational attainment, 
and participation in leisure activities contribute differently and independently to CR (Foubert-
Samier et al., 2012). In future, a practical suggestion for research is that the multiple indicator 
method be implemented when examining the CR theory. Specifically, the principal 
components analysis method, rather than a true factor analysis, should be used to increase the 
likelihood of separate CR contributors contributing to the final model (Jones et al., 2011; Satz 
et al., 2011).  If authors fail to implement this method, they run the risk of interpreting a CR 
variable with reduced predictive power (Satz et al., 2011), potentially limiting the significance 
and interpretability of their results. 
 
While attempts have been made to better operationalise a model of pre-existing CR (Lojo-
Seoane et al., 2014; Reed et al., 2011; Valenzuela & Sachdev, 2007), very few attempts have 
been made at producing a reliable and valid measure of change in CR over time. CR is a 
dynamic construct that is continuously updated or developed by new life experiences across 
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the lifespan (Richards & Sacker, 2003). In addition, the importance of interventions that 
increase CR is well-known (Tucker & Stern, 2011), but the efficacy of such interventions is 
unknown until the onset of symptoms of dementia. It is of significance then, that an 
operational measure of CR was successfully generated in the present study. The measure of 
current CR was developed with consideration to those variables that closely approximate 
traditional measures of CR, but also have a documented potential to change due to new life 
experience (Donnell et al., 2007; Roid & Ledbetter, 2006). It is recommended that such a 
method be implemented into the design of clinical trials that aim to increase CR, to allow for 
an estimate of the intervention’s efficacy prior to dementia onset. 
 
Due to the identification of a moderating effect of BDNF Val66Met on the relationship 
between CR and cognitive function, it may be necessary to perform BDNF genotyping in 
research that aims to substantiate a clinical intervention or elucidate CR mechanisms. For 
instance, there is an abundance of randomised clinical trials whose intention is to demonstrate 
the efficacy of cognitive exercise on longitudinal cognitive performance in healthy older 
adults (Valenzuela & Sachdev, 2009). However, the findings of the present thesis imply that a 
commonly occurring genetic polymorphism in BDNF may influence the degree to which 
environmental exposure to cognitive stimulation results in changes to cognitive function. It is 
therefore recommended that BDNF Val66Met polymorphism data be specified in the 
statistical models of such research, otherwise important genetic interactions may be 
overlooked.  
 
Future research 
 
Although the present study has advanced our knowledge of how CR can be modelled, genetic 
influences on healthy cognitive function and a genetic basis for CR, there are some obvious 
unanswered questions. Many of these issues will be addressed in future THBP investigations. 
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The first key area that should be the target of future research is to validate the multiple 
indicator method of assessing prior CR. Although the method implemented in the current 
investigation was efficacious in constructing a composite estimate of CR, it is not yet known 
whether the predictive power of the prior CR model is higher than that of simply using a 
single indicator. One way of assessing this would be to conduct an analysis of longitudinal 
data to determine whether a multivariate approach or that of a single indicator accounts for a 
greater proportion of the variance in, immediately, age-related cognitive decline and, later, 
time of onset of dementia symptoms. Similarly, the model of current CR has been developed 
from theory, and is yet to be validated longitudinally. For this, it will be necessary to show a 
significant increase in current CR due to the education intervention, which, in turn, 
demonstrates a reduced risk of dementia. 
 
The second key area that future investigations should explore is the interaction between 
BDNF Val66Met and CR that was identified in the present study. Primarily, if the modulating 
effect of the polymorphism on CR could be demonstrated in a longitudinal design, it would 
reinforce the notion that BDNF is a biological pathway through which CR is mediated. Such 
findings would have to demonstrate that variation in the BDNF Val66Met polymorphism 
influences the protection conferred by proxy CR from the rate of age-related cognitive decline 
and/or risk for dementia. The testing of this hypothesis is a priority of the THBP, with the 
relevant analyses to be conducted as longitudinal data become available.   
 
Conclusion 
 
In conclusion, CR remains an imprecise concept that is difficult to define. Estimates of 
participation in cognitively stimulating activities act as proxy measures for CR (Stern, 2002; 
Valenzuela & Sachdev, 2006), but in vivo assessments of neurological functioning, for 
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example neural efficiency (Lopez et al., 2014; Morbelli & Nobili, 2014), have been proposed 
as alternative approximations of CR. In this regard, the results of the present thesis have 
provided data that further knowledge on how to operationalise and estimate CR before the 
onset of dementia symptoms. These results also depict the impact of environmental and 
genetic factors on the cognitive function of healthy older adults. Here, higher CR was 
associated with higher cognitive functioning in all cognitive domains – a clear demonstration 
of the premorbid cognitive benefits of CR-related proxy variables that has been reported in 
other work (Gottesman et al., 2014; Singh-Manoux et al., 2011; Zahodne et al., 2011). 
Similarly, an interaction between APOE and BDNF Val66Met polymorphisms, consistent 
with previous investigations into the genes (Adamczuk et al., 2013; Kauppi et al., 2014), 
accounted for a substantial proportion of the genetically-derived variance in episodic memory. 
However, the most novel finding that emerged from the present research was that of a partial 
‘disconnect’ between CR and cognitive function in approximately one third of the population 
who carry a BDNF Met allele. Future investigations should aim to verify CR’s involvement in 
normal ageing and elucidate the biological mechanisms underpinning the moderating effect of 
BDNF Val66Met on CR.  
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Abstract 
 
The concept of cognitive reserve (CR) has been proposed to account for observed 
discrepancies between pathology and its clinical manifestation. Hypothesized to reduce the 
consequences of both ageing-related and pathology-related cognitive changes in the elderly, 
CR is assumed to be a functional consequence of underlying differences in brain structure 
and function. We investigated whether common polymorphic variations in apolipoprotein E 
(APOE) or brain-derived neurotrophic factor (BDNF) influenced the association between 
cognitive reserve contributors and healthy executive function in older adults. We show that 
BDNF Val66Met moderates the association between cognitive reserve and cognitive 
function. Cognitive reserve accounted for 8.5% of the variance in executive function in 
BDNF Val homozygotes, but cognitive reserve was a non-significant predictor in BDNF Met 
carriers. APOE polymorphisms were not linked to the influence of cognitive reserve on 
cognitive function. This result implicates BDNF in playing an important role in capacity for 
building or accessing cognitive reserve.  
 
 
KEYWORDS: brain-derived neurotrophic factor; BDNF; executive function: cognitive 
reserve; moderation; aging 
  
Observations of significant heterogeneity in the clinical manifestation of underlying brain 
pathology gas led to the development of the concept of cognitive reserve (CR) 1. CR level is 
considered to be determined by both biological and environmental exposures, notably  
intelligence 2, education 3 and occupational attainment 4. Epidemiological evidence further 
supports the notion of CR by demonstrating consistent associations between lifestyle 
characterized by intellectual and social engagement and slower cognitive decline 5. In older 
persons, fMRI studies of neural networks suggest differences in functionally connected 
regions in persons with high CR may enhance the compensatory capacity of individuals in the 
face of both normal and pathological brain ageing 6. Alzheimer’s disease (AD) patients with 
higher educational and occupational attainment have more rapid cognitive decline that those 
with lower attainment, consistent with the idea that at a given common level of severity, 
underlying AD pathology is more advanced in patients with more CR 7. That individuals with 
higher CR display greater resistance to the effects of neuropathology is likely due to induced 
cortical plasticity caused by a prolonged mismatch between functional supply and task 
demands 8, resulting in more flexible and denser neural networks 9. As adult cognitive 
function and cognitive ageing show significant heritability 10, research examining the 
interaction between genes and CR proxies are justified. The most likely candidate genes for 
CR are those that interact with environmental factors to induce effects on cognitive functions 
11. 
 
One gene that potentially interacts with CR is apolipoprotein E (APOE). While it has been 
established that specific allelic variants in the APOE gene are associated with risk for late-
onset AD 12, it is less clear whether other allelic variants of the APOE gene impart healthy 
cognitive function 13, 14. However, APOE polymorphisms have been shown to exert divergent 
neuroprotective effects 15, 16. For example, the presence of APOE İ4 is associated with an 
increased rate of AD-related hippocampal atrophy 17, and impaired synaptic plasticity 18 when 
compared to APOE İ4 non-carriers. Lifestyle activities that require cognitive effort (e.g. 
completing puzzles, playing chess) predict verbal fluency and semantic memory recall in 
APOE İ4 non-carriers but not in carriers 19. 
 
A second gene that may be associated with CR is brain-derived neurotrophic factor (BDNF). 
The encoded neurotrophin is crucial to neuronal survival, maintenance, neurogenesis, and 
synaptic plasticity 20, 21. The BDNF Val66Met polymorphism affects activity-dependent 
secretion of BDNF, with the Met allele associated with reduced depolarization-induced 
BDNF release into the synapse 22. BDNF Met alleles have been associated with reduced 
memory capacity 22, but not consistently 14, 23. Like APOE, impaired synaptic plasticity is a 
feature of BDNF Met alleles 24, 25.     
 
Synaptic plasticity is a key mechanism that facilitates the development of CR 26. Research to 
date has examined CR in the presence of pathology; however, as CR is developmentally 
acquired through both intrinsic (biologic) factors such as genetic heritability as well as 
extrinsic (environmental) factors such as education, it is imperative to examine the 
development of CR prior to the onset of clinical symptomatology. We aimed to use baseline 
data from the Tasmanian Healthy Brain Project (THBP) 27 to investigate the relationship 
between CR, cognitive function, and APOE and BDNF Val66Met polymorphisms in healthy 
older adults (50-79 years). We tested two hypotheses. First, that higher CR is associated with 
better cognitive performance. Second, that BDNF Val66Met and APOE polymorphisms 
independently moderate the association between CR and cognitive performance, with carriers 
of the putative detrimental alleles (Met and İ4, respectively) showing a reduced influence of 
CR when compared to non-carriers. 
 [INSERT TABLE 1 HERE] 
 
 
Methods 
 
Participants  
The participants were 433 community-residing healthy older adults, aged 50-79 years, who 
were all native-English speakers or spoke English as a primary language. They had consented 
to participate in the THBP, which involves comprehensive annual assessments of 
neuropsychological, health, and psychosocial function. The THBP is a prospective 
longitudinal study examining whether late-life education provides protection from dementia 
through enhancement of cognitive reserve 27. Subjects were excluded from participating if 
they had a history of any condition independently associated with impairments to cognitive 
function (dementia; multiple sclerosis; previous significant head injury requiring 
hospitalization; epilepsy; history of cerebro-vascular complications; diabetes – poorly 
controlled; blood pressure complications – poorly controlled; other neurological disorders; 
chronic obstructive pulmonary disease; heart disease; blindness; deafness; psychiatric 
disorder). The THBP was conducted with full approval from the Tasmania Human Research 
Ethics Network and in accordance with the ethical guidelines of the National Health and 
Medical Research Council of Australia (NHMRC). 
 
Materials 
A comprehensive test battery was completed by subjects as described in detail elsewhere 27. 
Multiple objective measures were used to screen participants for: symptoms of dementia, 
clinically significant symptoms of depression or anxiety, general health, medical conditions, 
prescription medication use, drug and alcohol use, handedness, height, weight, marital status, 
educational and occupational history. 
 
Neuropsychological assessment battery  
Cognitive functions were assessed using tests that measured learning and memory, working 
memory, executive function, and language processing, and are described in detail elsewhere 
27. The test battery incorporated standardised neuropsychological measures with established 
reliability and validity in the measurement of: visual and verbal episodic memory, visual and 
verbal immediate memory span, visual and verbal working memory capacity, word 
knowledge, semantic memory recall, language comprehension, and multiple executive 
functions including attention, concentration, information processing speed, decision making 
capacity, and reaction time.   
 
Assessment of cognitive reserve 
To generate an estimate of CR, we used a previously developed equation to combine 
measures of lifetime education, occupational attainment, intelligence, and participation in 
cognitively stimulating leisure activities into a single variable 28. The Wechsler Test of Adult 
Reading (WTAR) 29 was used to estimate premorbid intellectual capacity, the Lifetime of 
Experiences Questionnaire (LEQ) 30 to quantify prior lifetime participation in cognitive 
activities, and the Medical Health Screening questionnaire to record the number of years of 
prior formal education 27.  
 
Genotyping  
DNA samples were collected with Oragene DNA self-collection kits (Genotek Inc., 2012). 
APOE and BDNF genotypes were determined through one-step amplified refractory mutation 
system polymerase chain reaction (ARMS-PCR) 31 and subsequent gel electrophoresis. For 
APOE, rs429358 and rs7412 were determined by following the method described by 
Donohoe, Salomaki 32. For BDNF, Val66Met was determined by following the method 
described by Sheikha, Hayden 33. PCR amplifications were undertaken in a 12 ȝl reaction 
volume that contained approximately 50 ng of genomic DNA. PCR amplicons were resolved 
on 2% agarose gel. Genotyping was repeated on samples to ensure accuracy. 
 
Procedure  
Trained assessors carried out the neuropsychological testing as part of the baseline THBP 
assessments 27. The assessment process took approximately four hours to complete and was 
undertaken in a quiet room. Subjects were encouraged to take 10-minute breaks when 
required to reduce fatigue.  
 
Data analysis  
Prior to the main analyses, variables of CR and cognitive function were generated. To 
represent CR, we used a previously developed equation to create a comprehensive single-
point measure of the construct 28. Standardised scores of CR variables (Table 1) were entered 
into the CR equation to yield total CR for each subject. Composite cognitive domain 
variables were also computed through a principal components analysis that combined 
measured variables (raw scores) into specific domains (episodic memory, working memory, 
executive function, language processing). The extracted factor that explained the highest 
proportion of variance was retained to represent each cognitive domain (Table 2). The APOE 
and BDNF predictor variables were coded as carriers or non-carriers of the detrimental allele, 
İ4 and Met, respectively. To assist in interpretation, subjects with the APOE İ2/İ4 
polymorphism were excluded from the analysis.  
 
The primary analyses used PROCESS v2.11 34 to test whether CR was associated with 
cognitive function, either independently or through CR x APOE/CR x BDNF interaction. 
PROCESS is a computational tool for path analysis-based moderation and mediation analysis 
that provides coefficient estimates for total, direct, and indirect effects of variables using OLS 
regression. Prior to analysis, the continuous independent predictor (CR) was mean-centered 
to reduce potential multicollinearity. Subsequent analyses involved testing for direct effects 
of predictors (CR, APOE, BDNF) and indirect effects of possible CR moderators (APOE, 
BDNF) on cognitive function domains while covarying for age. First, regression equations 
were fitted to cognitive domain data and the predictive capacity of age and CR were assessed. 
Second, APOE/BDNF data and corresponding CR-gene product variables were entered to test 
for CR moderation in separate models. An alpha value of .05 was used for all statistical tests 
and all data were analysed in SPSS v21. 
 
Results 
 
Participants 
 
The sample comprised 433 participants with a mean age of 62.16 years (SD = 6.81) and an 
above average estimated full-scale IQ (M = 112.47, SD = 5.52). Participants were mostly 
female (66.7%) and had completed an average of 13.97 (SD = 2.73) years of formal 
education. To assist in interpretation, 11 participants were excluded due to possessing the 
APOE İ2/İ4 genotype. The characteristics of the remaining participants are presented in 
Table 1. The APOE (Ȥ2(1, N = 422) = 0.02, p. = 0.90) and BDNF Val66Met (Ȥ2(1, N = 422) = 0.31, p. 
= 0.58) genotype distributions did not differ significantly from Hardy-Weinberg equilibrium. 
 
[INSERT TABLE 2 HERE] 
 
Cognitive reserve and age 
 
PROCESS was used to fit linear regression models to the cognitive domain data. With the 
age and CR predictors entered, significant models were produced for all assessed cognitive 
functions: episodic memory (F(2, 398) = 22.15, p < .01, R2 = .10); working memory (F(2, 398) = 
28.96, p < .01, R2 = .13); executive function (F(2, 394) = 52.88, p < .01, R2 = .21); and language 
processing (F(2, 412) = 34.15, p < .01, R2 = .14). The CR variable had a significant positive 
association with each cognitive domain (p < .05) while the age variable had a significant 
negative association with each cognitive domain (p < .01), excluding language processing (p 
= .62). The individual contribution that each predictor made to the model is detailed in Table 
3. 
 
Gene-cognitive reserve interactions 
 
We then assessed whether the inclusion of APOE/BDNF Val66Met allelic carrier data 
significantly improved the fit of the models. Notably, no significant main effects of genetic 
predictors, APOE or BDNF Val66Met, were identified for any cognitive domain. A 
moderation analysis (PROCESS) was then conducted examining whether the inclusion of CR 
x APOE or CR x BDNF interaction terms significantly improved the fit of regression models. 
Results indicated that a single genetically based moderation effect on CR was present (Table 
3). Specifically, inclusion of the CR x BDNF Val66Met interaction term led to a significant 
increase in the amount of variance in executive function explained by the model (ǻR2 = .01, p 
=.05). Simple slopes analysis was conducted in order to determine the basis of the 
moderation effect of BDNF polymorphism on the conditional effect between CR and 
executive function and tested whether the slopes statistically differed from zero for BDNF 
Met carriers and non-carriers, separately. These analyses indicate that a significant positive 
relationship between CR and executive function was identified in BDNF Val homozygotes (B 
= 0.13, t = 5.44, SE = 0.02, p < .01), but was not evident in BDNF Met carriers (B = 0.05, t = 
1.41, SE = 0.03, p = .16). In BDNF Val homozygotes, CR accounted for a significant 8.5% of 
variance in executive function performance. In BDNF Met carriers, CR accounted for a non-
significant 1.2% of variance in executive function performance. Simple slopes are presented 
in Figure 1.  
 
 
 
[INSERT FIGURE 1 HERE] 
 
 
 
Discussion 
 
The present study was designed to investigate whether a composite measure of CR was 
associated with healthy cognitive function, either independently or through an interaction 
with genetic APOE/BDNF Val66Met polymorphic data, in participants of the Tasmanian 
Healthy Brain Project. The first hypothesis, that higher CR is associated with better cognitive 
performance, was supported. Our sample showed significant positive relationships between 
CR and cognitive function across all cognitive domains, after accounting for the effects of 
age. The second hypothesis, that BDNF Met carriers and APOE İ4 carriers would display a 
lower relationship between CR and cognitive function when compared to their respective 
non-carriers, was partially supported. The analyses revealed a single significant CR x BDNF 
interaction in predicting age-adjusted executive function performance. In this regard, the 
relationship between CR and executive function was moderated by BDNF genotype, with a 
positive association between the variables present in BDNF Val homozygotes that was absent 
in BDNF Met carriers.  
 
CR is of interest due to its potential role in varying the age at which an individual develops 
dementia and the subsequent rate of dementia progression experienced 9, as well as mitigating 
against the effect of other CNS insults. However, while previous research frequently 
highlights the relationship between increased CR and reduced dementia incidence 35, other 
investigations have suggested that CR is also involved in non-pathological cognitive function. 
For instance, during a memory task, higher functional connectivity, indicative of heightened 
cognitive effort, is found in subjects with lower CR, despite achieving the same level of 
performance as those with higher CR 36. Similarly, CR was positively associated with brain 
volume but negatively associated with cortical activity during a visual encoding task 37. Such 
findings are consistent with the CR hypothesis, which posits that CR is implicated in non-
pathological cognitive function 1, particularly in relation to cerebral network efficiency 38. 
Our finding, that CR was positively associated with all four assessed cognitive domains, adds 
further evidence that CR accounts for healthy cognitive function and that cognitive 
associations with CR are not limited to protection from the clinical expression of pathological 
processes. At the very least, higher scores on CR proxy variables would result in a delayed 
onset of dementia due to the pre-existing cognitive advantage afforded to high CR individuals 
through greater education, occupational attainment, intelligence, and participation in 
cognitively stimulating lifestyle activities. In high CR individuals a greater loss of cognitive 
function, resulting from greater levels of neuropathology, would be required to produce 
functional deficits of sufficient severity to meet diagnostic criteria for dementia.  
 
A comprehensive review of the evidence for genetic contributions to CR noted that those 
genes that interact with environmental factors to produce a cognitive effect are the most 
likely candidates 11. In our study, we identified a significant moderating influence of BDNF 
Val66Met polymorphism on the relationship between CR and executive function. In those 
individuals who were BDNF Val homozygotes, a one point increase in CR was associated 
with a 0.13 point of increase in executive function. Comparatively, in those individuals who 
were BDNF Met carriers, a one point of increase in CR was associated with a non-significant 
0.05 point increase in executive function. This finding is of particular importance due to the 
overlap between CR and executive function 39. Both executive function and CR have an 
underlying reliance on cognitive flexibility 1, 40 and resources associated with frontal lobe 
activity 41, with a positive association of education and frontal engagement present in older 
adults that is not seen in younger adults 42. Clinical studies confirm that there is an age-
related decline in executive function 43, and that the onset of dementia is often characterised 
by early impairment of executive function 44. Overall, our findings indicate that while BDNF 
Val homozygotes show normal positive associations between CR and executive function, 
BDNF Met carriers have a reduced influence of CR on executive function.  
 
No CR-APOE interaction was found in the current study. Previous longitudinal investigations 
have reported interactions between APOE İ4 alleles, education, and the rate of age-related 
cognitive decline 45, 46. However, a recent study found an interaction of CR and APOE 
polymorphism in cross-sectional but not longitudinal data 19. This investigation found that 
verbal fluency and semantic memory recall performance was predicted by participation in 
cognitively stimulating lifestyle activities in APOE İ4 non-carriers but not in carriers 19. The 
discrepancy between our results and those of Runge, Small 19 may reflect differences in the 
method used to quantify lifetime cognitive stimulation. Runge, Small 19 assessed low (e.g. 
singing, traveling) and high (e.g. puzzles, viewing educational television) cognitive demand 
lifestyle activities, whereas we took into account a wider range of CR measures, including 
years of formal education and occupational attainment 28.    
 
One explanation for the significant moderation of CR by BDNF Val66Met lies within 
differences in biochemical responses to cognitively stimulating environments. Namely, 
individuals with BDNF Met alleles may receive a lesser impact on neurological function of 
exposure to environmental activities that contribute to CR, whereas, for Met non-carriers 
there is a greater beneficial effect of exposure to environmental activities on neurological 
function. Previous research has demonstrated that long-term exposure to cognitively 
stimulating environments is associated with a widespread increase in BDNF expression in the 
brain 47, but BDNF Met carriers have both reduced activity-dependent secretion of BDNF 22 
and impaired synaptic capacity for long term potentiation/depression 48. Consequently, for 
two individuals exposed to the same level of extrinsic environmental stimulation, the 
individual who carries the BDNF Met polymorphism exhibits reduced synaptic plasticity and 
neuronal restructuring subsequent to environmental stimulation and consequently displays 
lowered functional capacity due to the negative intrinsic effect of BDNF Met polymorphism 
on development of CR. Studies examining the influence of environmental enrichment (EE) in 
rodents report that EE only confers benefits in the presence of BDNF protein. For example, 
environment-induced hippocampal neurogenesis occurs only in the presence of BDNF 49 and 
upregulation of BDNF by stimulating environments promotes neural plasticity 50. Although 
EE in experimental animals and measures of CR in humans are unlikely to be analogous, a 
comprehensive review concluded that, as with human educational and occupational 
attainment, EE develops reserve that can be used to offset the impact of cortical lesions 51.  
 
The results of the present study have several implications. First, as higher CR was associated 
with higher overall cognitive function, CR exerts an impact on healthy cognitive function, 
independent of dementia. While the cross-sectional analyses employed in the present study 
do not allow comment on the relationship between CR and rate of age-related cognitive 
decline, the results indicate that, at the very least, CR may benefit cognitive function in older 
age due to the persistent effects of improved cognitive function. Second, the results of the 
present study demonstrate that a genetic factor moderates the effect that CR has on cognitive 
function. Specifically, BDNF Met carriers showed a reduced relationship between CR and 
executive function when compared to non-carriers. This result provides evidence that BDNF 
Met carriers have a partial ‘disconnect’ between CR and cognitive function, and future 
longitudinal analyses will examine whether BDNF Val66Met mediates environmentally 
generated protection from dementia. In relation to non-carriers, the identification of persons 
with very high resistance to the functional consequences of brain pathology may provide a 
cohort for the development of future epigenetic strategies to reduce dementia in the face of 
AD disease progression. 
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Table 1. Descriptive statistics for study population stratified by APOE and BDNF genotype 
  
Characteristic N APOE status 
 BDNF status 
İ4- İ4+ p. Met- Met+ p. 
Demographics        
    Age (years) 422 62.31 (6.83) 61.67 (6.69) .53 62.16 (6.85) 61.99 (6.68) .81 
    Gender (male/female %) 422 31.9/68.1 35.8/64.2  31.6/68.4 36.4/63.6  
    Genotype (%) 422 67.5 32.5  66.8 33.2  
Screening        
    DRS-2 AEMSS 422 11.93 (2.12) 12.16 (2.03) .56 12.04 (2.10) 11.93 (2.08) .61 
    HADS anxiety 421 5.21 (3.12) 5.35 (2.97) .39 5.35 (3.19) 5.07 (2.80) .38 
    HADS depression 421 2.36 (2.14) 2.58 (2.34) .24 2.42 (2.26) 2.45 (2.10) .91 
Cognitive reserve 28        
    WTAR Est. FSIQ 421 112.57 (5.39) 112.16 (5.94) .86 112.40 (5.49) 112.51 (5.76) .85 
    Prior education (years) 422 14.13 (2.81) 13.61 (2.59) .19 13.73 (2.72) 14.44 (2.75) .01 
    LEQ Young Adulthood 
Specific 
421 16.19 (7.93) 15.51 (7.65) .41 15.56 (7.61) 16.78 (8.25) .13 
    LEQ Young Adulthood 
Nonspecific 
421 24.71 (5.54) 24.93 (5.11) .19 24.42 (5.45) 25.52 (5.23) .05 
    LEQ Midlife Specific 420 19.07 (5.01) 19.06 (4.93) .45 19.09 (4.82) 19.02 (5.28) .90 
    LEQ Midlife Nonspecific 420 24.37 (5.55) 24.36 (5.60) .46 24.08 (5.72) 24.93 (5.20) .14 
    LEQ Continuing 
Education Bonus 
418 10.22 (8.79) 9.38 (8.01) .46 9.95 (8.45) 9.94 (8.75) .99 
Note: Data represented are mean values (SD) for continuous variables and proportions for categorical variable. 
DRS-2 = Dementia Rating Scale-2; AEMSS = Age- and education-corrected Mayo Older American normative 
Studies (MOANS) scaled score; HADS = Hospital Anxiety and Depression Scale; WTAR = Wechsler Test of 
Adult Reading; FSIQ = Full-scale IQ; LEQ = Lifetime of Experiences Questionnaire; İ4-/Met- = participants 
not carrying the APOE İ4/BDNF Met alleles; İ4+/Met+ = participants carrying at least one copy of the APOE 
İ4/BDNF Met alleles.        
 
 
Table 2. Factor analysis results for composite cognitive domain variables 
Cognitive domain Initial eigenvalue Variable N Mean SD Loading 
Episodic memory 2.50 (62.46%) RAVLT 1-5 total 407 52.96 8.92 .76 
LM I immediate recall total 407 48.43 8.07 .89 
LM II delayed recall total 407 30.29 6.28 .86 
PAL first trial memory score 407 18.35 3.46 .63 
Working memory 2.04 (50.93%) Digit span 407 18.63 3.90 .76 
 Letter-number sequencing 407 11.59 2.40 .79 
SWM between errors 407 25.36 18.64 -.63 
 SSP length 407 5.75 1.20 .66 
Executive 
function 
1.80 (59.83%) Stroop trial C 403 26.26 7.63 .76 
 RVP A’ 403 0.91 0.05 -.81 
TMT trial B 403 59.09 18.82 .75 
Language 
processing 
1.88 (62.81%) WAIS Vocabulary 421 56.62 6.23 .88 
 WAIS Comprehension 421 26.21 3.33 .77 
 Boston Naming Test 421 57.49 3.42 .72 
Note: Data in parentheses represent the proportion of variance (%) explained by the resulting factor. 
RAVLT = Rey Auditory Verbal Learning Test; LM = Logical Memory; SWM = Spatial Working Memory; 
SSP = Spatial Span; RVP = Rapid Visual Processing; TMT = Trail Making Test; WAIS = Wechsler Adult 
Intelligence Scale. 
Table 3. Results of the regression analyses for cognitive domain data 
Cognitive domain Predictor N B SE t p. R2 change F 
Episodic memory Age 401 -0.05 0.01 -6.51 < .01 
CR 401 0.04 0.02 2.01 .05 
APOE 401 -0.08 0.10 -0.84 .40 
BDNF 401 -0.03 0.10 -0.25 .80 
CR x APOE 401 -0.02 0.05 -0.35 .72 0.00 0.12 
CR x BDNF 401 -0.06 0.04 -1.41 .16 0.00 1.99 
Working memory Age 401 -0.05 0.01 -7.11 < .01 
CR 401 0.07 0.02 3.37 < .01 
APOE 401 0.07 0.10 0.70 .48 
BDNF 401 -0.11 0.10 -1.12 .26 
CR x APOE 401 0.04 0.04 0.99 .32 0.00 0.99 
CR x BDNF 401 0.04 0.04 0.99 .32 0.00 0.98 
Executive function Age 397 -0.06 0.01 -9.40 < .01 
CR 397 0.10 0.02 5.23 < .01 
APOE 397 0.12 0.10 1.25 .21 
BDNF 397 -0.02 0.10 -0.17 .86 
CR x APOE 397 0.02 0.04 0.40 .69 0.00 0.16 
CR x BDNF 397 -0.08 0.04 -1.98 .05 0.01 3.94 
Language processing Age 415 0.00 0.01 0.49 .62 
CR 415 0.16 0.02 8.15 < .01 
APOE 415 0.08 0.10 0.87 .38 
BDNF 415 -0.07 0.10 -0.69 .49 
CR x APOE 415 0.03 0.04 0.62 .54 0.00 0.38 
CR x BDNF 415 -0.05 0.04 -1.30 .19 0.00 1.70 
Note: Apolipoprotein E and Brain-derived neurotrophic factor main and interaction effects were 
tested in separate models. CR = cognitive reserve; APOE = Apolipoprotein E; BDNF = Brain-
derived neurotrophic factor. 
Figure 1. BDNF Val66Met moderates the relationship between cognitive reserve (CR) and executive 
function scores. Plot represents age-adjusted executive function performance as predicted by the 
composite CR proxy variable for those with low CR (CR scores less than the mean – 1 standard 
deviation) and high CR (CR scores greater than the mean + 1 standard deviation) for BDNF Met 
carriers and Val homozygotes, separately. 

